data_2lqj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.040000000000006 103.472 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.119999999999997 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.340000000000003 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.400000000000006 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.239999999999995 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.430000000000007 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.130000000000003 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.329999999999998 109.105 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.230000000000004 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.209999999999994 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.349999999999994 110.089 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 113.245 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.140000000000001 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.230000000000004 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.319999999999993 110.291 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.140000000000001 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.420000000000002 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.340000000000003 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.209999999999994 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.439999999999998 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.519999999999996 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.230000000000004 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.200000000000003 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.030000000000001 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.450000000000003 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.239999999999995 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.520000000000003 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.030000000000001 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.130000000000003 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.530000000000001 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.329999999999998 107.414 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.540000000000006 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.200000000000003 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.420000000000002 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 37.130000000000003 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.219999999999999 110.52 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.450000000000003 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.109999999999999 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.209999999999994 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.319999999999993 108.126 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.310000000000002 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.329999999999998 106.554 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.200000000000003 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.129999999999995 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.540000000000006 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.509999999999998 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.039999999999999 106.604 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.019999999999996 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.310000000000002 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.430000000000007 107.377 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 37.130000000000003 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.515 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 25.4 t-80 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.340000000000003 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.439999999999998 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.530000000000001 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.43 ' O ' HG21 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.140000000000001 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.140000000000001 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.040000000000006 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.219999999999999 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.129999999999995 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.329999999999998 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.439999999999998 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.400000000000006 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.409999999999997 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.010000000000005 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.340000000000003 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.420000000000002 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.549999999999997 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.340000000000003 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.299999999999997 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . 0.45 ' CD1' HG23 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.230000000000004 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.530000000000001 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.409999999999997 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.409999999999997 110.982 -175.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.319999999999993 106.36 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.349999999999994 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.010000000000005 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 74.510000000000005 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.020000000000003 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 75.239999999999995 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.540000000000006 111.079 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.020000000000003 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.109999999999999 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.010000000000005 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.420000000000002 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 63.140000000000001 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.219999999999999 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' HG21 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 75.239999999999995 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.120000000000005 111.584 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.299999999999997 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.319999999999993 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.040000000000006 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.420000000000002 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.150000000000006 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 62.43 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.349999999999994 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.239999999999995 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.329999999999998 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.120000000000005 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 74.140000000000001 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.140000000000001 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.319999999999993 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.329999999999998 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 62.240000000000002 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.010000000000005 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.425 HH11 ' CE1' ' A' ' 196' ' ' HIS . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.150000000000006 108.315 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.530000000000001 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.209999999999994 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.310000000000002 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.239999999999995 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.510000000000005 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.219999999999999 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.120000000000005 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.109999999999999 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.329999999999998 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 73.430000000000007 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.430000000000007 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 54.520000000000003 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 70.310000000000002 108.134 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.340000000000003 107.979 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.130000000000003 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CE1' HH11 ' A' ' 179' ' ' ARG . 3.7 t60 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 74.329999999999998 106.043 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.130000000000003 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.099999999999994 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.219999999999999 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.420000000000002 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.539999999999999 112.892 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 74.299999999999997 111.471 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.530000000000001 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 74.109999999999999 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.230000000000004 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.209999999999994 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.430000000000007 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.229999999999997 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.409999999999997 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.439999999999998 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.340000000000003 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.200000000000003 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.449 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.120000000000005 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.120000000000005 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.310000000000002 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.409999999999997 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 37.829999999999998 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.019999999999996 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.409999999999997 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 72.420000000000002 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.420000000000002 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 74.140000000000001 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 64.109999999999999 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.049999999999997 102.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.239999999999995 110.481 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.430000000000007 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.481 ' HH ' ' CG ' ' A' ' 202' ' ' HIS . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.510000000000005 107.488 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 35.8 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.349999999999994 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.409999999999997 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.319999999999993 109.023 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.519999999999996 109.597 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.319999999999993 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.030000000000001 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.229999999999997 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.310000000000002 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 38.009999999999998 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.519999999999996 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.400000000000006 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.540000000000006 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.403 HG11 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 75.010000000000005 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' HG22 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.239999999999995 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.420000000000002 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.340000000000003 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.129999999999995 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.329999999999998 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 73.400000000000006 111.682 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.340000000000003 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 74.209999999999994 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.416 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.129999999999995 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.150000000000006 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.319999999999993 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.409999999999997 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.329999999999998 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.219999999999999 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.329999999999998 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.150000000000006 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.549999999999997 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.439999999999998 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.340000000000003 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 65.030000000000001 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.310000000000002 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.240000000000002 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.040000000000006 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.439999999999998 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 71.409999999999997 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.420000000000002 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 38.009999999999998 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.239999999999995 108.099 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.129999999999995 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.349999999999994 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.230000000000004 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.310000000000002 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.621 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.140000000000001 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.039999999999999 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.329999999999998 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.621 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 75.129999999999995 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.450000000000003 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.040000000000006 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.310000000000002 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.416 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.120000000000005 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.340000000000003 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.409999999999997 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.209999999999994 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.403 HD21 HG11 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.519999999999996 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.100000000000001 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 51.450000000000003 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.439999999999998 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.230000000000004 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.109999999999999 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 74.219999999999999 110.67 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 75.540000000000006 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 55.210000000000001 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.349999999999994 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.229999999999997 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.010000000000005 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.409999999999997 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 61.039999999999999 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.049999999999997 109.975 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 104.467 -2.42 . . . . 75.129999999999995 104.467 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.120000000000005 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.409999999999997 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.040000000000006 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.239999999999995 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 74.420000000000002 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 74.230000000000004 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.540000000000006 110.226 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.439999999999998 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.239999999999995 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.010000000000005 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.010000000000005 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 74.420000000000002 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.010000000000005 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.430000000000007 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.450000000000003 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 73.299999999999997 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 52.020000000000003 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.510000000000005 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 73.25 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 74.450000000000003 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 64.430000000000007 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 74.099999999999994 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.414 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.109999999999999 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.469 ' OG1' HD12 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.420000000000002 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.329999999999998 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.310000000000002 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.430000000000007 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.420000000000002 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 52.539999999999999 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.109999999999999 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 75.109999999999999 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.009999999999998 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 74.040000000000006 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.494 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.310000000000002 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 72.439999999999998 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.129999999999995 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 70.340000000000003 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.099999999999994 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.219999999999999 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.239999999999995 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.477 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 70.319999999999993 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.140000000000001 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.229999999999997 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.439999999999998 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 72.109999999999999 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.439999999999998 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.494 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 64.420000000000002 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.409999999999997 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 179' ' ' ARG . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.129999999999995 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.009999999999998 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.120000000000005 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 37.539999999999999 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.150000000000006 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.450000000000003 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.549999999999997 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.400000000000006 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 74.329999999999998 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.349999999999994 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.040000000000006 109.195 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.109999999999999 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.414 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.340000000000003 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 75.140000000000001 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.449 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.439999999999998 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.049999999999997 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.310000000000002 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.019999999999996 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.209999999999994 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.319999999999993 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 73.319999999999993 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 64.299999999999997 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.439999999999998 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 72.239999999999995 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.540000000000006 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.230000000000004 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.239999999999995 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.519999999999996 110.28 -177.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 108.26 -1.015 . . . . 71.439999999999998 108.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.430000000000007 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.400000000000006 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.310000000000002 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.310000000000002 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.400000000000006 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.240000000000002 110.318 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.409999999999997 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.519999999999996 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.150000000000006 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 62.509999999999998 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.530000000000001 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.109999999999999 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.430000000000007 111.118 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.120000000000005 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.450000000000003 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.409999999999997 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.200000000000003 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.049999999999997 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.129999999999995 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.530000000000001 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.129999999999995 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 63.43 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.129999999999995 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.430000000000007 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.129999999999995 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.450000000000003 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.229999999999997 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.420000000000002 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.438 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.019999999999996 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.129999999999995 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.409999999999997 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.049999999999997 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.219999999999999 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.119999999999997 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.010000000000005 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 74.340000000000003 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.140000000000001 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.299999999999997 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.530000000000001 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.030000000000001 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.219999999999999 109.694 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 74.219999999999999 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.219999999999999 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.319999999999993 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.109999999999999 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.439999999999998 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.310000000000002 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.129999999999995 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.530000000000001 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.319999999999993 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 74.219999999999999 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.399999999999999 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.340000000000003 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.039999999999999 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.510000000000005 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 72.140000000000001 109.381 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.430000000000007 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.399999999999999 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.329999999999998 110.636 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.299999999999997 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 73.510000000000005 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.549999999999997 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 72.540000000000006 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.488 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 73.420000000000002 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.540000000000006 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.540000000000006 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.540000000000006 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.140000000000001 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.439999999999998 110.025 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.120000000000005 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.120000000000005 106.992 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.340000000000003 107.196 170.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.219999999999999 113.084 -169.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.340000000000003 106.604 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.683 HE21 ' N ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.140000000000001 109.156 -177.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.049999999999997 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.430000000000007 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.129999999999995 107.627 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.130000000000003 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.430000000000007 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.140000000000001 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.239999999999995 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.340000000000003 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.319999999999993 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.239999999999995 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 54.200000000000003 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 74.310000000000002 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 64.230000000000004 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.409999999999997 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.219999999999999 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.340000000000003 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.329999999999998 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.009999999999998 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.540000000000006 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 72.010000000000005 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.010000000000005 111.723 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.519999999999996 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.340000000000003 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.415 ' OG1' HD22 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.209999999999994 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.039999999999999 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.409999999999997 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.439999999999998 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.019999999999996 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.549999999999997 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.430000000000007 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.415 HD22 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.229999999999997 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 74.019999999999996 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.409999999999997 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.310000000000002 108.421 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 65.230000000000004 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.409999999999997 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.200000000000003 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.430000000000007 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.400000000000006 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.150000000000006 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.329999999999998 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.502 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.109999999999999 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 75.439999999999998 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 74.120000000000005 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.420000000000002 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 74.310000000000002 107.556 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.240000000000002 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.530000000000001 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.129999999999995 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.530000000000001 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.44 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.409999999999997 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.099999999999994 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 65.209999999999994 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 62.310000000000002 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.409999999999997 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 73.420000000000002 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.423 ' HA ' HG23 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.230000000000004 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.209999999999994 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 74.0 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.109999999999999 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.430000000000007 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.239999999999995 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.230000000000004 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.200000000000003 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.319999999999993 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.340000000000003 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.219999999999999 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.310000000000002 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.439999999999998 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 54.32 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.510000000000005 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.439999999999998 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.549999999999997 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.450000000000003 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.140000000000001 111.763 -177.494 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 71.219999999999999 104.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.240000000000002 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 62.329999999999998 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 73.310000000000002 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.200000000000003 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.310000000000002 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 75.430000000000007 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.349999999999994 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.239999999999995 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.129999999999995 114.19 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.420000000000002 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.130000000000003 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 164' ' ' ARG . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.310000000000002 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 73.409999999999997 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 72.109999999999999 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.109999999999999 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 160' ' ' GLU . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.099999999999994 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.210000000000001 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.409999999999997 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.230000000000004 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.530000000000001 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.450000000000003 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.430000000000007 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.230000000000004 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.340000000000003 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.310000000000002 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.540000000000006 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.030000000000001 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.329999999999998 108.364 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.150000000000006 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.409999999999997 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 72.439999999999998 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.409999999999997 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 62.130000000000003 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.239999999999995 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.130000000000003 111.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.319999999999993 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.329999999999998 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.530000000000001 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.129999999999995 108.071 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.240000000000002 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.219999999999999 105.366 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 73.319999999999993 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 193' ' ' LEU . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.129999999999995 107.728 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.150000000000006 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 71.150000000000006 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.510000000000005 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.040000000000006 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.109999999999999 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.329999999999998 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.219999999999999 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 54.420000000000002 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.239999999999995 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.319999999999993 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.130000000000003 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 72.450000000000003 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.319999999999993 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.450000000000003 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.340000000000003 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.219999999999999 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.229999999999997 109.674 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 63.149999999999999 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.349999999999994 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.340000000000003 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.010000000000005 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.340000000000003 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.310000000000002 110.05 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.420000000000002 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.340000000000003 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.319999999999993 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.420000000000002 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.150000000000006 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.540000000000006 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 54.130000000000003 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.329999999999998 103.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.349999999999994 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.530000000000001 111.969 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.423 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.409999999999997 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.209999999999994 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.240000000000002 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 61.140000000000001 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.130000000000003 110.76 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.009999999999998 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.519999999999996 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.219999999999999 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.109999999999999 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.549999999999997 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.109999999999999 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.019999999999996 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.239999999999995 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.530000000000001 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.150000000000006 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.530000000000001 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.150000000000006 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.209999999999994 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.200000000000003 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.530000000000001 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.349999999999994 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 63.340000000000003 107.772 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.109999999999999 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.319999999999993 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.319999999999993 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.510000000000005 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 74.439999999999998 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.119999999999997 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.120000000000005 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.150000000000006 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.420000000000002 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.465 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.539999999999999 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.209999999999994 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.219999999999999 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.409999999999997 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 72.010000000000005 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.439999999999998 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.230000000000004 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 71.129999999999995 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 64.530000000000001 108.185 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.439999999999998 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.329999999999998 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.423 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.6 t-80 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.210000000000001 109.289 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 75.299999999999997 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.319999999999993 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.230000000000004 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.406 ' O ' HD11 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.299999999999997 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 72.099999999999994 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.219999999999999 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.239999999999995 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 73.340000000000003 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.109999999999999 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.310000000000002 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.030000000000001 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 73.319999999999993 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.329999999999998 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.399999999999999 110.936 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.109999999999999 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.209999999999994 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 70.019999999999996 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.230000000000004 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.340000000000003 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.310000000000002 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.439999999999998 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.239999999999995 111.141 179.174 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 64.420000000000002 105.26 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.129999999999995 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.299999999999997 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.099999999999994 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.129999999999995 107.326 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.219999999999999 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.219999999999999 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.329999999999998 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.009999999999998 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.230000000000004 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.450000000000003 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.349999999999994 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.219999999999999 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.329999999999998 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.140000000000001 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.409999999999997 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 167' ' ' ILE . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.209999999999994 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 63.43 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.030000000000001 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.420000000000002 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.540000000000006 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.310000000000002 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.200000000000003 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.109999999999999 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 74.549999999999997 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.010000000000005 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.439999999999998 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.430000000000007 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 72.409999999999997 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.409999999999997 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.549999999999997 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.210000000000001 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.549999999999997 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.530000000000001 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.040000000000006 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.340000000000003 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.400000000000006 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.350000000000001 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.140000000000001 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.430000000000007 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.049999999999997 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 70.200000000000003 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.140000000000001 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.340000000000003 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.299999999999997 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.340000000000003 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.299999999999997 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.430000000000007 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.530000000000001 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.310000000000002 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.230000000000004 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 62.439999999999998 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.120000000000005 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.589 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.310000000000002 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.349999999999994 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.439999999999998 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.109999999999999 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.299999999999997 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 71.230000000000004 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 74.409999999999997 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.340000000000003 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.530000000000001 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.299999999999997 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.219999999999999 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 220' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.109999999999999 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.099999999999994 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.120000000000005 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.519999999999996 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.209999999999994 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.219999999999999 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.119999999999997 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.040000000000006 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.049999999999997 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.519999999999996 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.450000000000003 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.049999999999997 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.409999999999997 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.120000000000005 110.351 -179.039 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.239999999999995 103.665 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.129999999999995 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.329999999999998 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.329999999999998 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.310000000000002 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.150000000000006 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.219999999999999 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.400000000000006 111.01 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.399999999999999 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 62.32 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.510000000000005 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.240000000000002 115.297 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.129999999999995 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.299999999999997 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.340000000000003 111.267 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.120000000000005 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 71.140000000000001 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.200000000000003 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.200000000000003 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.219999999999999 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.329999999999998 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.239999999999995 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.310000000000002 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 73.349999999999994 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.439999999999998 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.109999999999999 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.509999999999998 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.120000000000005 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.010000000000005 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.420000000000002 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 73.109999999999999 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.010000000000005 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.439999999999998 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.340000000000003 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.329999999999998 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.230000000000004 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 72.319999999999993 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.209999999999994 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 72.450000000000003 113.23 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.444 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.420000000000002 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.409999999999997 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.519999999999996 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.310000000000002 109.754 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.040000000000006 111.928 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.439999999999998 107.924 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 73.25 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.450000000000003 107.594 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 73.219999999999999 106.851 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.530000000000001 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 75.109999999999999 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.510000000000005 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 70.25 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.539999999999999 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.399999999999999 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.120000000000005 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.409999999999997 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.140000000000001 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.230000000000004 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.340000000000003 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.340000000000003 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.310000000000002 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.319999999999993 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.030000000000001 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.439999999999998 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.040000000000006 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.422 ' HA ' HG13 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.510000000000005 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 70.409999999999997 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.120000000000005 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.420000000000002 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.230000000000004 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.409999999999997 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 73.519999999999996 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.219999999999999 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.319999999999993 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.209999999999994 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.530000000000001 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.409999999999997 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 37.399999999999999 111.381 -177.45 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.430000000000007 104.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.430000000000007 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.040000000000006 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.349999999999994 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.310000000000002 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.040000000000006 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.519999999999996 110.774 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 74.310000000000002 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 75.349999999999994 108.836 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.430000000000007 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.450000000000003 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.150000000000006 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.310000000000002 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.200000000000003 111.39 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.100000000000001 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 74.329999999999998 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.120000000000005 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 110.366 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.229999999999997 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.319999999999993 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.400000000000006 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.109999999999999 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.400000000000006 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 73.340000000000003 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.409999999999997 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 75.25 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.412 HD21 HD23 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 62.25 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.430000000000007 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.299999999999997 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 75.109999999999999 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.310000000000002 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.329999999999998 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 74.219999999999999 108.514 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.030000000000001 111.321 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.219999999999999 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 73.349999999999994 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.240000000000002 113.053 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.420000000000002 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.430000000000007 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.230000000000004 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.230000000000004 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 74.030000000000001 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.450000000000003 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.010000000000005 106.392 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.150000000000006 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.319999999999993 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.239999999999995 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.150000000000006 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.450000000000003 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.430000000000007 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.510000000000005 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 75.120000000000005 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.030000000000001 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 74.239999999999995 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.099999999999994 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.540000000000006 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.409999999999997 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.340000000000003 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.030000000000001 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.310000000000002 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 73.049999999999997 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.329999999999998 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.120000000000005 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.435 HD22 ' NE2' ' A' ' 217' ' ' GLN . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 109.273 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.442 ' HA ' HG13 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.239999999999995 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.510000000000005 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.435 ' NE2' HD22 ' A' ' 214' ' ' LEU . 45.5 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.540000000000006 109.62 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.430000000000007 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.329999999999998 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.399999999999999 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.400000000000006 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 211' ' ' VAL . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.120000000000005 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.129999999999995 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 75.409999999999997 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.430000000000007 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.219999999999999 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . . . . . . 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.210000000000001 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.010000000000005 104.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.209999999999994 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.149999999999999 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.519999999999996 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.399999999999999 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.109999999999999 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.450000000000003 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.319999999999993 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.140000000000001 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 54.219999999999999 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.310000000000002 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.129999999999995 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.229999999999997 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.099999999999994 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 71.230000000000004 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.140000000000001 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.549999999999997 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 70.540000000000006 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.540000000000006 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 73.209999999999994 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 61.32 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.109999999999999 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.150000000000006 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.539999999999999 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.229999999999997 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.510000000000005 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.310000000000002 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.010000000000005 111.574 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.010000000000005 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 36.609999999999999 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 74.349999999999994 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.150000000000006 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.520000000000003 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.420000000000002 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.47 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.010000000000005 111.533 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.350000000000001 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.209999999999994 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 74.230000000000004 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.512 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 71.129999999999995 112.65 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.219999999999999 106.629 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.219999999999999 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.200000000000003 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.329999999999998 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.210000000000001 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.219999999999999 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.310000000000002 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.430000000000007 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.539999999999999 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.319999999999993 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.140000000000001 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.450000000000003 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.450000000000003 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.230000000000004 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.010000000000005 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.430000000000007 110.675 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.200000000000003 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.209999999999994 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 75.299999999999997 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.450000000000003 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.455 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.200000000000003 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.455 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 65.219999999999999 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.430000000000007 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 74.150000000000006 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.100000000000001 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 62.439999999999998 110.705 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.129999999999995 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 75.010000000000005 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.43 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.340000000000003 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.120000000000005 109.816 -173.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 64.209999999999994 103.289 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.030000000000001 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.400000000000006 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.299999999999997 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.349999999999994 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 52.509999999999998 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.329999999999998 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.209999999999994 109.836 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 HD21 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.140000000000001 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.340000000000003 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.319999999999993 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.519999999999996 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.120000000000005 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.350000000000001 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.219999999999999 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.430000000000007 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.109999999999999 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.409999999999997 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 37.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.450000000000003 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.399999999999999 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.310000000000002 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.140000000000001 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.409999999999997 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.42 ' OG1' HD13 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 75.540000000000006 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.409999999999997 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.129999999999995 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.439999999999998 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.340000000000003 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.549999999999997 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 74.230000000000004 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.42 HD13 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.530000000000001 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.409999999999997 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.310000000000002 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.530000000000001 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.420000000000002 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 73.129999999999995 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.420000000000002 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 64.150000000000006 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.219999999999999 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.109999999999999 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.409999999999997 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.329999999999998 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.491 HD21 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.430000000000007 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.530000000000001 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.150000000000006 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.229999999999997 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.099999999999994 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.349999999999994 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 75.019999999999996 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 73.200000000000003 107.76 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 62.310000000000002 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.120000000000005 109.123 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.530000000000001 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.399999999999999 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 72.099999999999994 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.530000000000001 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.119999999999997 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.010000000000005 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.109999999999999 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 73.129999999999995 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.219999999999999 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.409999999999997 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 70.409999999999997 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 64.109999999999999 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.230000000000004 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.310000000000002 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 51.210000000000001 110.977 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.140000000000001 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.420000000000002 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.409999999999997 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.310000000000002 110.077 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 75.450000000000003 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.109999999999999 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.409999999999997 108.755 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 75.519999999999996 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.230000000000004 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.219999999999999 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.310000000000002 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.439999999999998 114.531 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.349999999999994 105.257 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.409999999999997 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.140000000000001 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.329999999999998 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.310000000000002 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 53.350000000000001 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.209999999999994 110.143 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.030000000000001 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.457 HD13 HD21 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.239999999999995 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.420000000000002 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.239999999999995 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.549999999999997 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.340000000000003 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.49 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.340000000000003 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.340000000000003 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.030000000000001 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.049999999999997 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.340000000000003 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 74.519999999999996 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.120000000000005 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.109999999999999 112.227 -176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.120000000000005 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.439999999999998 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.329999999999998 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.450000000000003 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.414 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.120000000000005 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.310000000000002 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.400000000000006 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.400000000000006 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.439999999999998 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.519999999999996 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.209999999999994 108.357 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.539999999999999 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.420000000000002 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.401 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.219999999999999 112.219 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.130000000000003 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.200000000000003 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.492 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 75.510000000000005 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 72.430000000000007 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.130000000000003 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 74.239999999999995 109.09 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.319999999999993 108.509 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.209999999999994 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.400000000000006 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 73.329999999999998 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.230000000000004 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.414 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.229999999999997 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.299999999999997 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 38.5 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.540000000000006 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.420000000000002 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 74.030000000000001 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.299999999999997 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.439999999999998 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.439999999999998 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.310000000000002 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.040000000000006 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.329999999999998 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.400000000000006 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.476 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.200000000000003 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.230000000000004 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.495 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.510000000000005 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.329999999999998 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.349999999999994 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.329999999999998 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.439999999999998 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.409999999999997 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 64.340000000000003 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 73.129999999999995 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.239999999999995 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.430000000000007 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.230000000000004 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.349999999999994 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.020000000000003 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.409999999999997 109.896 -173.121 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.509999999999998 105.427 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.439999999999998 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.430000000000007 109.159 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.299999999999997 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.219999999999999 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.140000000000001 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.230000000000004 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.119999999999997 109.031 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.520000000000003 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.140000000000001 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.239999999999995 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.439999999999998 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.439999999999998 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.219999999999999 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 61.350000000000001 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.520000000000003 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.434 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.409999999999997 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.049999999999997 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.409999999999997 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.239999999999995 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.540000000000006 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.400000000000006 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.129999999999995 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.310000000000002 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.409999999999997 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.120000000000005 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.299999999999997 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.209999999999994 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 172' ' ' SER . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.200000000000003 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.030000000000001 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.5 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.329999999999998 108.595 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.409999999999997 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.239999999999995 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.429 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.400000000000006 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.310000000000002 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.119999999999997 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.340000000000003 111.111 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.545 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 62.439999999999998 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.340000000000003 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.209999999999994 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.120000000000005 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.545 ' ND2' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.530000000000001 107.624 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.230000000000004 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.519999999999996 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.310000000000002 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.319999999999993 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.510000000000005 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 74.129999999999995 107.094 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.420000000000002 109.771 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.209999999999994 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . 0.419 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.8 t-160 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.439999999999998 108.877 -176.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.200000000000003 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.039999999999999 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.439999999999998 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.540000000000006 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.439999999999998 109.261 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.420000000000002 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.030000000000001 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 71.310000000000002 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.430000000000007 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.150000000000006 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.130000000000003 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.239999999999995 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.200000000000003 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.109999999999999 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 38.420000000000002 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 72.239999999999995 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.519999999999996 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.420000000000002 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.019999999999996 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.200000000000003 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.120000000000005 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.439999999999998 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.319999999999993 112.061 178.582 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.714 0.292 . . . . 50.539999999999999 111.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -92.24 157.94 16.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.745 -0.835 . . . . 74.340000000000003 108.745 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -115.3 93.87 4.48 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.957 0.408 . . . . 73.120000000000005 110.455 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.0 28.05 6.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 124.595 2.141 . . . . 44.25 106.957 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.89 0.79 4.55 Favored Glycine 0 C--N 1.269 -3.148 0 CA-C-N 111.714 -2.494 . . . . 65.409999999999997 110.446 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp -135.19 102.47 5.19 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.040000000000006 103.472 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.119999999999997 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.340000000000003 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.400000000000006 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.239999999999995 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.430000000000007 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.130000000000003 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.329999999999998 109.105 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.230000000000004 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.209999999999994 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.349999999999994 110.089 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 113.245 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.140000000000001 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.499 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.230000000000004 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.319999999999993 110.291 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.140000000000001 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.499 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.420000000000002 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.340000000000003 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.209999999999994 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.439999999999998 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.519999999999996 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.230000000000004 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.200000000000003 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.030000000000001 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.450000000000003 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.239999999999995 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.520000000000003 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.030000000000001 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.130000000000003 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.530000000000001 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.329999999999998 107.414 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.540000000000006 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.200000000000003 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.420000000000002 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 37.130000000000003 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.219999999999999 110.52 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.450000000000003 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.109999999999999 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.209999999999994 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.319999999999993 108.126 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.310000000000002 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.329999999999998 106.554 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.200000000000003 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.129999999999995 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.540000000000006 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.509999999999998 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.039999999999999 106.604 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.019999999999996 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.310000000000002 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.430000000000007 107.377 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 37.130000000000003 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.515 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 25.4 t-80 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.340000000000003 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.439999999999998 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.530000000000001 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.415 ' HB3' HD22 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.43 ' O ' HG21 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.140000000000001 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.140000000000001 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.040000000000006 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.219999999999999 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.129999999999995 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.329999999999998 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.439999999999998 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.400000000000006 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.409999999999997 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.010000000000005 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.340000000000003 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.420000000000002 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.549999999999997 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.340000000000003 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.299999999999997 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . 0.45 ' CD1' HG23 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.230000000000004 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.530000000000001 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.409999999999997 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.28 117.44 3.34 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.409999999999997 110.982 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -64.85 -40.09 94.6 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.889 1.276 . . . . 70.0 110.818 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -94.35 14.14 21.42 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.038 -0.983 . . . . 75.430000000000007 109.584 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 58.51 67.18 0.97 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.001 -0.999 . . . . 42.130000000000003 109.517 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.04 92.6 7.42 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.575 -1.193 . . . . 63.350000000000001 110.388 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -95.94 90.24 5.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.555 -1.646 . . . . 70.340000000000003 106.555 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.859 -0.609 . . . . 75.430000000000007 111.262 -175.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.052 -1.092 . . . . 73.019999999999996 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.32 144.43 34.59 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.892 -0.323 . . . . 74.299999999999997 110.436 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . 0.264 3.2 m-20 58.29 54.86 5.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 114.94 1.459 . . . . 73.140000000000001 114.94 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.14 69.75 9.94 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.491 -0.777 . . . . 64.430000000000007 109.174 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.82 -48.36 0.03 OUTLIER Glycine 0 C--N 1.287 -2.182 0 N-CA-C 109.016 -1.634 . . . . 61.020000000000003 109.016 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.41 156.05 16.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.319999999999993 106.36 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.349999999999994 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.010000000000005 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 74.510000000000005 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.020000000000003 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 75.239999999999995 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.540000000000006 111.079 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.020000000000003 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.109999999999999 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.010000000000005 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.420000000000002 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 63.140000000000001 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.219999999999999 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' O ' HG21 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 75.239999999999995 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.120000000000005 111.584 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.299999999999997 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.319999999999993 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.040000000000006 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.420000000000002 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.150000000000006 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 62.43 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.349999999999994 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.239999999999995 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.329999999999998 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.120000000000005 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 74.140000000000001 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.140000000000001 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.319999999999993 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.329999999999998 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 62.240000000000002 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.010000000000005 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.425 HH11 ' CE1' ' A' ' 196' ' ' HIS . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.150000000000006 108.315 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.530000000000001 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.209999999999994 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.310000000000002 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.239999999999995 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.510000000000005 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.219999999999999 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.120000000000005 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.109999999999999 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.329999999999998 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 73.430000000000007 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.430000000000007 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 54.520000000000003 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 70.310000000000002 108.134 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.340000000000003 107.979 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.130000000000003 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CE1' HH11 ' A' ' 179' ' ' ARG . 3.7 t60 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 74.329999999999998 106.043 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.130000000000003 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.099999999999994 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.219999999999999 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.420000000000002 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.539999999999999 112.892 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 74.299999999999997 111.471 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.530000000000001 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 74.109999999999999 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.230000000000004 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.209999999999994 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.430000000000007 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.229999999999997 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.409999999999997 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.439999999999998 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.340000000000003 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.200000000000003 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.449 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.120000000000005 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.120000000000005 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.310000000000002 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.409999999999997 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 37.829999999999998 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.019999999999996 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.409999999999997 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 72.420000000000002 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.420000000000002 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 74.140000000000001 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 64.109999999999999 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.85 -173.44 50.08 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.73 64.99 3.57 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.866 -1.161 . . . . 60.130000000000003 107.866 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.94 24.69 13.72 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.231 -1.349 . . . . 74.319999999999993 110.914 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.25 55.45 6.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.397 -1.274 . . . . 74.209999999999994 111.067 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -109.74 129.52 55.61 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.534 -1.212 . . . . 70.430000000000007 108.117 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -100.42 107.56 19.33 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.181 0.515 . . . . 74.439999999999998 111.38 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 107.842 -1.17 . . . . 74.519999999999996 107.842 175.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.238 0.492 0 N-CA-C 107.778 -1.193 . . . . 74.349999999999994 107.778 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 71.56 115.36 0.05 Allowed 'General case' 0 C--O 1.244 0.788 0 C-N-CA 125.335 1.454 . . . . 71.319999999999993 110.488 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.82 107.88 4.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.892 -1.049 . . . . 74.019999999999996 112.964 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.78 19.72 4.63 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 123.137 1.446 . . . . 53.140000000000001 110.43 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.95 -46.7 5.56 Favored Glycine 0 C--N 1.273 -2.932 0 CA-C-N 112.038 -2.346 . . . . 71.329999999999998 107.71 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.21 142.05 47.87 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.049999999999997 102.422 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.239999999999995 110.481 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.430000000000007 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.481 ' HH ' ' CG ' ' A' ' 202' ' ' HIS . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.510000000000005 107.488 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 35.8 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.349999999999994 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.409999999999997 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.319999999999993 109.023 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.519999999999996 109.597 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.319999999999993 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.030000000000001 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.229999999999997 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.310000000000002 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 38.009999999999998 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.519999999999996 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.400000000000006 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.540000000000006 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.403 HG11 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 75.010000000000005 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' HG22 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.239999999999995 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.420000000000002 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.340000000000003 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.129999999999995 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.329999999999998 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 73.400000000000006 111.682 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.340000000000003 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 74.209999999999994 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.416 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.129999999999995 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.150000000000006 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.319999999999993 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.409999999999997 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.329999999999998 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.219999999999999 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.329999999999998 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.150000000000006 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.549999999999997 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.439999999999998 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.340000000000003 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 65.030000000000001 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.310000000000002 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.240000000000002 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.040000000000006 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.439999999999998 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 71.409999999999997 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.420000000000002 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 38.009999999999998 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.239999999999995 108.099 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.129999999999995 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.349999999999994 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.230000000000004 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.310000000000002 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.621 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.140000000000001 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.039999999999999 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.329999999999998 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.621 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 75.129999999999995 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.450000000000003 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.040000000000006 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.310000000000002 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.416 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.120000000000005 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.340000000000003 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 72.409999999999997 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.409999999999997 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.209999999999994 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.403 HD21 HG11 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.519999999999996 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.100000000000001 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 51.450000000000003 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.439999999999998 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.230000000000004 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.109999999999999 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 74.219999999999999 110.67 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 75.540000000000006 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 55.210000000000001 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.349999999999994 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.229999999999997 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.010000000000005 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.409999999999997 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 61.039999999999999 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 100.48 161.47 28.11 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.049999999999997 109.975 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.98 77.49 6.1 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.266 1.031 . . . . 71.530000000000001 111.039 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 42.1 t60 74.87 -13.27 0.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.495 -1.684 . . . . 62.32 112.803 176.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.6 43.58 7.49 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 106.083 -1.821 . . . . 65.219999999999999 106.083 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.17 106.32 7.72 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 112.04 -2.345 . . . . 54.340000000000003 109.168 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.69 95.42 5.28 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.541 -0.911 . . . . 45.310000000000002 108.541 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 106.613 -1.625 . . . . 74.530000000000001 106.613 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.753 0.787 . . . . 74.109999999999999 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.37 141.27 49.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.484 -1.302 . . . . 72.439999999999998 107.484 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.45 ' OD1' HD23 ' A' ' 198' ' ' LEU . 45.9 m-20 -86.48 86.17 7.33 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.691 0.997 . . . . 72.310000000000002 113.691 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -118.08 35.59 4.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.655 -1.157 . . . . 74.519999999999996 109.556 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.91 -53.78 0.13 Allowed Glycine 0 C--N 1.256 -3.862 0 N-CA-C 108.117 -1.993 . . . . 74.540000000000006 108.117 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.0 140.44 49.74 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 104.467 -2.42 . . . . 75.129999999999995 104.467 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.120000000000005 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.409999999999997 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.040000000000006 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.239999999999995 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 74.420000000000002 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 74.230000000000004 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.540000000000006 110.226 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.439999999999998 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.239999999999995 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.010000000000005 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.010000000000005 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 74.420000000000002 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.010000000000005 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 157' ' ' PRO . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.430000000000007 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.450000000000003 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 73.299999999999997 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 52.020000000000003 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.510000000000005 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 73.25 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 74.450000000000003 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 64.430000000000007 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 74.099999999999994 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.414 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.109999999999999 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.469 ' OG1' HD12 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.420000000000002 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.329999999999998 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.310000000000002 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.430000000000007 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.420000000000002 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 52.539999999999999 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.109999999999999 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.469 HD12 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 75.109999999999999 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.009999999999998 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 74.040000000000006 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.494 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.310000000000002 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.412 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 72.439999999999998 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.129999999999995 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 70.340000000000003 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.099999999999994 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.219999999999999 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.239999999999995 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.477 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 70.319999999999993 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.140000000000001 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.229999999999997 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.439999999999998 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 72.109999999999999 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.439999999999998 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.494 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 64.420000000000002 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.409999999999997 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.45 HD23 ' OD1' ' A' ' 143' ' ' ASP . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.129999999999995 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.454 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.009999999999998 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.120000000000005 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 37.539999999999999 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.150000000000006 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.450000000000003 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.549999999999997 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.400000000000006 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 74.329999999999998 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.349999999999994 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.040000000000006 109.195 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.109999999999999 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.414 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.340000000000003 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 75.140000000000001 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.449 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.439999999999998 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.049999999999997 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.310000000000002 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.019999999999996 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.209999999999994 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.319999999999993 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 73.319999999999993 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 64.299999999999997 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.439999999999998 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 72.239999999999995 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.540000000000006 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.230000000000004 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.239999999999995 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.3 135.56 8.7 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.519999999999996 110.28 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.07 -25.57 55.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.353 -0.98 . . . . 71.010000000000005 108.353 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -67.73 96.64 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.687 -1.142 . . . . 73.420000000000002 109.382 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.56 79.97 1.3 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.492 0.663 . . . . 73.420000000000002 109.353 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -139.49 94.06 2.74 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.075 -1.824 . . . . 71.019999999999996 106.075 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -141.55 103.36 4.37 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.508 -0.923 . . . . 64.329999999999998 108.508 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 107.286 -1.376 . . . . 61.119999999999997 107.286 179.118 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.728 0.299 . . . . 71.400000000000006 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -128.97 93.66 3.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.904 -1.147 . . . . 74.239999999999995 107.904 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -102.5 19.38 19.08 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 122.93 1.347 . . . . 74.230000000000004 109.029 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.19 62.2 1.1 Allowed 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.58 -2.1 . . . . 75.420000000000002 109.41 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.19 -46.78 0.03 OUTLIER Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 112.999 -1.91 . . . . 74.129999999999995 108.93 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.88 169.84 8.21 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 113.673 -1.264 . . . . 71.439999999999998 108.26 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.430000000000007 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.400000000000006 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.310000000000002 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.310000000000002 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.400000000000006 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.240000000000002 110.318 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.409999999999997 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.519999999999996 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.150000000000006 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 62.509999999999998 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.530000000000001 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.109999999999999 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.430000000000007 111.118 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.120000000000005 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.450000000000003 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.409999999999997 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.200000000000003 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.049999999999997 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.129999999999995 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.530000000000001 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.129999999999995 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 63.43 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.129999999999995 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.430000000000007 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.129999999999995 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.450000000000003 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 72.209999999999994 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.229999999999997 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.420000000000002 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.438 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.019999999999996 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.129999999999995 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.409999999999997 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.049999999999997 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.219999999999999 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.119999999999997 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.010000000000005 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 74.340000000000003 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.140000000000001 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.299999999999997 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.530000000000001 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.030000000000001 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.219999999999999 109.694 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 74.219999999999999 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.219999999999999 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.319999999999993 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.109999999999999 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.439999999999998 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.310000000000002 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.129999999999995 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.530000000000001 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.319999999999993 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 74.219999999999999 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.399999999999999 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.340000000000003 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.039999999999999 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.510000000000005 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 72.140000000000001 109.381 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.430000000000007 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.399999999999999 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.329999999999998 110.636 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.299999999999997 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 73.510000000000005 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.549999999999997 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 72.540000000000006 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.488 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 73.420000000000002 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.540000000000006 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.540000000000006 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.540000000000006 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.140000000000001 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.439999999999998 110.025 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.120000000000005 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.120000000000005 106.992 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.340000000000003 107.196 170.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -69.49 119.24 9.09 Favored Glycine 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.219999999999999 113.084 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 69.1 14.83 8.76 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.648 1.213 . . . . 72.120000000000005 110.755 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -105.62 -59.01 1.83 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.686 -1.143 . . . . 64.109999999999999 108.607 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 226' ' ' TYR . . . 59.54 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.491 -1.231 . . . . 73.310000000000002 112.949 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 69.49 39.15 1.64 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.504 1.122 . . . . 71.319999999999993 111.334 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -130.66 125.29 33.62 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.222 -1.354 . . . . 63.329999999999998 107.393 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.987 -1.116 . . . . 61.340000000000003 107.987 -178.547 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.764 0.792 . . . . 70.510000000000005 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -153.58 95.34 1.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.513 -1.221 . . . . 75.430000000000007 109.91 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 57.41 65.34 1.37 Allowed 'General case' 0 C--O 1.244 0.764 0 O-C-N 124.142 0.901 . . . . 71.230000000000004 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.09 57.09 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.208 -0.905 . . . . 71.340000000000003 111.937 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -39.66 0.05 OUTLIER Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 114.965 -1.016 . . . . 54.119999999999997 110.636 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.41 144.89 35.39 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.340000000000003 106.604 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.683 HE21 ' N ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.140000000000001 109.156 -177.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.049999999999997 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.430000000000007 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.129999999999995 107.627 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.130000000000003 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.430000000000007 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.140000000000001 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.239999999999995 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.340000000000003 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.319999999999993 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.239999999999995 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 54.200000000000003 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 74.310000000000002 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 64.230000000000004 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.409999999999997 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.219999999999999 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.340000000000003 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.329999999999998 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.009999999999998 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.540000000000006 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 72.010000000000005 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.010000000000005 111.723 -174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.519999999999996 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.340000000000003 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.415 ' OG1' HD22 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.209999999999994 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.039999999999999 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.409999999999997 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.439999999999998 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.019999999999996 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.549999999999997 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.430000000000007 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.415 HD22 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.229999999999997 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 74.019999999999996 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.409999999999997 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.310000000000002 108.421 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 65.230000000000004 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.409999999999997 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.200000000000003 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.430000000000007 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.400000000000006 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.150000000000006 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.329999999999998 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.502 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.109999999999999 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 75.439999999999998 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 74.120000000000005 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.420000000000002 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 74.310000000000002 107.556 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.240000000000002 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.530000000000001 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.129999999999995 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.530000000000001 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.44 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.409999999999997 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.099999999999994 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 65.209999999999994 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 62.310000000000002 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.409999999999997 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 73.420000000000002 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.423 ' HA ' HG23 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.230000000000004 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.209999999999994 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 74.0 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.109999999999999 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.430000000000007 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.239999999999995 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.230000000000004 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.200000000000003 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.319999999999993 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.340000000000003 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.219999999999999 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.310000000000002 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.439999999999998 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 54.32 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.510000000000005 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.439999999999998 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.549999999999997 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.450000000000003 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.07 158.62 9.46 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.140000000000001 111.763 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.84 -47.44 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.659 0.742 . . . . 72.209999999999994 110.841 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -85.74 -65.33 1.02 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.42 -0.955 . . . . 74.25 108.42 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 173.99 49.48 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.015 -1.476 . . . . 65.219999999999999 107.015 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -68.11 114.14 6.37 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.133 -1.394 . . . . 64.340000000000003 113.074 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -125.3 85.36 2.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 104.271 -2.492 . . . . 70.25 104.271 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.291 -1.97 0 CA-C-N 114.743 -1.117 . . . . 60.350000000000001 109.37 -171.025 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 122.083 0.944 . . . . 64.209999999999994 109.695 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.97 162.58 40.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.04 -0.982 . . . . 75.200000000000003 109.045 -171.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.4 41.06 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.813 0.816 . . . . 72.200000000000003 110.065 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.19 69.25 10.46 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.748 1.261 . . . . 73.219999999999999 111.199 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.74 -40.88 0.04 OUTLIER Glycine 0 C--N 1.29 -2.021 0 CA-C-N 112.599 -2.092 . . . . 38.390000000000001 107.877 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.95 -171.91 1.94 Allowed 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 71.219999999999999 104.191 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.240000000000002 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 62.329999999999998 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 73.310000000000002 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.200000000000003 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.310000000000002 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 75.430000000000007 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.349999999999994 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.239999999999995 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.129999999999995 114.19 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.420000000000002 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.130000000000003 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 164' ' ' ARG . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.310000000000002 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 73.409999999999997 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 72.109999999999999 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.109999999999999 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 160' ' ' GLU . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.099999999999994 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.210000000000001 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.409999999999997 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.230000000000004 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.530000000000001 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.450000000000003 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.430000000000007 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.230000000000004 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.340000000000003 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.310000000000002 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.540000000000006 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.030000000000001 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.329999999999998 108.364 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.150000000000006 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.409999999999997 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 72.439999999999998 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.409999999999997 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 62.130000000000003 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.239999999999995 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.130000000000003 111.781 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.319999999999993 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.329999999999998 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.530000000000001 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.129999999999995 108.071 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.240000000000002 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.219999999999999 105.366 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 73.319999999999993 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 193' ' ' LEU . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.129999999999995 107.728 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.150000000000006 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 71.150000000000006 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.510000000000005 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.040000000000006 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.109999999999999 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.329999999999998 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.219999999999999 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 54.420000000000002 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.239999999999995 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.319999999999993 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.130000000000003 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 72.450000000000003 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.319999999999993 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.450000000000003 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.340000000000003 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.219999999999999 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.229999999999997 109.674 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 63.149999999999999 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.349999999999994 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.340000000000003 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.010000000000005 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.340000000000003 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.310000000000002 110.05 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.420000000000002 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.340000000000003 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.319999999999993 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.420000000000002 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.150000000000006 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.540000000000006 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 54.130000000000003 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.93 -156.41 27.46 Favored Glycine 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.35 10.05 31.7 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.51 0.671 . . . . 71.140000000000001 110.808 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -88.83 102.92 15.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.001 -1.0 . . . . 73.430000000000007 108.63 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.32 72.69 9.78 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.69 0.757 . . . . 53.219999999999999 109.162 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -99.41 112.33 24.54 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.798 -1.092 . . . . 72.239999999999995 110.207 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.68 15.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.382 -0.372 . . . . 74.439999999999998 111.174 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 107.467 -1.308 . . . . 74.409999999999997 107.467 175.474 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.89 -0.411 . . . . 75.209999999999994 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -92.29 130.8 37.89 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 108.034 -1.098 . . . . 51.5 108.034 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -90.31 71.46 7.13 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.606 -0.838 . . . . 74.439999999999998 110.59 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.26 24.98 4.18 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 122.524 1.154 . . . . 64.400000000000006 111.066 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -97.43 -40.98 3.53 Favored Glycine 0 C--N 1.268 -3.222 0 N-CA-C 106.375 -2.69 . . . . 61.420000000000002 106.375 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.01 128.65 42.43 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.329999999999998 103.235 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.349999999999994 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.530000000000001 111.969 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.423 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.409999999999997 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.209999999999994 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.240000000000002 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 61.140000000000001 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.130000000000003 110.76 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.009999999999998 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.519999999999996 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.219999999999999 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.109999999999999 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.549999999999997 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.109999999999999 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.019999999999996 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.239999999999995 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.530000000000001 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.150000000000006 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.530000000000001 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.150000000000006 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.209999999999994 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.200000000000003 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.530000000000001 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.349999999999994 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 63.340000000000003 107.772 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.109999999999999 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.319999999999993 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.319999999999993 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.510000000000005 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 74.439999999999998 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.119999999999997 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.120000000000005 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.150000000000006 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.420000000000002 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.465 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.539999999999999 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.209999999999994 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.219999999999999 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.409999999999997 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 72.010000000000005 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.439999999999998 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.230000000000004 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 71.129999999999995 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 64.530000000000001 108.185 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.439999999999998 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.329999999999998 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.423 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.6 t-80 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.210000000000001 109.289 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 75.299999999999997 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.319999999999993 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.230000000000004 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.406 ' O ' HD11 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.299999999999997 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 72.099999999999994 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.219999999999999 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.239999999999995 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 73.340000000000003 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.109999999999999 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.310000000000002 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.030000000000001 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 73.319999999999993 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.329999999999998 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.399999999999999 110.936 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.109999999999999 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.209999999999994 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 70.019999999999996 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.230000000000004 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.340000000000003 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.310000000000002 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.439999999999998 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.72 113.35 5.64 Favored Glycine 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.239999999999995 111.141 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -69.75 -66.71 0.55 Allowed 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.649 -1.241 . . . . 74.120000000000005 107.649 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -128.47 -49.27 1.28 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.34 -1.726 . . . . 73.099999999999994 106.34 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 52.11 40.16 28.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.93 -1.486 . . . . 73.299999999999997 109.567 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -98.32 129.13 45.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 113.173 -1.83 . . . . 74.319999999999993 109.638 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.42 86.43 7.08 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.47 0.653 . . . . 63.530000000000001 109.924 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 107.443 -1.317 . . . . 55.399999999999999 107.443 176.283 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.365 0 CA-C-O 122.119 0.961 . . . . 73.400000000000006 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.33 80.03 4.43 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 71.129999999999995 109.105 -172.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 61.17 31.54 19.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.851 1.26 . . . . 54.310000000000002 110.343 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.31 71.6 9.95 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.104 -1.862 . . . . 75.219999999999999 110.016 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -37.64 0.05 OUTLIER Glycine 0 C--N 1.274 -2.865 0 CA-C-N 112.176 -2.284 . . . . 62.240000000000002 107.662 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.31 149.73 30.21 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 64.420000000000002 105.26 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.129999999999995 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.299999999999997 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.099999999999994 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.44 HE22 ' HB1' ' A' ' 231' ' ' ALA . 43.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.129999999999995 107.326 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.219999999999999 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.219999999999999 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.329999999999998 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.009999999999998 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.230000000000004 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.450000000000003 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.349999999999994 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.219999999999999 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.329999999999998 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.140000000000001 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.409999999999997 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 167' ' ' ILE . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.209999999999994 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 63.43 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.030000000000001 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.420000000000002 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.540000000000006 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.310000000000002 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.200000000000003 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.109999999999999 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 74.549999999999997 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.010000000000005 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.439999999999998 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.430000000000007 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 72.409999999999997 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.409999999999997 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.549999999999997 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.210000000000001 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.549999999999997 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.530000000000001 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.040000000000006 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.340000000000003 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.400000000000006 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.350000000000001 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.140000000000001 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.430000000000007 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.049999999999997 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 70.200000000000003 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.140000000000001 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.340000000000003 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.299999999999997 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.340000000000003 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.299999999999997 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.430000000000007 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.530000000000001 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.310000000000002 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.230000000000004 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 62.439999999999998 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.120000000000005 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.589 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.310000000000002 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.349999999999994 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.439999999999998 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.109999999999999 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.299999999999997 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 71.230000000000004 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 74.409999999999997 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.340000000000003 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.530000000000001 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.299999999999997 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.219999999999999 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 220' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.109999999999999 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.099999999999994 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.120000000000005 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.519999999999996 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.209999999999994 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.219999999999999 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.119999999999997 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.040000000000006 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.049999999999997 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.519999999999996 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.450000000000003 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.049999999999997 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.409999999999997 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.94 144.26 15.81 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.120000000000005 110.351 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -24.26 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.707 0.753 . . . . 44.420000000000002 111.225 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -125.1 5.63 7.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.194 0.521 . . . . 71.340000000000003 110.435 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.44 ' HB1' HE22 ' A' ' 150' ' ' GLN . . . 69.39 54.94 0.4 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.228 1.011 . . . . 60.039999999999999 111.84 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.34 110.49 23.07 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 105.29 -2.115 . . . . 74.230000000000004 105.29 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.71 99.82 12.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 110.174 -0.306 . . . . 61.109999999999999 110.174 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 107.161 -1.422 . . . . 54.439999999999998 107.161 177.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 108.336 -0.987 . . . . 72.239999999999995 108.336 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.07 107.87 8.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.489 -2.041 . . . . 72.319999999999993 105.489 170.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.53 66.97 0.73 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.346 1.07 . . . . 74.5 112.103 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.91 32.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.766 1.746 . . . . 71.430000000000007 107.745 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.87 -45.92 1.24 Allowed Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 111.459 -2.609 . . . . 61.32 106.854 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.73 163.63 13.93 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.239999999999995 103.665 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.129999999999995 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.329999999999998 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.329999999999998 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.310000000000002 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.150000000000006 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.219999999999999 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.400000000000006 111.01 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.399999999999999 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 62.32 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.510000000000005 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.240000000000002 115.297 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.129999999999995 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.299999999999997 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.340000000000003 111.267 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.120000000000005 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 71.140000000000001 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.200000000000003 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.200000000000003 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.219999999999999 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.329999999999998 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.239999999999995 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.310000000000002 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 73.349999999999994 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.439999999999998 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.109999999999999 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.509999999999998 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.120000000000005 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.010000000000005 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.420000000000002 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 73.109999999999999 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.010000000000005 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.439999999999998 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.340000000000003 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.329999999999998 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.230000000000004 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 72.319999999999993 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.209999999999994 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 72.450000000000003 113.23 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.444 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.420000000000002 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.409999999999997 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.519999999999996 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.310000000000002 109.754 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.040000000000006 111.928 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.439999999999998 107.924 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 73.25 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.450000000000003 107.594 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 73.219999999999999 106.851 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.530000000000001 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 75.109999999999999 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.510000000000005 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 70.25 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.539999999999999 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.399999999999999 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.120000000000005 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.409999999999997 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.140000000000001 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.230000000000004 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.340000000000003 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.340000000000003 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.310000000000002 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.319999999999993 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.030000000000001 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.439999999999998 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.040000000000006 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.422 ' HA ' HG13 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.510000000000005 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 70.409999999999997 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.120000000000005 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.420000000000002 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.230000000000004 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.409999999999997 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 73.519999999999996 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.219999999999999 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.319999999999993 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.209999999999994 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.530000000000001 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.409999999999997 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.72 139.23 10.7 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 37.399999999999999 111.381 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.33 -44.77 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.167 0.508 . . . . 74.439999999999998 111.27 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -93.18 24.46 3.79 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.969 0.89 . . . . 72.230000000000004 108.683 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.76 57.11 2.75 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.045 -1.434 . . . . 53.149999999999999 111.149 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 66.28 89.51 0.1 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.587 -1.188 . . . . 72.030000000000001 110.438 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -80.35 88.49 5.55 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.594 0.711 . . . . 71.5 110.061 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 107.883 -1.154 . . . . 71.109999999999999 107.883 -178.441 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 122.138 0.971 . . . . 61.329999999999998 111.229 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -126.57 99.91 6.0 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.074 -1.454 . . . . 73.239999999999995 107.074 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -87.17 109.91 19.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.299 0.852 . . . . 64.319999999999993 113.299 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -147.88 31.66 0.86 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.174 1.464 . . . . 70.400000000000006 109.929 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -99.05 -49.69 1.56 Allowed Glycine 0 C--N 1.267 -3.252 0 N-CA-C 106.731 -2.547 . . . . 51.340000000000003 106.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.7 140.96 30.52 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.430000000000007 104.101 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.430000000000007 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.040000000000006 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.349999999999994 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.310000000000002 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.040000000000006 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.519999999999996 110.774 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 74.310000000000002 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 75.349999999999994 108.836 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.430000000000007 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.450000000000003 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.150000000000006 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.53 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.310000000000002 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.200000000000003 111.39 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.100000000000001 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.53 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 74.329999999999998 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.120000000000005 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 110.366 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.229999999999997 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.319999999999993 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.400000000000006 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.109999999999999 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.400000000000006 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 73.340000000000003 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.409999999999997 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 75.25 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.412 HD21 HD23 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 62.25 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.430000000000007 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.299999999999997 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 75.109999999999999 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.310000000000002 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.329999999999998 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 74.219999999999999 108.514 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.030000000000001 111.321 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.219999999999999 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 73.349999999999994 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.240000000000002 113.053 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.420000000000002 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.430000000000007 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.230000000000004 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.230000000000004 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 74.030000000000001 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.487 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.450000000000003 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.010000000000005 106.392 174.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.150000000000006 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.319999999999993 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.239999999999995 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.150000000000006 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.450000000000003 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.430000000000007 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.510000000000005 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 75.120000000000005 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.030000000000001 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 74.239999999999995 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.099999999999994 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.540000000000006 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.409999999999997 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.340000000000003 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.030000000000001 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.310000000000002 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 73.049999999999997 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.458 ' O ' HD11 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.329999999999998 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.120000000000005 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.435 HD22 ' NE2' ' A' ' 217' ' ' GLN . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 109.273 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.442 ' HA ' HG13 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.239999999999995 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.510000000000005 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.435 ' NE2' HD22 ' A' ' 214' ' ' LEU . 45.5 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.540000000000006 109.62 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.430000000000007 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.329999999999998 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.5 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.399999999999999 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.400000000000006 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 211' ' ' VAL . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.120000000000005 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.129999999999995 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 75.409999999999997 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.430000000000007 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.219999999999999 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . 83.49 -158.8 36.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.210000000000001 110.044 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.55 19.09 3.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 117.699 0.75 . . . . 55.240000000000002 111.798 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.42 103.61 15.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.428 -0.953 . . . . 70.549999999999997 108.428 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.29 5.57 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.828 -0.624 . . . . 64.530000000000001 109.94 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -104.5 113.15 26.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.548 -0.538 . . . . 63.329999999999998 109.548 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -90.94 84.61 5.8 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.404 0.621 . . . . 74.109999999999999 109.574 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 115.238 -0.892 . . . . 74.540000000000006 108.656 -179.127 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 121.51 0.672 . . . . 71.439999999999998 109.735 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -119.04 152.74 35.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.73 91.55 4.7 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.814 -0.439 . . . . 64.340000000000003 109.814 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.33 23.77 12.17 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 123.242 1.496 . . . . 75.329999999999998 110.71 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.02 -25.82 8.21 Favored Glycine 0 C--N 1.272 -2.997 0 CA-C-N 112.048 -2.342 . . . . 64.510000000000005 108.896 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.36 153.44 23.27 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.010000000000005 104.639 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.209999999999994 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.149999999999999 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.519999999999996 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.399999999999999 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.109999999999999 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.450000000000003 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.319999999999993 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.140000000000001 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 54.219999999999999 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.310000000000002 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.129999999999995 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.229999999999997 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.099999999999994 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 71.230000000000004 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.140000000000001 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.549999999999997 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 70.540000000000006 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.540000000000006 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 73.209999999999994 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 61.32 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.109999999999999 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.150000000000006 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.539999999999999 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.229999999999997 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.510000000000005 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.310000000000002 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.010000000000005 111.574 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.010000000000005 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 36.609999999999999 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 74.349999999999994 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.150000000000006 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.520000000000003 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.420000000000002 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.47 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.010000000000005 111.533 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.350000000000001 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.209999999999994 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 74.230000000000004 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.512 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 71.129999999999995 112.65 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.219999999999999 106.629 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.219999999999999 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.200000000000003 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.329999999999998 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.210000000000001 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.219999999999999 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.310000000000002 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.430000000000007 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.539999999999999 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.319999999999993 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.140000000000001 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.450000000000003 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.450000000000003 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.230000000000004 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.010000000000005 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.430000000000007 110.675 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.200000000000003 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.209999999999994 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 75.299999999999997 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 72.129999999999995 112.387 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.450000000000003 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.455 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.200000000000003 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.455 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 65.219999999999999 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.430000000000007 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 74.150000000000006 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.100000000000001 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 62.439999999999998 110.705 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.129999999999995 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 75.010000000000005 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.43 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.340000000000003 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.412 ' HA2' ' OE1' ' A' ' 232' ' ' GLN . . . 111.09 141.37 8.63 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.120000000000005 109.816 -173.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.15 -46.55 6.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.263 1.209 . . . . 74.519999999999996 114.263 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.44 -69.16 0.55 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -178.87 71.71 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.278 1.431 . . . . 72.219999999999999 107.168 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.412 ' OE1' ' HA2' ' A' ' 228' ' ' GLY . 50.4 mt-30 -95.13 83.06 3.84 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.899 . . . . 74.219999999999999 111.546 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -159.86 150.64 19.13 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.045 -1.835 . . . . 70.129999999999995 106.045 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.888 -1.153 . . . . 72.209999999999994 107.888 -179.407 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.504 -0.804 0 CA-C-O 121.793 0.806 . . . . 61.509999999999998 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -125.37 165.87 17.61 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.835 -1.172 . . . . 64.040000000000006 107.835 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.66 70.3 9.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.877 1.322 . . . . 53.310000000000002 110.548 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 52.7 1.04 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.206 -1.776 . . . . 61.509999999999998 106.206 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -133.12 -48.73 0.1 OUTLIER Glycine 0 C--N 1.279 -2.605 0 N-CA-C 105.259 -3.136 . . . . 40.329999999999998 105.259 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.28 137.66 35.95 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 64.209999999999994 103.289 169.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.030000000000001 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.400000000000006 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.299999999999997 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.349999999999994 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 52.509999999999998 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.329999999999998 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.209999999999994 109.836 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD11 HD21 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.140000000000001 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.340000000000003 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.319999999999993 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.519999999999996 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.120000000000005 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.350000000000001 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.219999999999999 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.430000000000007 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.109999999999999 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.409999999999997 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 37.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.450000000000003 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.399999999999999 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.310000000000002 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.140000000000001 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.409999999999997 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.42 ' OG1' HD13 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 75.540000000000006 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.409999999999997 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.129999999999995 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.439999999999998 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.340000000000003 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.549999999999997 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 74.230000000000004 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.42 HD13 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.530000000000001 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.409999999999997 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.310000000000002 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.530000000000001 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.420000000000002 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 73.129999999999995 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.420000000000002 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 64.150000000000006 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.219999999999999 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.109999999999999 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.409999999999997 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.329999999999998 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.491 HD21 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.430000000000007 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.530000000000001 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.150000000000006 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.229999999999997 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.099999999999994 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.349999999999994 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 75.019999999999996 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 73.200000000000003 107.76 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 62.310000000000002 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.120000000000005 109.123 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.530000000000001 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.399999999999999 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 72.099999999999994 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.530000000000001 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.119999999999997 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.010000000000005 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.109999999999999 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 73.129999999999995 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.219999999999999 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.409999999999997 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 70.409999999999997 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 64.109999999999999 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.230000000000004 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.310000000000002 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 51.210000000000001 110.977 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.140000000000001 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.420000000000002 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.409999999999997 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.310000000000002 110.077 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 75.450000000000003 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.109999999999999 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.409999999999997 108.755 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 75.519999999999996 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.230000000000004 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.219999999999999 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.310000000000002 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -37.88 112.24 0.18 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.439999999999998 114.531 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.69 -50.77 61.79 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.434 -0.883 . . . . 70.420000000000002 110.009 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -101.33 -5.13 25.83 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.303 -0.862 . . . . 72.25 109.966 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.36 83.94 1.97 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 109.845 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -61.35 109.13 1.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.9 -1.046 . . . . 73.239999999999995 109.766 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 146.96 46.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.87 -0.605 . . . . 63.210000000000001 110.132 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 108.637 -0.875 . . . . 72.310000000000002 108.637 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 107.268 -1.382 . . . . 63.439999999999998 107.268 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -128.98 40.33 3.65 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.525 1.155 . . . . 63.210000000000001 108.476 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 145' ' ' GLY . 7.2 m-20 -100.41 58.61 0.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.419 -1.719 . . . . 74.519999999999996 107.367 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.82 33.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.482 -1.236 . . . . 54.009999999999998 113.008 -171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 143' ' ' ASP . . . -104.93 -7.84 37.76 Favored Glycine 0 C--N 1.26 -3.693 0 N-CA-C 108.914 -1.674 . . . . 53.140000000000001 108.914 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp -137.12 153.8 50.43 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.349999999999994 105.257 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.409999999999997 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.140000000000001 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.329999999999998 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.310000000000002 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 53.350000000000001 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.209999999999994 110.143 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.030000000000001 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.457 HD13 HD21 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.239999999999995 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.420000000000002 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.239999999999995 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.549999999999997 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.340000000000003 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.49 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.340000000000003 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.340000000000003 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.030000000000001 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.049999999999997 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.476 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.340000000000003 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 74.519999999999996 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.120000000000005 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.109999999999999 112.227 -176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.120000000000005 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.439999999999998 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.329999999999998 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.450000000000003 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.414 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.120000000000005 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.310000000000002 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.400000000000006 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.400000000000006 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.439999999999998 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.519999999999996 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.209999999999994 108.357 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.539999999999999 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.420000000000002 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.401 ' HB2' ' ND2' ' A' ' 190' ' ' ASN . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.219999999999999 112.219 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.130000000000003 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.200000000000003 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.492 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 75.510000000000005 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 72.430000000000007 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.130000000000003 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 74.239999999999995 109.09 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.319999999999993 108.509 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.209999999999994 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.400000000000006 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 73.329999999999998 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.230000000000004 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.414 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.229999999999997 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.299999999999997 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 38.5 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.540000000000006 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.420000000000002 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 74.030000000000001 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.299999999999997 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.439999999999998 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.439999999999998 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.310000000000002 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.040000000000006 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.329999999999998 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.400000000000006 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.476 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.200000000000003 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.230000000000004 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.495 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.510000000000005 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.329999999999998 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.349999999999994 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.329999999999998 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.439999999999998 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.409999999999997 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 64.340000000000003 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 73.129999999999995 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.239999999999995 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.430000000000007 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.230000000000004 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.349999999999994 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.020000000000003 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 114.17 161.18 13.81 Favored Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.409999999999997 109.896 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.1 -10.79 17.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.254 0.464 . . . . 74.409999999999997 112.254 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 232' ' ' GLN . 26.4 m-70 -78.1 111.38 13.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.002 -0.74 . . . . 73.439999999999998 109.002 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.03 38.49 0.76 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.715 0.769 . . . . 64.420000000000002 111.354 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 230' ' ' HIS . 50.3 mt-30 -156.72 115.12 3.3 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 125.667 1.587 . . . . 73.319999999999993 108.928 -178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -167.09 -48.29 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.891 0 CA-C-O 123.488 1.613 . . . . 75.120000000000005 109.505 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 1 C--N 1.23 -4.621 0 CA-C-N 111.366 -2.652 . . . . 72.439999999999998 107.196 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.506 -0.724 0 N-CA-C 108.274 -1.01 . . . . 74.319999999999993 108.274 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.75 130.38 54.48 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.008 -1.108 . . . . 70.209999999999994 108.008 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.66 31.53 4.37 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.509 1.147 . . . . 72.010000000000005 110.68 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.64 39.79 1.04 Allowed 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 113.785 -1.552 . . . . 73.140000000000001 111.16 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.23 -5.28 8.04 Favored Glycine 0 C--N 1.279 -2.586 0 CA-C-N 112.921 -1.945 . . . . 62.450000000000003 108.929 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.59 150.77 45.58 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.509999999999998 105.427 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.439999999999998 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.430000000000007 109.159 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.299999999999997 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.219999999999999 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.140000000000001 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.230000000000004 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.119999999999997 109.031 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.520000000000003 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.140000000000001 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.239999999999995 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.439999999999998 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.439999999999998 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.219999999999999 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 61.350000000000001 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.520000000000003 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.434 ' O ' HG22 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.409999999999997 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.049999999999997 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.409999999999997 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.239999999999995 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.540000000000006 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.400000000000006 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.129999999999995 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.310000000000002 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.409999999999997 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.120000000000005 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.299999999999997 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.209999999999994 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 172' ' ' SER . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.200000000000003 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.030000000000001 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.5 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.329999999999998 108.595 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.409999999999997 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.239999999999995 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.429 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.400000000000006 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.310000000000002 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.119999999999997 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.340000000000003 111.111 175.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.545 ' HB1' ' ND2' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 62.439999999999998 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.340000000000003 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.209999999999994 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.120000000000005 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.545 ' ND2' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.530000000000001 107.624 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.230000000000004 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.519999999999996 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.310000000000002 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.319999999999993 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.510000000000005 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 74.129999999999995 107.094 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.420000000000002 109.771 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.209999999999994 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.419 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.8 t-160 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.439999999999998 108.877 -176.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.200000000000003 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.039999999999999 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.439999999999998 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.540000000000006 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.439999999999998 109.261 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.420000000000002 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.030000000000001 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 71.310000000000002 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.430000000000007 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.150000000000006 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.130000000000003 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.239999999999995 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.200000000000003 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.109999999999999 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 38.420000000000002 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 72.239999999999995 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.519999999999996 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.420000000000002 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.019999999999996 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.200000000000003 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.120000000000005 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.439999999999998 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.82 156.42 9.49 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.319999999999993 112.061 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -63.94 -44.58 92.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.898 0.856 . . . . 64.230000000000004 108.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -115.9 12.93 15.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.557 -1.201 . . . . 75.340000000000003 108.643 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 57.89 62.57 2.03 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.752 -1.113 . . . . 74.230000000000004 110.85 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.93 115.0 21.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.81 -1.086 . . . . 73.409999999999997 109.961 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.95 139.96 15.37 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.246 -1.761 . . . . 65.129999999999995 106.246 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.288 -2.067 0 N-CA-C 108.816 -0.809 . . . . 73.310000000000002 108.816 -176.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.04 103.472 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.12 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.34 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.4 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.24 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.43 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.13 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.33 109.105 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.23 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.21 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.35 110.089 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.33 113.245 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.14 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.23 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 191' ' ' ILE . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.32 110.291 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.14 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.42 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.34 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.21 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.44 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.52 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.23 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.2 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.03 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.45 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.43 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.24 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.52 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.03 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.13 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.53 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.33 107.414 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.54 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.2 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.42 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 31.42 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HA ' HG12 ' A' ' 191' ' ' ILE . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.22 110.52 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.45 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.11 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.21 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.32 108.126 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.31 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.482 HG21 ' HG3' ' A' ' 160' ' ' GLU . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.33 106.554 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.2 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.13 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.54 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.51 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.04 106.604 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.13 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.02 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.31 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.432 HG22 ' HG ' ' A' ' 146' ' ' LEU . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.43 107.377 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 33.41 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' HIS . . . . . 0.517 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 79.7 t60 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.34 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.44 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.53 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.32 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' HD21 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.14 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.14 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.04 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.22 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.13 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.595 ' HB2' HG11 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.33 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.44 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.4 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.41 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.01 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.34 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.42 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.55 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.34 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.3 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TRP . . . . . 0.461 ' CD1' HG21 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.23 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.53 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.41 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.41 110.982 -175.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.32 106.36 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.35 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.01 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 72.41 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.02 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 65.54 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' THR . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.54 111.079 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.02 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.11 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.01 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.42 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 55.45 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.22 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 72.02 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' HD21 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.12 111.584 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.33 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.3 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.32 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.04 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.42 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.15 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 54.21 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.35 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.24 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.12 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.33 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.12 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 64.21 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.14 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.32 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.33 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 61.14 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.01 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.425 HH11 ' CE1' ' A' ' 196' ' ' HIS . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.15 108.315 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.53 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.21 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.31 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.24 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.51 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.22 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.12 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.11 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.33 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 71.2 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.43 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.21 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 52.11 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 160' ' ' GLU . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 42.21 108.134 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.13 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CE1' HH11 ' A' ' 179' ' ' ARG . 3.7 t60 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 72.53 106.043 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.13 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.1 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.22 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.42 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 202' ' ' HIS . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.54 112.892 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 201' ' ' GLY . 71.4 t60 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 72.14 111.471 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.53 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 54.23 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.23 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 210' ' ' LEU . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.21 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.43 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.23 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.41 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.44 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.34 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.2 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.53 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.12 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.12 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.31 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.41 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 21.44 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.02 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.41 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 63.33 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.42 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 73.52 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 53.34 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.05 102.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.24 110.481 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.43 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.51 107.488 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 36.9 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.35 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.41 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 194' ' ' THR . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.32 109.023 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 220' ' ' VAL . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.02 109.597 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.32 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.03 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.23 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.31 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 34.22 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.52 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.4 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.54 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 64.54 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.24 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.42 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.34 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.13 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.33 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 174' ' ' ASN . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 71.43 111.682 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.34 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 71.15 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.13 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.15 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.41 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.33 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.22 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.33 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.15 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.55 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.44 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.34 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 63.43 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.31 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.24 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.04 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.44 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 62.34 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.42 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 34.01 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 152' ' ' ARG . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.24 108.099 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.13 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.35 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.23 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.31 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.14 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.04 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.33 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' HIS . . . . . 0.59 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 73.3 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.45 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.04 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.31 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.43 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.12 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.24 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.34 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.23 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.13 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 62.1 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.41 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.21 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.52 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.1 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 44.52 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.44 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.23 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.11 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 153' ' ' VAL . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 64.13 110.67 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 72.55 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 51.43 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.35 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.23 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.01 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.41 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.05 109.975 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 104.467 -2.42 . . . . 75.13 104.467 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.12 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.41 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.04 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.24 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 62.31 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 71.11 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 220' ' ' VAL . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.54 110.226 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.44 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.24 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.01 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.01 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 71.45 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.01 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.43 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.45 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 64.24 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 44.11 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.51 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 72.34 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 54.0 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 43.45 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.43 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.427 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.11 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.42 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.33 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.31 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.43 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.42 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 44.14 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.11 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.478 HD11 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 63.2 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.01 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 73.24 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.507 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.31 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 64.33 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.13 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 35.55 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.1 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.22 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.24 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 64.32 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.14 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.23 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 55.11 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.44 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.507 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 63.0 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.41 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 179' ' ' ARG . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.13 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.504 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.01 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.12 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 33.11 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.15 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.45 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.55 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.34 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 71.12 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.35 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' LEU . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.04 109.195 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.11 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.427 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.34 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 71.12 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.465 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.44 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.05 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.31 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.02 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.21 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.32 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 70.23 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 53.22 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.44 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 62.14 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.54 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.15 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.24 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.52 110.28 -177.978 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 108.26 -1.015 . . . . 64.13 108.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.43 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.4 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 227' ' ' ALA . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.31 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.31 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.21 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.24 110.318 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.41 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.52 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.15 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 32.04 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.53 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.11 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 191' ' ' ILE . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.43 111.118 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.12 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.45 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.41 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.2 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.05 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.13 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.53 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.42 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.13 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 42.52 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.13 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.43 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.33 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.13 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.45 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 62.5 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.23 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.42 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.02 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.13 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.41 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.05 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.22 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.12 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.01 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 51.21 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.14 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.3 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.53 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.03 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.406 HD13 ' HG3' ' A' ' 160' ' ' GLU . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.22 109.694 -176.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 73.11 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.22 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.32 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.11 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.44 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.31 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.13 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.53 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.32 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 72.3 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.25 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.34 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.04 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.51 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 71.23 109.381 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.44 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.43 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.4 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 207' ' ' LEU . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.33 110.636 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.3 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 62.41 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.55 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.22 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 55.2 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 64.33 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.54 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.54 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.54 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.14 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 153' ' ' VAL . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.44 110.025 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.12 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.12 106.992 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.34 107.196 170.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.22 113.084 -169.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.34 106.604 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.14 109.156 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.05 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.404 ' HG2' ' ND1' ' A' ' 196' ' ' HIS . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.13 107.627 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.13 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.43 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.14 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.24 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.34 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.32 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.24 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 52.51 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 63.23 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 62.5 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.41 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.22 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.34 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.33 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.01 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.54 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 63.31 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 178' ' ' LEU . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.01 111.723 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.52 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.34 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.21 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.04 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.41 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.44 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.02 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.55 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.424 HD21 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.23 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 61.02 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.41 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.31 108.421 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 44.11 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.41 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.2 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.43 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.4 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.15 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.33 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.11 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 70.13 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 62.11 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.42 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.404 ' ND1' ' HG2' ' A' ' 150' ' ' GLN . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 73.43 107.556 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.24 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.53 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.13 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.53 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.4 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.1 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 43.34 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 60.41 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.41 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 65.24 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.23 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.473 ' O ' ' HD3' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.21 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 61.13 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.11 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.43 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.24 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.23 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.2 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.32 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.34 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.22 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.31 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.44 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 50.51 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.51 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.44 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.55 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.45 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.14 111.763 -177.494 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 64.15 104.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.24 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 52.14 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 72.3 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.2 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.21 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.31 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 61.31 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.35 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.24 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.13 114.19 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.42 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.13 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 191' ' ' ILE . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.31 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 65.35 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 64.11 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.11 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 168' ' ' VAL . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.1 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.21 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.41 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.23 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.22 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.53 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.45 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.43 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.41 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.23 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.34 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.31 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.54 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.03 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 167' ' ' ILE . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.33 108.364 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.15 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.41 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 64.12 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.41 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 60.32 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.24 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 191' ' ' ILE . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.13 111.781 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.32 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.33 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.53 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.13 108.071 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.24 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 160' ' ' GLU . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.22 105.366 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 72.21 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.13 107.728 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.15 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 50.13 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.51 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.04 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.11 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.33 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.22 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 51.02 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.24 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.32 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.13 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.35 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 44.21 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.34 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.32 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.34 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.22 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 220' ' ' VAL . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.23 109.674 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 52.15 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.15 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.34 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.01 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.34 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 214' ' ' LEU . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.31 110.05 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.42 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.34 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.32 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.42 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.15 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.54 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 51.04 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.33 103.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.35 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.53 111.969 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.41 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.21 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.24 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 44.03 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 220' ' ' VAL . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.13 110.76 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.01 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.52 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.22 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.11 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.55 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.11 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.02 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.24 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.53 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.15 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.53 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.15 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.21 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.2 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.53 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.35 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 210' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 198' ' ' LEU . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 53.35 107.772 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.11 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.32 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.3 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.32 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.51 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 70.13 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.12 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.12 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.15 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.42 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.54 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.21 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.22 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.41 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 53.55 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.44 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.23 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 61.3 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 177' ' ' THR . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 61.01 108.185 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.44 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.33 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.21 109.289 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 41.44 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.32 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.23 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.3 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 62.15 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 176' ' ' ILE . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.4 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.22 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.24 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.24 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 62.01 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.11 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.31 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.03 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 72.52 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.33 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 153' ' ' VAL . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.4 110.936 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.11 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.21 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 63.54 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.23 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.34 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.31 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.44 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.24 111.141 179.174 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 62.22 105.26 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.13 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.3 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.1 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.13 107.326 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.22 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.22 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.33 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.01 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.23 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.45 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.35 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.22 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.33 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.14 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.21 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.593 HG13 HD12 ' A' ' 214' ' ' LEU . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.21 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 61.41 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.03 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.42 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.54 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.31 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.2 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.406 ' OG1' HD11 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.11 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 72.42 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.01 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.44 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.43 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 71.33 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.41 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.55 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.21 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.55 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.53 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.04 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.34 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.4 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.35 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.14 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.32 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.05 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 64.34 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.14 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.34 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.3 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.34 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.3 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.43 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.53 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.31 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.23 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 54.15 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.12 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' HIS . . . . . 0.568 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.31 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.35 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.44 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.11 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.3 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 62.23 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 72.14 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.34 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.04 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.3 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.22 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.593 HD12 HG13 ' A' ' 163' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.11 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.1 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.12 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.52 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.21 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.22 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.12 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.04 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.05 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.43 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.52 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.3 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.05 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.41 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.12 110.351 -179.039 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.24 103.665 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.13 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.33 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.31 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.15 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.22 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 220' ' ' VAL . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.4 111.01 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.4 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 41.52 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.51 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.24 115.297 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.13 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.3 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HG2' HD21 ' A' ' 193' ' ' LEU . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.34 111.267 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.12 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 62.11 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.2 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.2 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.22 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.41 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.33 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.24 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.31 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 72.51 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.44 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.11 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.51 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.12 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.01 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.42 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 71.31 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.01 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.44 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.34 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.33 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.1 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 54.51 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.21 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 34.53 113.23 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.42 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.41 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.52 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 157' ' ' PRO . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.31 109.754 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.04 111.928 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.44 107.924 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.474 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 64.11 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 160' ' ' GLU . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.45 107.594 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 71.34 106.851 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.53 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 71.11 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.51 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 62.32 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.54 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.4 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.12 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.41 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.54 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.14 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.23 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.05 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.34 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.31 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.32 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.03 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.44 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.04 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.57 ' HA ' HG11 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.51 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 65.25 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.12 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.42 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.23 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.41 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 72.2 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.22 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.32 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.21 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.53 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.41 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 31.35 111.381 -177.45 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.43 104.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.43 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.04 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.35 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.31 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.04 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.34 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.44 110.774 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 54.22 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' CYS . . . . . 0.403 ' SG ' HD13 ' A' ' 193' ' ' LEU . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 64.34 108.836 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.43 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.45 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.15 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.31 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.2 111.39 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.1 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 73.51 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.12 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.32 110.366 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.23 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.32 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.4 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.11 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.4 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 63.33 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.41 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 64.31 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.55 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.468 HD22 HD22 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 52.2 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.52 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.43 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.3 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 61.32 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.31 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.33 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 182' ' ' ARG . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 71.41 108.514 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.461 HG22 ' HG ' ' A' ' 193' ' ' LEU . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.03 111.321 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.22 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 53.2 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.24 113.053 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.42 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.43 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.23 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.03 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 70.32 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.503 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.45 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 183' ' ' THR . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.01 106.392 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.15 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.32 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.21 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.24 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.15 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.45 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.43 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.51 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 18.7 t60 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 73.31 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.03 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 65.52 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.1 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.54 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.41 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.34 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.03 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.31 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 54.1 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.33 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.12 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.31 109.273 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.645 ' HA ' HG11 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.24 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.51 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.54 109.62 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.43 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.33 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.13 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.4 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.4 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 215' ' ' SER . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.12 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.13 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 74.04 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.43 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.22 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . . . . . . 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.21 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.01 104.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.21 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.15 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.52 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.4 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.11 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.45 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.41 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.32 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.14 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 52.14 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.31 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.13 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.23 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.1 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 52.43 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 61.54 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.14 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.33 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 60.45 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.54 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 65.31 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 54.33 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.11 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.15 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.54 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.23 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.51 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.31 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 197' ' ' LEU . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.01 111.574 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.01 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 35.14 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 72.54 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.15 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 70.1 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.52 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.42 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.01 111.533 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.35 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.21 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 53.23 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 3.3 p30 -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 62.31 112.65 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 160' ' ' GLU . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.22 106.629 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.22 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.2 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.42 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.33 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.21 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.22 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.31 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.43 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.54 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.5 t60 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.32 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.14 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.45 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.45 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.23 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.01 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HA ' HG12 ' A' ' 211' ' ' VAL . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.43 110.675 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.2 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 208' ' ' GLU . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.21 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 63.23 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.5 ' HB3' HG11 ' A' ' 223' ' ' VAL . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 70.21 112.387 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.45 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.2 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 40.32 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.43 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 73.43 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.1 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 215' ' ' SER . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 41.33 110.705 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.13 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 71.42 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.41 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.34 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.12 109.816 -173.872 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 200' ' ' VAL . 6.4 mp . . . . . 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 62.42 103.289 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.03 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.4 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.3 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.35 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 51.02 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.33 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 223' ' ' VAL . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.21 109.836 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 HD22 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.14 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.34 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.32 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.52 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.12 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.35 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.22 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.13 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.31 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.11 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.41 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 31.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.42 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.4 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.31 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.14 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.41 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.419 ' OG1' HD11 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 65.53 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.41 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.13 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.44 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.34 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.55 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 72.31 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.419 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.53 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.41 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.31 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.53 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.42 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 72.51 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.42 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 54.02 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.22 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.11 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.41 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.33 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.629 HD22 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.43 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.53 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.33 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.11 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.23 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.1 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.35 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 72.12 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 146' ' ' LEU . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 64.21 107.76 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 61.14 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 146' ' ' LEU . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.12 109.123 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.53 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.5 t60 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.4 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 71.14 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.53 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.12 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.01 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.11 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 72.33 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.22 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.41 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 62.44 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 35.3 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.23 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.31 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.549 ' HA ' HG11 ' A' ' 220' ' ' VAL . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 41.5 110.977 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.12 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.14 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.42 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.41 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 215' ' ' SER . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.31 110.077 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 72.51 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.11 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 153' ' ' VAL . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.41 108.755 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 74.21 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.23 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.22 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.31 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.44 114.531 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.35 105.257 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.41 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.14 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.33 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.31 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 43.12 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.21 110.143 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.03 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.42 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.24 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.55 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.34 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.43 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.34 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.34 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.21 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.03 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.05 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.34 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 63.42 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.12 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 170' ' ' ARG . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.11 112.227 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.12 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.44 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.33 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.45 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.479 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.12 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.31 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.4 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.4 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.44 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.52 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 194' ' ' THR . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.21 108.357 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.54 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.42 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.22 112.219 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.13 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.2 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.501 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 63.42 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 HD11 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 63.22 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.13 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 65.43 109.09 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.32 108.509 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 182' ' ' ARG . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.21 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.4 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 63.51 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.23 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.479 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.23 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.3 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 33.31 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.54 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.42 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 63.4 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.3 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.44 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.44 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.41 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.31 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.04 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.33 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.4 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.2 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.432 ' O ' HG21 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.23 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.506 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.51 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.33 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.35 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.33 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.44 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.41 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 63.21 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 62.53 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.24 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.43 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.03 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.35 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.02 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.41 109.896 -173.121 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.21 105.427 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.44 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.43 109.159 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.3 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.22 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.14 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.23 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.12 109.031 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.52 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.14 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.24 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.44 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.44 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.22 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 41.15 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.52 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.03 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.05 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.41 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.24 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.54 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.4 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.13 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.31 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.14 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.3 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.21 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.2 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.03 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.22 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.4 ' HD3' HD11 ' A' ' 198' ' ' LEU . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.33 108.595 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.41 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.24 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.4 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.13 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.12 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.34 111.111 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.407 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 61.42 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.34 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.21 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.12 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.3 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.53 107.624 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.23 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.52 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.31 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.32 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.51 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 179' ' ' ARG . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 73.02 107.094 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 207' ' ' LEU . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.42 109.771 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.14 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.21 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.44 108.877 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.2 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.04 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.44 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.54 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' A' ' 199' ' ' MET . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.44 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.42 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.03 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 54.32 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.43 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.15 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.13 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.24 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.2 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.11 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 35.52 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 71.45 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.52 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.42 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.02 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.2 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.12 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.44 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.32 112.061 178.582 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.714 0.292 . . . . 50.54 111.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -92.24 157.94 16.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.745 -0.835 . . . . 74.34 108.745 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -115.3 93.87 4.48 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.957 0.408 . . . . 73.12 110.455 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.0 28.05 6.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 124.595 2.141 . . . . 44.25 106.957 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.89 0.79 4.55 Favored Glycine 0 C--N 1.269 -3.148 0 CA-C-N 111.714 -2.494 . . . . 65.41 110.446 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp -135.19 102.47 5.19 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.04 103.472 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.12 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.34 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.4 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.24 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.43 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.13 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.33 109.105 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.23 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.21 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.35 110.089 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.33 113.245 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.14 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.23 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 191' ' ' ILE . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.32 110.291 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.14 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.42 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.34 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.21 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.44 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.52 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.23 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.2 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.03 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.45 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.43 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.24 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.52 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.03 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.13 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.53 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.33 107.414 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.54 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.2 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.42 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 31.42 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HA ' HG12 ' A' ' 191' ' ' ILE . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.22 110.52 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.45 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.11 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.21 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.32 108.126 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.31 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.482 HG21 ' HG3' ' A' ' 160' ' ' GLU . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.33 106.554 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.2 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.13 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.54 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.51 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.04 106.604 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.13 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.02 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.31 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.432 HG22 ' HG ' ' A' ' 146' ' ' LEU . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.43 107.377 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 33.41 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.517 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 79.7 t60 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.34 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.44 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.53 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.32 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' HD21 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.14 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.14 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.04 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.22 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.13 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.595 ' HB2' HG11 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.33 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.44 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.4 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.41 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.01 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.34 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.42 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.55 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.34 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.3 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TRP . . . . . 0.461 ' CD1' HG21 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.23 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.53 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.41 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.28 117.44 3.34 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.41 110.982 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -64.85 -40.09 94.6 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.889 1.276 . . . . 70.0 110.818 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -94.35 14.14 21.42 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.038 -0.983 . . . . 75.43 109.584 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 58.51 67.18 0.97 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.001 -0.999 . . . . 42.13 109.517 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.04 92.6 7.42 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.575 -1.193 . . . . 63.35 110.388 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -95.94 90.24 5.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.555 -1.646 . . . . 70.34 106.555 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.859 -0.609 . . . . 75.43 111.262 -175.848 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.052 -1.092 . . . . 73.02 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.32 144.43 34.59 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.892 -0.323 . . . . 74.3 110.436 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . 0.264 3.2 m-20 58.29 54.86 5.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 114.94 1.459 . . . . 73.14 114.94 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.14 69.75 9.94 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.491 -0.777 . . . . 64.43 109.174 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.82 -48.36 0.03 OUTLIER Glycine 0 C--N 1.287 -2.182 0 N-CA-C 109.016 -1.634 . . . . 61.02 109.016 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.41 156.05 16.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.32 106.36 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.35 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.01 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 72.41 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.02 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 65.54 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' THR . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.54 111.079 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.02 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.11 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.01 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.42 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 55.45 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.22 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 72.02 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' HD21 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.12 111.584 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.33 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.3 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.32 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.04 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.42 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.15 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 54.21 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.35 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.24 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.12 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.33 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.12 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 64.21 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.14 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.32 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.33 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 61.14 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.01 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.15 108.315 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.53 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.21 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.31 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.24 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.51 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.22 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.12 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.11 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.33 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 71.2 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.43 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.21 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 52.11 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 160' ' ' GLU . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 42.21 108.134 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.34 107.979 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.13 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 72.53 106.043 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.13 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.1 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.22 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.42 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 202' ' ' HIS . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.54 112.892 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 201' ' ' GLY . 71.4 t60 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 72.14 111.471 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.53 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 54.23 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.23 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 210' ' ' LEU . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.21 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.43 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.23 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.41 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.44 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.34 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.2 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.53 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.12 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.12 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.31 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.41 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 21.44 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.33 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.02 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.41 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 63.33 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.42 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 73.52 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 53.34 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.85 -173.44 50.08 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.73 64.99 3.57 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.866 -1.161 . . . . 60.13 107.866 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 63.94 24.69 13.72 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.231 -1.349 . . . . 74.32 110.914 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.25 55.45 6.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.397 -1.274 . . . . 74.21 111.067 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -109.74 129.52 55.61 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.534 -1.212 . . . . 70.43 108.117 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -100.42 107.56 19.33 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.181 0.515 . . . . 74.44 111.38 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 107.842 -1.17 . . . . 74.52 107.842 175.06 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.238 0.492 0 N-CA-C 107.778 -1.193 . . . . 34.21 107.778 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 71.56 115.36 0.05 Allowed 'General case' 0 C--O 1.244 0.788 0 C-N-CA 125.335 1.454 . . . . 71.32 110.488 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.82 107.88 4.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.892 -1.049 . . . . 74.02 112.964 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.78 19.72 4.63 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 123.137 1.446 . . . . 53.14 110.43 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.95 -46.7 5.56 Favored Glycine 0 C--N 1.273 -2.932 0 CA-C-N 112.038 -2.346 . . . . 71.33 107.71 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.21 142.05 47.87 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.05 102.422 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.24 110.481 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.43 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.51 107.488 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.46 HE22 ' HA ' ' A' ' 230' ' ' HIS . 36.9 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.35 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.41 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 194' ' ' THR . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.32 109.023 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 220' ' ' VAL . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.02 109.597 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.32 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.03 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.23 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.31 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 34.22 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.52 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.4 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.54 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 64.54 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.24 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.42 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.34 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.13 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.33 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 174' ' ' ASN . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 71.43 111.682 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.34 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 71.15 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.13 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.15 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.41 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.33 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.22 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.33 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.15 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.55 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.44 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.34 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 63.43 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.31 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.24 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.04 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.44 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 62.34 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.42 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 34.01 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 152' ' ' ARG . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.24 108.099 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.13 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.35 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.23 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.31 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.14 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.04 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.33 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.59 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 73.3 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.45 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.04 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.31 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.43 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.12 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.24 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.34 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.23 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.13 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 62.1 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.41 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.21 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.52 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.1 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 44.52 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.44 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.23 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.11 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 153' ' ' VAL . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 64.13 110.67 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 72.55 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 51.43 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.35 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.23 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.01 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.41 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 100.48 161.47 28.11 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.05 109.975 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.98 77.49 6.1 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.266 1.031 . . . . 71.53 111.039 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.46 ' HA ' HE22 ' A' ' 150' ' ' GLN . 42.1 t60 74.87 -13.27 0.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.495 -1.684 . . . . 62.32 112.803 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.6 43.58 7.49 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 106.083 -1.821 . . . . 65.22 106.083 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.17 106.32 7.72 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 112.04 -2.345 . . . . 54.34 109.168 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.69 95.42 5.28 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.541 -0.911 . . . . 45.31 108.541 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 106.613 -1.625 . . . . 74.53 106.613 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.753 0.787 . . . . 74.11 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.37 141.27 49.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.484 -1.302 . . . . 72.44 107.484 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.459 ' OD1' HD21 ' A' ' 198' ' ' LEU . 45.9 m-20 -86.48 86.17 7.33 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.691 0.997 . . . . 72.31 113.691 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -118.08 35.59 4.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.655 -1.157 . . . . 72.35 109.556 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.91 -53.78 0.13 Allowed Glycine 0 C--N 1.256 -3.862 0 N-CA-C 108.117 -1.993 . . . . 74.54 108.117 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.0 140.44 49.74 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 104.467 -2.42 . . . . 75.13 104.467 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.12 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.41 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.04 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.24 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 62.31 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 71.11 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 220' ' ' VAL . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.54 110.226 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.44 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.24 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.01 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.01 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 71.45 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.01 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.43 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.45 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 64.24 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 44.11 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.51 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 72.34 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 54.0 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 43.45 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.43 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.427 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.11 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.42 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.33 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.31 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.43 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.42 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 44.14 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.11 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD11 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 63.2 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.01 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 73.24 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.507 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.31 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 64.33 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.13 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 35.55 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.1 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.22 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.24 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 64.32 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.14 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.23 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 55.11 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.44 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.507 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 63.0 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.41 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 179' ' ' ARG . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.13 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.504 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.01 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.12 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 33.11 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.15 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.45 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.55 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.34 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 71.12 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.35 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' LEU . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.04 109.195 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.11 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.427 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.34 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 71.12 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.465 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.44 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.05 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.31 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.02 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.21 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.32 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 70.23 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 53.22 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.44 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 62.14 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.54 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.15 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.24 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.3 135.56 8.7 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.52 110.28 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.07 -25.57 55.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.353 -0.98 . . . . 71.01 108.353 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -67.73 96.64 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.687 -1.142 . . . . 54.13 109.382 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.56 79.97 1.3 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.492 0.663 . . . . 73.42 109.353 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -139.49 94.06 2.74 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.075 -1.824 . . . . 71.02 106.075 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -141.55 103.36 4.37 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.508 -0.923 . . . . 64.33 108.508 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 107.286 -1.376 . . . . 51.24 107.286 179.118 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.728 0.299 . . . . 71.4 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -128.97 93.66 3.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.904 -1.147 . . . . 74.24 107.904 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -102.5 19.38 19.08 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 122.93 1.347 . . . . 74.23 109.029 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.19 62.2 1.1 Allowed 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.58 -2.1 . . . . 75.42 109.41 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.19 -46.78 0.03 OUTLIER Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 112.999 -1.91 . . . . 74.13 108.93 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.88 169.84 8.21 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 113.673 -1.264 . . . . 64.13 108.26 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.43 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.4 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 227' ' ' ALA . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.31 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.31 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.21 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.24 110.318 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.41 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.52 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.15 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 32.04 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.53 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.11 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 191' ' ' ILE . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.43 111.118 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.12 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.45 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.41 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.2 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.05 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.13 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.53 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.42 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.13 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 42.52 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.13 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.43 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.33 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.13 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.45 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 62.5 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.23 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.42 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.02 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.13 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.41 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.05 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.22 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.12 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.01 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 51.21 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.14 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.3 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.53 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.03 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.406 HD13 ' HG3' ' A' ' 160' ' ' GLU . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.22 109.694 -176.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 73.11 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.22 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.32 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.11 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.44 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.31 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.13 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.53 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.32 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 72.3 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.25 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.34 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.04 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.51 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 71.23 109.381 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.44 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.43 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.4 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 207' ' ' LEU . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.33 110.636 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.3 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 62.41 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.55 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.22 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 55.2 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 64.33 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.54 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.54 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.54 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.14 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 153' ' ' VAL . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.44 110.025 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.23 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.12 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.12 106.992 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 230' ' ' HIS . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.34 107.196 170.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -69.49 119.24 9.09 Favored Glycine 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.22 113.084 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 69.1 14.83 8.76 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.648 1.213 . . . . 72.12 110.755 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 50.8 m80 -105.62 -59.01 1.83 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.686 -1.143 . . . . 61.31 108.607 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 226' ' ' TYR . . . 59.54 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.491 -1.231 . . . . 73.31 112.949 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 69.49 39.15 1.64 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.504 1.122 . . . . 71.32 111.334 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 230' ' ' HIS . . . -130.66 125.29 33.62 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.222 -1.354 . . . . 43.12 107.393 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.987 -1.116 . . . . 61.34 107.987 -178.547 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.764 0.792 . . . . 70.51 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -153.58 95.34 1.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.513 -1.221 . . . . 75.43 109.91 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 57.41 65.34 1.37 Allowed 'General case' 0 C--O 1.244 0.764 0 O-C-N 124.142 0.901 . . . . 71.23 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.09 57.09 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.208 -0.905 . . . . 71.34 111.937 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -39.66 0.05 OUTLIER Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 114.965 -1.016 . . . . 54.12 110.636 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.41 144.89 35.39 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.34 106.604 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.14 109.156 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.05 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.43 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' HG2' ' ND1' ' A' ' 196' ' ' HIS . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.13 107.627 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.13 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.43 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.14 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.24 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.34 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.32 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.24 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 52.51 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 63.23 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 62.5 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.41 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.22 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.34 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.33 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.01 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.54 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 63.31 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 178' ' ' LEU . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.01 111.723 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.52 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.34 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.21 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.04 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.41 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.44 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.02 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.55 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.43 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.424 HD21 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.23 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 61.02 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.41 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.31 108.421 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 44.11 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.41 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.2 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.43 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.4 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.15 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.33 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.11 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 70.13 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 62.11 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.42 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.404 ' ND1' ' HG2' ' A' ' 150' ' ' GLN . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 73.43 107.556 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.24 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.53 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.13 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.53 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.4 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.1 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 43.34 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 60.41 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.41 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 65.24 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.23 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.473 ' O ' ' HD3' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.21 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 61.13 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.11 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.43 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.24 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.23 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.2 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.32 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.34 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.22 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.31 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.44 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 50.51 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.51 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.44 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.55 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.45 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.07 158.62 9.46 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.14 111.763 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.84 -47.44 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.659 0.742 . . . . 72.21 110.841 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -85.74 -65.33 1.02 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.42 -0.955 . . . . 73.32 108.42 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 173.99 49.48 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.015 -1.476 . . . . 65.22 107.015 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -68.11 114.14 6.37 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.133 -1.394 . . . . 64.34 113.074 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -125.3 85.36 2.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 104.271 -2.492 . . . . 63.24 104.271 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.291 -1.97 0 CA-C-N 114.743 -1.117 . . . . 60.35 109.37 -171.025 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 122.083 0.944 . . . . 42.04 109.695 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.97 162.58 40.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.04 -0.982 . . . . 75.2 109.045 -171.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.4 41.06 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.813 0.816 . . . . 72.2 110.065 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.19 69.25 10.46 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.748 1.261 . . . . 73.22 111.199 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.74 -40.88 0.04 OUTLIER Glycine 0 C--N 1.29 -2.021 0 CA-C-N 112.599 -2.092 . . . . 13.52 107.877 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.95 -171.91 1.94 Allowed 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 64.15 104.191 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.24 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 52.14 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 72.3 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.2 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.21 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.31 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 61.31 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.35 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.24 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.13 114.19 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.42 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.13 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 191' ' ' ILE . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.31 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 65.35 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 64.11 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.11 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 168' ' ' VAL . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.1 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.21 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.41 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.23 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.22 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.53 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.45 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.43 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.41 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.23 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.34 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.31 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.54 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.03 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 167' ' ' ILE . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.33 108.364 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.15 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.41 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 64.12 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.41 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 60.32 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.24 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 191' ' ' ILE . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.13 111.781 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.32 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.33 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.53 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.13 108.071 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.24 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 160' ' ' GLU . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.22 105.366 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 72.21 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.13 107.728 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.15 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 50.13 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.51 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.04 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.11 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.33 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.22 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 51.02 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.24 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.32 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.13 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.35 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 44.21 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.34 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.32 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.34 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.22 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 220' ' ' VAL . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.23 109.674 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 52.15 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.15 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.34 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.01 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.34 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 214' ' ' LEU . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.31 110.05 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.42 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.34 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.32 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.42 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.15 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.54 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 51.04 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.93 -156.41 27.46 Favored Glycine 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.35 10.05 31.7 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.51 0.671 . . . . 71.14 110.808 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -88.83 102.92 15.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.001 -1.0 . . . . 73.43 108.63 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.32 72.69 9.78 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.69 0.757 . . . . 53.22 109.162 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -99.41 112.33 24.54 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.798 -1.092 . . . . 72.24 110.207 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.68 15.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.382 -0.372 . . . . 74.44 111.174 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 107.467 -1.308 . . . . 74.41 107.467 175.474 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.89 -0.411 . . . . 75.21 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -92.29 130.8 37.89 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 108.034 -1.098 . . . . 51.5 108.034 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -90.31 71.46 7.13 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.606 -0.838 . . . . 74.44 110.59 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.26 24.98 4.18 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 122.524 1.154 . . . . 64.4 111.066 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -97.43 -40.98 3.53 Favored Glycine 0 C--N 1.268 -3.222 0 N-CA-C 106.375 -2.69 . . . . 61.42 106.375 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.01 128.65 42.43 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.33 103.235 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.35 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.53 111.969 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.41 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.21 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.24 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 44.03 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 220' ' ' VAL . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.13 110.76 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.01 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.52 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.22 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.11 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.55 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.11 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.02 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.24 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.53 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.15 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.53 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.15 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.21 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.43 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.2 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.53 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.35 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 210' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 198' ' ' LEU . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 53.35 107.772 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.11 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.32 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.3 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.32 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.51 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 70.13 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.12 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.12 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.15 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.42 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.54 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.21 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.22 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.41 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 53.55 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.44 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.43 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.23 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 61.3 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 177' ' ' THR . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 61.01 108.185 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.44 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.33 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.21 109.289 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 41.44 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.32 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.23 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.3 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 62.15 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 176' ' ' ILE . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.4 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.22 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.24 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.24 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 62.01 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.11 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.31 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.03 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 72.52 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.33 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 153' ' ' VAL . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.4 110.936 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.11 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.21 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 63.54 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.23 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.34 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.31 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.44 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.72 113.35 5.64 Favored Glycine 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.24 111.141 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -69.75 -66.71 0.55 Allowed 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.649 -1.241 . . . . 74.12 107.649 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.47 -49.27 1.28 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.34 -1.726 . . . . 73.1 106.34 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 52.11 40.16 28.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.93 -1.486 . . . . 73.3 109.567 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -98.32 129.13 45.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 113.173 -1.83 . . . . 53.14 109.638 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.42 86.43 7.08 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.47 0.653 . . . . 63.53 109.924 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 107.443 -1.317 . . . . 55.4 107.443 176.283 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.365 0 CA-C-O 122.119 0.961 . . . . 73.4 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.33 80.03 4.43 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 71.13 109.105 -172.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 61.17 31.54 19.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.851 1.26 . . . . 51.41 110.343 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.31 71.6 9.95 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.104 -1.862 . . . . 72.52 110.016 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -37.64 0.05 OUTLIER Glycine 0 C--N 1.274 -2.865 0 CA-C-N 112.176 -2.284 . . . . 62.24 107.662 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.31 149.73 30.21 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 62.22 105.26 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.13 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.3 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.1 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.13 107.326 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.22 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.22 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.33 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.01 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.23 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.45 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.35 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.22 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.33 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.14 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.21 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.593 HG13 HD12 ' A' ' 214' ' ' LEU . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.21 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 61.41 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.03 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.42 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.54 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.31 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.2 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.406 ' OG1' HD11 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.11 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 72.42 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.01 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.44 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.43 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 71.33 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.41 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.55 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.21 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.55 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.53 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.04 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.34 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.4 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.35 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.14 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.32 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.05 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 64.34 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.14 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.34 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.3 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.34 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.3 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.43 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.53 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.31 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.23 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 54.15 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.12 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.568 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.31 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.35 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.44 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.11 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.3 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 62.23 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 72.14 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.34 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.04 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.3 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.22 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.593 HD12 HG13 ' A' ' 163' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.11 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.1 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.12 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.52 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.21 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.22 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.12 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.04 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.05 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.43 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.52 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.3 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.05 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.41 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.94 144.26 15.81 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.12 110.351 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -24.26 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.707 0.753 . . . . 44.42 111.225 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -125.1 5.63 7.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.194 0.521 . . . . 71.34 110.435 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 69.39 54.94 0.4 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.228 1.011 . . . . 60.04 111.84 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.34 110.49 23.07 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 105.29 -2.115 . . . . 74.23 105.29 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.71 99.82 12.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 110.174 -0.306 . . . . 61.11 110.174 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 107.161 -1.422 . . . . 54.44 107.161 177.815 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 108.336 -0.987 . . . . 72.24 108.336 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.07 107.87 8.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.489 -2.041 . . . . 72.32 105.489 170.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.53 66.97 0.73 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.346 1.07 . . . . 74.5 112.103 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.91 32.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.766 1.746 . . . . 71.43 107.745 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.87 -45.92 1.24 Allowed Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 111.459 -2.609 . . . . 61.32 106.854 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.73 163.63 13.93 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.24 103.665 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.13 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.33 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.31 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.15 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.22 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 220' ' ' VAL . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.4 111.01 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.4 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 41.52 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.51 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.24 115.297 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.13 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.3 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HG2' HD21 ' A' ' 193' ' ' LEU . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.34 111.267 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.12 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 62.11 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.2 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.2 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.22 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.41 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.33 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.24 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.31 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 72.51 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.44 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.11 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.51 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.12 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.01 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.42 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 71.31 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.01 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.44 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.34 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.33 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.1 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 54.51 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.21 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 34.53 113.23 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.42 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.41 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.52 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 157' ' ' PRO . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.31 109.754 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.04 111.928 175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.44 107.924 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.474 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 64.11 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 160' ' ' GLU . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.45 107.594 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 71.34 106.851 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.13 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.53 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 71.11 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.51 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 62.32 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.54 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.4 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.12 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.41 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.54 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.14 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.23 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.05 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.34 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.31 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.32 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.03 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.44 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.04 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.57 ' HA ' HG11 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.51 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 65.25 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.12 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.42 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.23 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.41 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 72.2 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.22 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.32 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.21 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.53 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.41 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.72 139.23 10.7 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 31.35 111.381 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.33 -44.77 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.167 0.508 . . . . 72.41 111.27 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -93.18 24.46 3.79 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.969 0.89 . . . . 72.23 108.683 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.76 57.11 2.75 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.045 -1.434 . . . . 53.15 111.149 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 66.28 89.51 0.1 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.587 -1.188 . . . . 72.03 110.438 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -80.35 88.49 5.55 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.594 0.711 . . . . 71.5 110.061 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 107.883 -1.154 . . . . 65.22 107.883 -178.441 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 122.138 0.971 . . . . 61.33 111.229 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -126.57 99.91 6.0 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.074 -1.454 . . . . 73.24 107.074 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -87.17 109.91 19.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.299 0.852 . . . . 64.32 113.299 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -147.88 31.66 0.86 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.174 1.464 . . . . 70.4 109.929 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -99.05 -49.69 1.56 Allowed Glycine 0 C--N 1.267 -3.252 0 N-CA-C 106.731 -2.547 . . . . 51.34 106.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.7 140.96 30.52 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.43 104.101 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.43 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.04 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.35 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.31 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.04 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.34 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.44 110.774 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 54.22 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CYS . . . . . 0.403 ' SG ' HD13 ' A' ' 193' ' ' LEU . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 64.34 108.836 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.43 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.45 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.15 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.31 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.2 111.39 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.1 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 73.51 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.12 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.32 110.366 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.23 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.32 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.4 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.11 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.4 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 63.33 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.41 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 64.31 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.55 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.468 HD22 HD22 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 52.2 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.52 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.43 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.3 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 61.32 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.31 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.33 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 182' ' ' ARG . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 71.41 108.514 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.461 HG22 ' HG ' ' A' ' 193' ' ' LEU . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.03 111.321 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.22 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 53.2 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.24 113.053 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.42 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.43 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.23 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.03 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 70.32 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.503 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.45 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 183' ' ' THR . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.01 106.392 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.15 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.32 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.21 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.24 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.15 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.45 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.43 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.51 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 18.7 t60 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 73.31 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.03 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 65.52 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.1 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.54 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.41 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.34 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.03 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.31 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 54.1 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.33 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.12 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.31 109.273 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.645 ' HA ' HG11 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.24 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.51 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.54 109.62 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.43 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.33 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.13 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.4 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.4 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 215' ' ' SER . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.12 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.13 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 74.04 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.43 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.22 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . 83.49 -158.8 36.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.21 110.044 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.55 19.09 3.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 117.699 0.75 . . . . 51.22 111.798 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.42 103.61 15.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.428 -0.953 . . . . 70.55 108.428 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.29 5.57 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.828 -0.624 . . . . 64.53 109.94 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -104.5 113.15 26.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.548 -0.538 . . . . 61.01 109.548 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -90.94 84.61 5.8 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.404 0.621 . . . . 74.11 109.574 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 115.238 -0.892 . . . . 74.54 108.656 -179.127 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 121.51 0.672 . . . . 71.44 109.735 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -119.04 152.74 35.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.79 -0.818 . . . . 72.21 108.79 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.73 91.55 4.7 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.814 -0.439 . . . . 64.34 109.814 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.33 23.77 12.17 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 123.242 1.496 . . . . 75.33 110.71 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.02 -25.82 8.21 Favored Glycine 0 C--N 1.272 -2.997 0 CA-C-N 112.048 -2.342 . . . . 64.51 108.896 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.36 153.44 23.27 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.01 104.639 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.21 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.15 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.52 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.4 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.11 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.45 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.41 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.32 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.14 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 52.14 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.31 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.13 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.23 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.1 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 52.43 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 61.54 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.14 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.33 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 60.45 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.54 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 65.31 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 54.33 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.11 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.15 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.54 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.23 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.51 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.31 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 197' ' ' LEU . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.01 111.574 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.01 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 35.14 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 72.54 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.15 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 70.1 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.52 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.42 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.01 111.533 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.35 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.21 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 53.23 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 3.3 p30 -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 62.31 112.65 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 160' ' ' GLU . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.22 106.629 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.22 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.2 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.42 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.33 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.21 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.22 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.31 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.43 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.54 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.5 t60 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.32 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.14 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.45 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.45 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.23 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.01 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HA ' HG12 ' A' ' 211' ' ' VAL . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.43 110.675 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.2 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 208' ' ' GLU . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.21 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 63.23 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.5 ' HB3' HG11 ' A' ' 223' ' ' VAL . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 70.21 112.387 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.45 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.2 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 40.32 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.43 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 73.43 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.1 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 215' ' ' SER . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 41.33 110.705 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.13 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 71.42 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.41 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.34 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA2' ' OE1' ' A' ' 232' ' ' GLN . . . 111.09 141.37 8.63 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.12 109.816 -173.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.15 -46.55 6.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.263 1.209 . . . . 74.52 114.263 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.44 -69.16 0.55 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.223 -1.028 . . . . 74.22 108.223 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -178.87 71.71 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.278 1.431 . . . . 72.22 107.168 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.416 ' OE1' ' HA2' ' A' ' 228' ' ' GLY . 50.4 mt-30 -95.13 83.06 3.84 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.899 . . . . 74.22 111.546 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -159.86 150.64 19.13 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.045 -1.835 . . . . 70.13 106.045 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.888 -1.153 . . . . 72.21 107.888 -179.407 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.504 -0.804 0 CA-C-O 121.793 0.806 . . . . 61.51 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -125.37 165.87 17.61 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.835 -1.172 . . . . 64.04 107.835 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' CG ' ' HE ' ' A' ' 179' ' ' ARG . 5.6 p-10 -82.66 70.3 9.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.877 1.322 . . . . 53.31 110.548 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 52.7 1.04 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.206 -1.776 . . . . 61.51 106.206 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -133.12 -48.73 0.1 OUTLIER Glycine 0 C--N 1.279 -2.605 0 N-CA-C 105.259 -3.136 . . . . 40.33 105.259 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 200' ' ' VAL . 6.4 mp -97.28 137.66 35.95 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 62.42 103.289 169.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.03 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.4 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.3 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.35 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 51.02 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.33 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 223' ' ' VAL . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.21 109.836 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 HD22 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.14 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.34 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.32 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.52 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.12 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.35 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.22 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.13 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.31 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.11 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.41 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 31.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.42 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.4 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.31 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.14 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.41 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.419 ' OG1' HD11 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 65.53 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.41 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.13 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.44 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.34 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.55 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 72.31 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.53 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.41 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.31 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.53 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.42 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 72.51 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.42 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 54.02 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.22 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.11 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.41 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.33 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.629 HD22 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.43 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.53 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.33 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.11 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.23 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.1 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.35 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 72.12 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 146' ' ' LEU . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 64.21 107.76 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 61.14 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 146' ' ' LEU . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.12 109.123 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.53 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.5 t60 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.4 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 71.14 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.53 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.12 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.01 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.11 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 72.33 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.22 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.41 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 62.44 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 35.3 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.23 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.31 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.549 ' HA ' HG11 ' A' ' 220' ' ' VAL . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 41.5 110.977 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.12 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.14 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.42 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.41 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 215' ' ' SER . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.31 110.077 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 72.51 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.11 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 153' ' ' VAL . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.41 108.755 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 74.21 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.23 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.22 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.31 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -37.88 112.24 0.18 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.44 114.531 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.69 -50.77 61.79 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.434 -0.883 . . . . 70.42 110.009 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -101.33 -5.13 25.83 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.303 -0.862 . . . . 72.25 109.966 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.36 83.94 1.97 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.074 -0.512 . . . . 74.24 109.845 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -61.35 109.13 1.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.9 -1.046 . . . . 73.24 109.766 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 146.96 46.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.87 -0.605 . . . . 62.32 110.132 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 108.637 -0.875 . . . . 72.31 108.637 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 107.268 -1.382 . . . . 63.44 107.268 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -128.98 40.33 3.65 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.525 1.155 . . . . 63.21 108.476 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.41 58.61 0.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.419 -1.719 . . . . 74.52 107.367 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.82 33.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.482 -1.236 . . . . 54.01 113.008 -171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.93 -7.84 37.76 Favored Glycine 0 C--N 1.26 -3.693 0 N-CA-C 108.914 -1.674 . . . . 53.14 108.914 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp -137.12 153.8 50.43 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.35 105.257 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.41 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.14 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.33 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.31 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 43.12 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.21 110.143 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.03 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.24 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.42 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.24 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.55 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.34 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.43 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.34 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.34 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.21 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.03 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.05 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.34 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 63.42 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.12 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 170' ' ' ARG . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.11 112.227 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.12 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.44 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.33 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.45 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.479 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.12 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.31 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.4 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.4 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.44 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.52 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 194' ' ' THR . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.21 108.357 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.54 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.42 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.22 112.219 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.13 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.2 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.501 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 63.42 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 HD11 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 63.22 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.13 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 65.43 109.09 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.32 108.509 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 182' ' ' ARG . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.21 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.4 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 63.51 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.23 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.479 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.23 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.3 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 33.31 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.54 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.42 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 63.4 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.3 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.44 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.44 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.41 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.31 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.04 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.33 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.4 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.2 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.432 ' O ' HG21 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.23 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.506 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.51 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.33 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.35 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.33 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.44 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.41 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 63.21 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 62.53 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.24 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.43 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.03 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.35 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.02 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 114.17 161.18 13.81 Favored Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.41 109.896 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.1 -10.79 17.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.254 0.464 . . . . 74.41 112.254 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -78.1 111.38 13.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.002 -0.74 . . . . 73.44 109.002 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.03 38.49 0.76 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.715 0.769 . . . . 64.42 111.354 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -156.72 115.12 3.3 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 125.667 1.587 . . . . 73.14 108.928 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -167.09 -48.29 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.891 0 CA-C-O 123.488 1.613 . . . . 74.32 109.505 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 1 C--N 1.23 -4.621 0 CA-C-N 111.366 -2.652 . . . . 72.44 107.196 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.506 -0.724 0 N-CA-C 108.274 -1.01 . . . . 74.32 108.274 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -106.75 130.38 54.48 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.008 -1.108 . . . . 70.21 108.008 176.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.66 31.53 4.37 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.509 1.147 . . . . 72.01 110.68 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.64 39.79 1.04 Allowed 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 113.785 -1.552 . . . . 73.14 111.16 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.23 -5.28 8.04 Favored Glycine 0 C--N 1.279 -2.586 0 CA-C-N 112.921 -1.945 . . . . 62.45 108.929 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.59 150.77 45.58 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.21 105.427 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.44 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.43 109.159 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.3 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.22 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.14 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.23 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.12 109.031 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.52 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.14 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.24 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.44 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.44 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.22 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 41.15 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.52 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.03 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.05 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.41 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.24 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.54 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.4 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.13 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.31 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.14 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.3 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.21 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.2 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.03 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.22 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.4 ' HD3' HD11 ' A' ' 198' ' ' LEU . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.33 108.595 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.41 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.24 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.4 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.13 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.12 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.34 111.111 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.407 ' HB3' ' OD1' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 61.42 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.34 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.21 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.12 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.3 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.53 107.624 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.23 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.52 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.31 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.32 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.51 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 179' ' ' ARG . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 73.02 107.094 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 207' ' ' LEU . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.42 109.771 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.14 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.21 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.44 108.877 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.2 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.04 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.44 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.54 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' A' ' 199' ' ' MET . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.44 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.42 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.03 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 54.32 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.43 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.15 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.13 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.24 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.2 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.42 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.11 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 35.52 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 71.45 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.52 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.42 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.02 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.2 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.12 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.44 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.82 156.42 9.49 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.32 112.061 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -63.94 -44.58 92.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.898 0.856 . . . . 64.23 108.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -115.9 12.93 15.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.557 -1.201 . . . . 75.34 108.643 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 57.89 62.57 2.03 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.752 -1.113 . . . . 74.23 110.85 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -82.93 115.0 21.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.81 -1.086 . . . . 73.41 109.961 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.95 139.96 15.37 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.246 -1.761 . . . . 65.13 106.246 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.288 -2.067 0 N-CA-C 108.816 -0.809 . . . . 73.31 108.816 -176.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.040000000000006 103.472 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.119999999999997 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.340000000000003 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.400000000000006 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.239999999999995 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.430000000000007 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.130000000000003 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.329999999999998 109.105 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.230000000000004 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.209999999999994 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.349999999999994 110.089 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 113.245 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.140000000000001 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.230000000000004 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 191' ' ' ILE . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.319999999999993 110.291 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.140000000000001 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.420000000000002 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.340000000000003 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.209999999999994 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.439999999999998 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.519999999999996 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.230000000000004 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.200000000000003 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.030000000000001 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.450000000000003 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.239999999999995 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.520000000000003 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.030000000000001 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.130000000000003 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.530000000000001 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.329999999999998 107.414 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.540000000000006 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.200000000000003 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.420000000000002 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 31.420000000000002 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HA ' HG12 ' A' ' 191' ' ' ILE . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.219999999999999 110.52 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.450000000000003 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.109999999999999 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.209999999999994 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.319999999999993 108.126 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.310000000000002 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.482 HG21 ' HG3' ' A' ' 160' ' ' GLU . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.329999999999998 106.554 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.200000000000003 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.129999999999995 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.540000000000006 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.509999999999998 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.039999999999999 106.604 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.019999999999996 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.310000000000002 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.432 HG22 ' HG ' ' A' ' 146' ' ' LEU . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.430000000000007 107.377 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 33.409999999999997 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.517 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 25.4 t-80 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.340000000000003 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.439999999999998 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.530000000000001 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' HD21 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.140000000000001 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.140000000000001 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.040000000000006 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.219999999999999 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.129999999999995 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.595 ' HB2' HG11 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.329999999999998 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.439999999999998 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.400000000000006 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.409999999999997 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.010000000000005 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.340000000000003 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.420000000000002 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.549999999999997 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.340000000000003 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.299999999999997 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . 0.461 ' CD1' HG21 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.230000000000004 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.530000000000001 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.409999999999997 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.409999999999997 110.982 -175.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.319999999999993 106.36 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.349999999999994 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.010000000000005 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 72.409999999999997 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.020000000000003 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 65.540000000000006 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' THR . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.540000000000006 111.079 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.020000000000003 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.109999999999999 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.010000000000005 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.420000000000002 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 55.450000000000003 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.219999999999999 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 72.019999999999996 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' HD21 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.120000000000005 111.584 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.299999999999997 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.319999999999993 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.040000000000006 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.420000000000002 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.150000000000006 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 54.210000000000001 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.349999999999994 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.239999999999995 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.329999999999998 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.120000000000005 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 64.209999999999994 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.140000000000001 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.319999999999993 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.329999999999998 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 61.140000000000001 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.010000000000005 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.425 HH11 ' CE1' ' A' ' 196' ' ' HIS . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.150000000000006 108.315 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.530000000000001 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.209999999999994 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.310000000000002 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.239999999999995 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.510000000000005 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.219999999999999 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.120000000000005 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.109999999999999 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.329999999999998 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 71.200000000000003 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.430000000000007 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 52.109999999999999 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 160' ' ' GLU . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 42.210000000000001 108.134 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.340000000000003 107.979 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.130000000000003 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CE1' HH11 ' A' ' 179' ' ' ARG . 3.7 t60 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 72.530000000000001 106.043 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.130000000000003 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.099999999999994 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.219999999999999 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.420000000000002 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 202' ' ' HIS . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.539999999999999 112.892 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 201' ' ' GLY . 23.9 t-80 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 72.140000000000001 111.471 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.530000000000001 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 54.229999999999997 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.230000000000004 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 210' ' ' LEU . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.209999999999994 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.430000000000007 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.229999999999997 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.409999999999997 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.439999999999998 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.340000000000003 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.200000000000003 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.53 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.120000000000005 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.120000000000005 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.310000000000002 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.409999999999997 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 21.440000000000001 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.019999999999996 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.409999999999997 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 63.329999999999998 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.420000000000002 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 73.519999999999996 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 53.340000000000003 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.049999999999997 102.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.239999999999995 110.481 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.430000000000007 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.510000000000005 107.488 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 35.8 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.349999999999994 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.409999999999997 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 194' ' ' THR . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.319999999999993 109.023 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 220' ' ' VAL . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.019999999999996 109.597 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.319999999999993 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.030000000000001 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.229999999999997 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.310000000000002 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 34.219999999999999 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.519999999999996 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.400000000000006 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.540000000000006 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 64.540000000000006 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.239999999999995 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.420000000000002 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.340000000000003 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.129999999999995 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.329999999999998 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 174' ' ' ASN . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 71.430000000000007 111.682 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.340000000000003 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 71.150000000000006 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.129999999999995 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.150000000000006 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.319999999999993 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.409999999999997 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.329999999999998 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.219999999999999 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.329999999999998 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.150000000000006 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.549999999999997 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.439999999999998 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.340000000000003 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 63.43 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.310000000000002 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.240000000000002 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.040000000000006 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.439999999999998 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 62.340000000000003 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.420000000000002 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 34.009999999999998 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 152' ' ' ARG . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.239999999999995 108.099 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.129999999999995 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.349999999999994 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.230000000000004 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.310000000000002 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.140000000000001 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.039999999999999 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.329999999999998 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.59 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 73.299999999999997 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.450000000000003 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.040000000000006 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.310000000000002 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.43 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.120000000000005 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.340000000000003 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 62.100000000000001 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.409999999999997 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.209999999999994 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.519999999999996 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.100000000000001 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 44.520000000000003 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.439999999999998 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.230000000000004 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.109999999999999 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 153' ' ' VAL . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 64.129999999999995 110.67 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 72.549999999999997 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 51.43 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.349999999999994 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.229999999999997 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.010000000000005 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.409999999999997 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 55.439999999999998 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.049999999999997 109.975 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.41 -2.446 0 N-CA-C 104.467 -2.42 . . . . 75.129999999999995 104.467 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.120000000000005 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.409999999999997 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.040000000000006 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.239999999999995 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 62.310000000000002 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 71.109999999999999 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 220' ' ' VAL . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.540000000000006 110.226 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.439999999999998 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.239999999999995 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.010000000000005 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.010000000000005 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 71.450000000000003 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.010000000000005 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.430000000000007 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.450000000000003 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 64.239999999999995 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 44.109999999999999 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.510000000000005 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 72.340000000000003 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 73.430000000000007 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 54.0 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 43.450000000000003 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.427 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.109999999999999 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.420000000000002 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.329999999999998 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.310000000000002 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.430000000000007 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.420000000000002 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 44.140000000000001 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.109999999999999 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.478 HD11 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 63.200000000000003 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.009999999999998 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 73.239999999999995 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.507 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.310000000000002 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 64.329999999999998 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.129999999999995 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 35.549999999999997 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.099999999999994 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.219999999999999 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.239999999999995 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 64.319999999999993 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.140000000000001 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.229999999999997 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.439999999999998 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 55.109999999999999 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.439999999999998 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.507 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 63.0 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.409999999999997 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 179' ' ' ARG . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.129999999999995 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.504 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.009999999999998 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.120000000000005 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 33.109999999999999 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.150000000000006 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.450000000000003 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.549999999999997 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.400000000000006 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 71.120000000000005 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.349999999999994 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' LEU . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.040000000000006 109.195 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.109999999999999 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.427 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.340000000000003 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 71.120000000000005 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.465 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.439999999999998 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.049999999999997 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.310000000000002 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.019999999999996 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.209999999999994 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.319999999999993 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 70.230000000000004 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 53.219999999999999 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.439999999999998 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 62.140000000000001 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.540000000000006 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.150000000000006 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.239999999999995 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.519999999999996 110.28 -177.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 108.26 -1.015 . . . . 64.129999999999995 108.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.430000000000007 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.400000000000006 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 227' ' ' ALA . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.310000000000002 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.310000000000002 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.209999999999994 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.240000000000002 110.318 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.409999999999997 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.519999999999996 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.150000000000006 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 32.039999999999999 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.530000000000001 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.109999999999999 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 191' ' ' ILE . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.430000000000007 111.118 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.120000000000005 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.450000000000003 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.409999999999997 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.200000000000003 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.049999999999997 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.129999999999995 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.530000000000001 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.129999999999995 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 42.520000000000003 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.129999999999995 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.430000000000007 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.129999999999995 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.450000000000003 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 62.5 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.229999999999997 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.420000000000002 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.019999999999996 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.129999999999995 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.409999999999997 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.049999999999997 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.219999999999999 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.119999999999997 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.010000000000005 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 51.210000000000001 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.140000000000001 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.299999999999997 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.530000000000001 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.030000000000001 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.406 HD13 ' HG3' ' A' ' 160' ' ' GLU . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.219999999999999 109.694 -176.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 73.109999999999999 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.219999999999999 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.319999999999993 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.109999999999999 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.439999999999998 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.310000000000002 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.129999999999995 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.530000000000001 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.319999999999993 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 72.299999999999997 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.25 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.340000000000003 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.039999999999999 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.510000000000005 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 71.230000000000004 109.381 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.430000000000007 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.399999999999999 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 207' ' ' LEU . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.329999999999998 110.636 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.299999999999997 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 62.409999999999997 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.549999999999997 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 55.200000000000003 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 64.329999999999998 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.540000000000006 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.540000000000006 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.540000000000006 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.140000000000001 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 153' ' ' VAL . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.439999999999998 110.025 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.120000000000005 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.120000000000005 106.992 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.340000000000003 107.196 170.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.219999999999999 113.084 -169.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.340000000000003 106.604 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.140000000000001 109.156 -177.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.049999999999997 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.430000000000007 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.404 ' HG2' ' ND1' ' A' ' 196' ' ' HIS . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.129999999999995 107.627 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.130000000000003 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.430000000000007 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.140000000000001 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.239999999999995 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.340000000000003 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.319999999999993 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.239999999999995 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 52.509999999999998 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 63.229999999999997 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 62.5 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.409999999999997 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.219999999999999 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.340000000000003 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.329999999999998 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.009999999999998 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.540000000000006 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 63.310000000000002 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 178' ' ' LEU . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.010000000000005 111.723 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.519999999999996 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.340000000000003 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.209999999999994 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.039999999999999 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.409999999999997 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.439999999999998 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.019999999999996 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.549999999999997 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.430000000000007 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.424 HD21 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.229999999999997 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 61.020000000000003 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.409999999999997 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.310000000000002 108.421 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 44.109999999999999 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.409999999999997 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.200000000000003 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.430000000000007 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.400000000000006 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.150000000000006 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.329999999999998 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.109999999999999 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 70.129999999999995 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 62.109999999999999 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.420000000000002 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.404 ' ND1' ' HG2' ' A' ' 150' ' ' GLN . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 73.430000000000007 107.556 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.240000000000002 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.530000000000001 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.129999999999995 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.530000000000001 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.400000000000006 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.099999999999994 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 43.340000000000003 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 60.409999999999997 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.409999999999997 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 65.239999999999995 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.230000000000004 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.209999999999994 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 61.130000000000003 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.109999999999999 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.430000000000007 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.239999999999995 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.230000000000004 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.200000000000003 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.319999999999993 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.340000000000003 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.219999999999999 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.310000000000002 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.439999999999998 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 50.509999999999998 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.510000000000005 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.439999999999998 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.549999999999997 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.450000000000003 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.140000000000001 111.763 -177.494 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 64.150000000000006 104.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.240000000000002 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 52.140000000000001 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 72.299999999999997 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.200000000000003 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.310000000000002 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 61.310000000000002 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.349999999999994 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.239999999999995 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.129999999999995 114.19 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.420000000000002 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.130000000000003 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 191' ' ' ILE . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.310000000000002 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 65.349999999999994 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 64.109999999999999 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.109999999999999 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 168' ' ' VAL . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.099999999999994 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.210000000000001 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.409999999999997 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.230000000000004 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.530000000000001 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.450000000000003 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.430000000000007 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.230000000000004 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.340000000000003 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.310000000000002 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.540000000000006 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.030000000000001 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 167' ' ' ILE . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.329999999999998 108.364 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.150000000000006 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.409999999999997 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 64.120000000000005 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.409999999999997 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 60.32 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.239999999999995 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 191' ' ' ILE . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.130000000000003 111.781 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.319999999999993 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.329999999999998 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.530000000000001 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.129999999999995 108.071 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.240000000000002 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 160' ' ' GLU . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.219999999999999 105.366 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 72.209999999999994 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.129999999999995 107.728 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.150000000000006 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 50.130000000000003 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.510000000000005 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.040000000000006 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.109999999999999 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.329999999999998 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.219999999999999 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 51.020000000000003 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.239999999999995 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.319999999999993 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.130000000000003 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 44.210000000000001 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.319999999999993 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.450000000000003 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.340000000000003 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.219999999999999 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 220' ' ' VAL . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.229999999999997 109.674 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 52.149999999999999 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.340000000000003 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.010000000000005 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.340000000000003 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 214' ' ' LEU . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.310000000000002 110.05 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.420000000000002 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.340000000000003 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.319999999999993 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.420000000000002 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.150000000000006 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.540000000000006 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 51.039999999999999 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.329999999999998 103.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.349999999999994 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.530000000000001 111.969 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.423 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.409999999999997 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.209999999999994 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.240000000000002 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 44.030000000000001 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 220' ' ' VAL . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.130000000000003 110.76 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.009999999999998 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.519999999999996 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.219999999999999 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.109999999999999 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.549999999999997 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.109999999999999 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.019999999999996 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.239999999999995 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.530000000000001 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.150000000000006 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.530000000000001 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.150000000000006 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.209999999999994 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.200000000000003 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.530000000000001 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.349999999999994 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 210' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 198' ' ' LEU . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 53.350000000000001 107.772 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.109999999999999 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.319999999999993 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.319999999999993 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.510000000000005 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 70.129999999999995 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.119999999999997 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.120000000000005 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.150000000000006 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.420000000000002 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.539999999999999 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.209999999999994 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.219999999999999 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.409999999999997 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 53.549999999999997 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.439999999999998 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.230000000000004 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 61.299999999999997 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 177' ' ' THR . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 61.009999999999998 108.185 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.439999999999998 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.329999999999998 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.423 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.6 t-80 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.210000000000001 109.289 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 41.439999999999998 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.319999999999993 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.230000000000004 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.299999999999997 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 62.149999999999999 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 176' ' ' ILE . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.400000000000006 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.219999999999999 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.239999999999995 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 62.009999999999998 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.109999999999999 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.310000000000002 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.030000000000001 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 72.519999999999996 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.329999999999998 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 153' ' ' VAL . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.399999999999999 110.936 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.109999999999999 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.209999999999994 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 63.539999999999999 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.230000000000004 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.340000000000003 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.310000000000002 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.439999999999998 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.239999999999995 111.141 179.174 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 62.219999999999999 105.26 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.129999999999995 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.299999999999997 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.099999999999994 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.129999999999995 107.326 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.219999999999999 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.219999999999999 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.329999999999998 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.009999999999998 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.230000000000004 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.450000000000003 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.349999999999994 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.219999999999999 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.329999999999998 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.140000000000001 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.209999999999994 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.593 HG13 HD12 ' A' ' 214' ' ' LEU . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.209999999999994 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 61.409999999999997 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.030000000000001 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.420000000000002 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.540000000000006 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.310000000000002 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.200000000000003 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.406 ' OG1' HD11 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.109999999999999 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 72.420000000000002 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.010000000000005 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.439999999999998 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.430000000000007 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 71.329999999999998 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.406 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.409999999999997 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.549999999999997 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.210000000000001 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.549999999999997 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.530000000000001 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.040000000000006 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.340000000000003 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.400000000000006 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.350000000000001 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.140000000000001 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.319999999999993 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.049999999999997 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 64.340000000000003 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.140000000000001 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.340000000000003 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.299999999999997 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.340000000000003 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.299999999999997 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.430000000000007 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.530000000000001 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.310000000000002 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.230000000000004 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 54.149999999999999 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.120000000000005 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . 0.568 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.310000000000002 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.349999999999994 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.439999999999998 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.109999999999999 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.299999999999997 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 62.229999999999997 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 72.140000000000001 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.340000000000003 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.040000000000006 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.299999999999997 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.219999999999999 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.593 HD12 HG13 ' A' ' 163' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.109999999999999 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.099999999999994 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.120000000000005 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.519999999999996 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.209999999999994 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.219999999999999 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.119999999999997 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.040000000000006 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.049999999999997 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.519999999999996 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.299999999999997 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.049999999999997 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.409999999999997 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.120000000000005 110.351 -179.039 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.239999999999995 103.665 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.129999999999995 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.329999999999998 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.329999999999998 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.310000000000002 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.150000000000006 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.474 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.219999999999999 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 220' ' ' VAL . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.400000000000006 111.01 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.399999999999999 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 41.520000000000003 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.510000000000005 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.240000000000002 115.297 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.129999999999995 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.299999999999997 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HG2' HD21 ' A' ' 193' ' ' LEU . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.340000000000003 111.267 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.120000000000005 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 62.109999999999999 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.200000000000003 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.200000000000003 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.219999999999999 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.329999999999998 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.239999999999995 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.310000000000002 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 72.510000000000005 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.439999999999998 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.109999999999999 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.509999999999998 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.120000000000005 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.010000000000005 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.420000000000002 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 71.310000000000002 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.010000000000005 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.439999999999998 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.340000000000003 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.329999999999998 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.099999999999994 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 54.509999999999998 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.209999999999994 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 34.530000000000001 113.23 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.420000000000002 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.409999999999997 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.519999999999996 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 157' ' ' PRO . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.310000000000002 109.754 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.040000000000006 111.928 175.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.439999999999998 107.924 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.474 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 160' ' ' GLU . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.450000000000003 107.594 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 71.340000000000003 106.851 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.530000000000001 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 71.109999999999999 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.510000000000005 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 62.32 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.539999999999999 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.399999999999999 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.120000000000005 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.409999999999997 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.140000000000001 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.230000000000004 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.049999999999997 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.340000000000003 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.310000000000002 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.319999999999993 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.030000000000001 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.439999999999998 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.040000000000006 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.57 ' HA ' HG11 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.510000000000005 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 65.25 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.120000000000005 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.420000000000002 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.230000000000004 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.409999999999997 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 72.200000000000003 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.219999999999999 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.319999999999993 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.209999999999994 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.530000000000001 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.409999999999997 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 31.350000000000001 111.381 -177.45 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.430000000000007 104.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.430000000000007 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.040000000000006 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.349999999999994 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.310000000000002 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.040000000000006 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.439999999999998 110.774 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 54.219999999999999 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . 0.403 ' SG ' HD13 ' A' ' 193' ' ' LEU . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 64.340000000000003 108.836 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.430000000000007 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.450000000000003 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.150000000000006 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.310000000000002 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.200000000000003 111.39 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.100000000000001 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 73.510000000000005 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.120000000000005 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 110.366 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.229999999999997 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.319999999999993 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.400000000000006 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.109999999999999 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.400000000000006 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 63.329999999999998 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.409999999999997 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 64.310000000000002 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.468 HD22 HD22 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 52.200000000000003 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.430000000000007 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.299999999999997 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 61.32 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.310000000000002 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.329999999999998 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 182' ' ' ARG . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 71.409999999999997 108.514 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.461 HG22 ' HG ' ' A' ' 193' ' ' LEU . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.030000000000001 111.321 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.219999999999999 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 53.200000000000003 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.240000000000002 113.053 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.420000000000002 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.430000000000007 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.230000000000004 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.030000000000001 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 70.319999999999993 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.503 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.450000000000003 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 183' ' ' THR . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.010000000000005 106.392 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.150000000000006 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.319999999999993 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.239999999999995 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.150000000000006 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.450000000000003 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.430000000000007 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.510000000000005 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 73.310000000000002 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.030000000000001 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 65.519999999999996 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.099999999999994 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.540000000000006 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.409999999999997 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.340000000000003 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.030000000000001 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.310000000000002 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 54.100000000000001 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.329999999999998 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.120000000000005 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.452 HD22 ' NE2' ' A' ' 217' ' ' GLN . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 109.273 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.645 ' HA ' HG11 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.239999999999995 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.510000000000005 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.482 HE22 HG13 ' A' ' 163' ' ' VAL . 45.5 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.540000000000006 109.62 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.430000000000007 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.329999999999998 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.399999999999999 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.400000000000006 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 215' ' ' SER . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.120000000000005 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.129999999999995 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 74.040000000000006 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.430000000000007 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.219999999999999 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . . . . . . 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.210000000000001 110.044 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.010000000000005 104.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.209999999999994 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.149999999999999 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.519999999999996 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.399999999999999 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.109999999999999 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.450000000000003 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.319999999999993 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.140000000000001 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 52.140000000000001 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.310000000000002 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.129999999999995 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.229999999999997 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.099999999999994 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 52.43 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 61.539999999999999 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.140000000000001 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.329999999999998 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 60.450000000000003 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.540000000000006 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 65.310000000000002 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 54.329999999999998 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.109999999999999 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.150000000000006 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.539999999999999 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.229999999999997 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.510000000000005 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.310000000000002 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 197' ' ' LEU . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.010000000000005 111.574 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.010000000000005 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 35.140000000000001 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 72.540000000000006 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.150000000000006 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 70.099999999999994 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.520000000000003 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.420000000000002 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.442 ' HB3' ' ND2' ' A' ' 190' ' ' ASN . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.010000000000005 111.533 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.350000000000001 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.209999999999994 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 53.229999999999997 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 62.310000000000002 112.65 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 160' ' ' GLU . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.219999999999999 106.629 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.219999999999999 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.200000000000003 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.329999999999998 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.210000000000001 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.219999999999999 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.310000000000002 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.430000000000007 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.539999999999999 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.319999999999993 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.140000000000001 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.450000000000003 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.450000000000003 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.230000000000004 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.010000000000005 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HA ' HG12 ' A' ' 211' ' ' VAL . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.430000000000007 110.675 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.200000000000003 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 208' ' ' GLU . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.209999999999994 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 63.229999999999997 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.5 ' HB3' HG11 ' A' ' 223' ' ' VAL . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 70.209999999999994 112.387 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.450000000000003 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.200000000000003 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 40.32 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.430000000000007 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 73.430000000000007 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.100000000000001 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 215' ' ' SER . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 41.329999999999998 110.705 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.129999999999995 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 71.420000000000002 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.409999999999997 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.340000000000003 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.120000000000005 109.816 -173.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 200' ' ' VAL . 6.4 mp . . . . . 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 62.420000000000002 103.289 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.030000000000001 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.400000000000006 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.299999999999997 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.349999999999994 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 51.020000000000003 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.329999999999998 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 223' ' ' VAL . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.209999999999994 109.836 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 HD22 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.140000000000001 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.340000000000003 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.319999999999993 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.519999999999996 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.120000000000005 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.350000000000001 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.219999999999999 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.310000000000002 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.109999999999999 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.409999999999997 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 31.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.420000000000002 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.399999999999999 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.310000000000002 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.140000000000001 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.409999999999997 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.419 ' OG1' HD11 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 65.530000000000001 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.409999999999997 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.129999999999995 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.439999999999998 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.340000000000003 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.549999999999997 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 72.310000000000002 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.419 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.530000000000001 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.409999999999997 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.310000000000002 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.530000000000001 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.420000000000002 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 72.510000000000005 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.420000000000002 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 54.020000000000003 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.219999999999999 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.109999999999999 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.409999999999997 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.329999999999998 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.629 HD22 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.430000000000007 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.530000000000001 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.109999999999999 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.229999999999997 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.099999999999994 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.349999999999994 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 72.120000000000005 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 146' ' ' LEU . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 64.209999999999994 107.76 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 61.140000000000001 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 146' ' ' LEU . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.120000000000005 109.123 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.530000000000001 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.399999999999999 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 71.140000000000001 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.530000000000001 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.119999999999997 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.010000000000005 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.109999999999999 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 72.329999999999998 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.219999999999999 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.409999999999997 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 62.439999999999998 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 35.299999999999997 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.230000000000004 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.310000000000002 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.549 ' HA ' HG11 ' A' ' 220' ' ' VAL . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 41.5 110.977 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.140000000000001 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.420000000000002 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.409999999999997 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 215' ' ' SER . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.310000000000002 110.077 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 72.510000000000005 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.109999999999999 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 153' ' ' VAL . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.409999999999997 108.755 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 74.209999999999994 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.230000000000004 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.219999999999999 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.310000000000002 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.439999999999998 114.531 176.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.349999999999994 105.257 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.409999999999997 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.140000000000001 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.329999999999998 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.310000000000002 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 43.119999999999997 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.209999999999994 110.143 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.030000000000001 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.239999999999995 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.420000000000002 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.239999999999995 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.549999999999997 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.340000000000003 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.340000000000003 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.340000000000003 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.030000000000001 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.049999999999997 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.340000000000003 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 63.420000000000002 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.120000000000005 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 170' ' ' ARG . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.109999999999999 112.227 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.120000000000005 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.439999999999998 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.329999999999998 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.450000000000003 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.479 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.120000000000005 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.310000000000002 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.400000000000006 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.400000000000006 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.439999999999998 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.519999999999996 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 194' ' ' THR . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.209999999999994 108.357 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.539999999999999 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.420000000000002 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.219999999999999 112.219 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.130000000000003 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.200000000000003 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.501 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 63.420000000000002 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 HD11 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 63.219999999999999 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.130000000000003 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 65.430000000000007 109.09 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.319999999999993 108.509 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 182' ' ' ARG . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.209999999999994 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.400000000000006 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 63.509999999999998 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.230000000000004 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.479 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.229999999999997 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.299999999999997 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 33.310000000000002 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.540000000000006 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.420000000000002 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 63.399999999999999 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.299999999999997 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.439999999999998 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.439999999999998 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.310000000000002 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.040000000000006 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.329999999999998 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.400000000000006 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.200000000000003 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.432 ' O ' HG21 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.230000000000004 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.506 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.510000000000005 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.329999999999998 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.349999999999994 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.329999999999998 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.439999999999998 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.409999999999997 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 63.210000000000001 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 62.530000000000001 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.239999999999995 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.430000000000007 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.030000000000001 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.349999999999994 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.020000000000003 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.409999999999997 109.896 -173.121 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.210000000000001 105.427 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.439999999999998 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.430000000000007 109.159 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.299999999999997 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.219999999999999 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.140000000000001 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.230000000000004 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.119999999999997 109.031 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.520000000000003 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.140000000000001 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.239999999999995 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.439999999999998 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.439999999999998 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.219999999999999 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 41.149999999999999 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.520000000000003 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.030000000000001 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.049999999999997 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.409999999999997 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.239999999999995 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.540000000000006 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.400000000000006 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.129999999999995 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.310000000000002 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.140000000000001 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.120000000000005 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.299999999999997 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.209999999999994 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.200000000000003 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.030000000000001 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.219999999999999 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.4 ' HD3' HD11 ' A' ' 198' ' ' LEU . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.329999999999998 108.595 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.409999999999997 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.239999999999995 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.400000000000006 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.129999999999995 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.119999999999997 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.340000000000003 111.111 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.557 ' HB3' ' ND2' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 61.420000000000002 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.340000000000003 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.209999999999994 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.120000000000005 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.530000000000001 107.624 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.230000000000004 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.519999999999996 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.310000000000002 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.319999999999993 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.510000000000005 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 179' ' ' ARG . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 73.019999999999996 107.094 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 207' ' ' LEU . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.420000000000002 109.771 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.209999999999994 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.439999999999998 108.877 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.200000000000003 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.039999999999999 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.439999999999998 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.540000000000006 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' A' ' 199' ' ' MET . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.439999999999998 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.420000000000002 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.030000000000001 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 54.32 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.430000000000007 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.150000000000006 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.130000000000003 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.239999999999995 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.200000000000003 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.109999999999999 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 35.520000000000003 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 71.450000000000003 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.519999999999996 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.420000000000002 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.019999999999996 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.200000000000003 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.120000000000005 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.439999999999998 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.319999999999993 112.061 178.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.714 0.292 . . . . 50.539999999999999 111.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -92.24 157.94 16.4 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.745 -0.835 . . . . 74.340000000000003 108.745 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -115.3 93.87 4.48 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.957 0.408 . . . . 73.120000000000005 110.455 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.0 28.05 6.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 124.595 2.141 . . . . 44.25 106.957 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.89 0.79 4.55 Favored Glycine 0 C--N 1.269 -3.148 0 CA-C-N 111.714 -2.494 . . . . 65.409999999999997 110.446 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 198' ' ' LEU . 3.6 mp -135.19 102.47 5.19 Favored 'General case' 0 N--CA 1.403 -2.811 0 N-CA-C 103.472 -2.788 . . . . 74.040000000000006 103.472 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -75.13 129.35 82.97 Favored Pre-proline 0 C--N 1.288 -2.107 0 C-N-CA 120.721 -0.392 . . . . 63.119999999999997 111.741 -174.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 45.7 Cg_endo -71.96 120.96 7.19 Favored 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 122.4 2.066 . . . . 75.340000000000003 111.383 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -125.92 137.97 53.75 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 107.8 -1.185 . . . . 65.400000000000006 107.8 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -110.41 127.54 55.15 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.906 -1.146 . . . . 71.239999999999995 107.906 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.7 t -110.32 113.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.086 0 N-CA-C 107.581 -1.266 . . . . 74.430000000000007 107.581 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.9 ptp180 -107.79 117.72 34.85 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.405 0.621 . . . . 55.130000000000003 110.782 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.6 p -118.17 127.16 75.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.145 -0.934 . . . . 74.329999999999998 109.105 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.7 mt -101.47 114.13 39.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 107.395 -1.335 . . . . 74.230000000000004 107.395 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 27.8 p -145.16 170.48 16.15 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 120.177 -0.609 . . . . 75.209999999999994 111.405 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 18.6 mmt180 -58.34 141.38 82.99 Favored Pre-proline 0 C--N 1.314 -0.962 0 CA-C-N 114.985 -1.007 . . . . 74.349999999999994 110.089 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 45.3 Cg_exo -57.09 -28.04 76.96 Favored 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 113.245 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -72.42 -21.22 61.29 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.134 0.492 . . . . 63.140000000000001 110.237 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.95 -38.63 13.53 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.417 -0.957 . . . . 75.230000000000004 108.417 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 191' ' ' ILE . 13.9 tm-20 -47.12 -38.28 11.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.139 1.775 . . . . 71.319999999999993 110.291 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -49.58 77.29 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.226 -0.897 . . . . 72.140000000000001 111.869 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.519 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 37.8 p90 -87.45 -24.74 24.05 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.79 -0.764 . . . . 70.420000000000002 111.669 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 167' ' ' ILE . 77.2 t -67.04 -42.31 88.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 110.237 -0.282 . . . . 72.340000000000003 110.237 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -67.79 -35.73 79.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.55 -0.46 . . . . 74.209999999999994 110.421 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.14 76.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.328 0.585 . . . . 64.439999999999998 109.748 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -65.41 -37.98 88.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.586 -0.733 . . . . 75.519999999999996 110.014 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -62.41 -48.84 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 CA-C-N 116.437 -0.347 . . . . 75.230000000000004 110.421 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.72 -33.46 61.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.063 -0.655 . . . . 74.200000000000003 111.957 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -79.39 -29.51 42.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 121.677 -0.639 . . . . 73.030000000000001 111.521 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -72.63 -45.98 56.34 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 120.028 -0.669 . . . . 73.450000000000003 111.142 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -63.47 -42.74 98.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.2 p -66.09 -26.01 67.28 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.17 0.509 . . . . 63.32 111.817 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -94.46 -15.88 23.86 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.028 0.442 . . . . 71.239999999999995 111.127 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 206' ' ' LYS . 7.2 t-20 -100.17 6.67 44.83 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.951 0.405 . . . . 60.520000000000003 112.07 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 76.22 21.07 1.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 123.998 0.919 . . . . 75.030000000000001 111.208 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.456 HG12 ' HG3' ' A' ' 199' ' ' MET . 58.9 mt -102.54 130.68 52.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.99 -0.744 . . . . 61.130000000000003 108.99 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.7 m -98.19 142.78 29.44 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.298 -1.001 . . . . 71.530000000000001 108.298 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -98.66 143.15 29.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.166 0.508 . . . . 52.43 110.545 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 196' ' ' HIS . 2.6 mmp_? -93.42 -51.43 4.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.414 -1.328 . . . . 73.329999999999998 107.414 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.02 165.86 29.81 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.47 -1.452 . . . . 65.540000000000006 109.47 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 64.7 mt -120.86 121.4 65.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.988 -0.745 . . . . 73.200000000000003 108.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -95.93 112.18 23.98 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.16 -1.793 . . . . 75.25 106.16 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.9 t -110.79 121.9 46.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.446 -0.946 . . . . 73.420000000000002 108.446 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.14 142.27 10.38 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.93 -1.129 . . . . 31.420000000000002 112.655 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.414 ' HA ' HG12 ' A' ' 191' ' ' ILE . 35.9 Cg_endo -67.51 123.78 11.21 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.861 2.374 . . . . 62.219999999999999 110.52 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -139.35 71.35 1.38 Allowed 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 119.778 -0.769 . . . . 43.450000000000003 111.504 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.82 -110.95 0.46 Allowed Glycine 0 N--CA 1.401 -3.658 0 N-CA-C 111.093 -0.803 . . . . 73.109999999999999 111.093 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.07 -54.2 1.04 Allowed 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.5 0.667 . . . . 74.209999999999994 110.141 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.9 m-20 -127.49 27.82 5.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 108.126 -1.065 . . . . 65.319999999999993 108.126 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 114.631 1.345 . . . . 70.310000000000002 114.631 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.482 HG21 ' HG3' ' A' ' 160' ' ' GLU . 6.8 mt -132.13 137.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 CA-C-N 112.521 -2.127 . . . . 75.329999999999998 106.554 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.7 m -104.17 117.97 35.53 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.099 -0.704 . . . . 64.200000000000003 109.099 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 3.6 mp -94.85 112.71 24.42 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.942 -1.503 . . . . 73.129999999999995 106.942 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 11.2 m -103.13 105.38 15.67 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.432 -1.321 . . . . 73.540000000000006 107.432 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.66 115.51 27.54 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.435 -0.58 . . . . 61.509999999999998 109.435 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 56.6 m170 -90.38 114.55 26.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.604 -1.628 . . . . 54.039999999999999 106.604 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.1 mt -122.68 154.65 37.78 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 109.938 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 146' ' ' LEU . 90.4 mt -121.31 118.82 30.46 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.799 -1.926 . . . . 72.019999999999996 105.799 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.5 ttt -107.74 124.38 49.94 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.618 -1.233 . . . . 73.310000000000002 111.359 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.432 HG22 ' HG ' ' A' ' 146' ' ' LEU . 47.3 t -70.06 125.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.377 -1.342 . . . . 75.430000000000007 107.377 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 82.65 -65.86 4.03 Favored Glycine 0 C--N 1.312 -0.791 0 C-N-CA 119.849 -1.167 . . . . 33.409999999999997 113.892 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.517 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 25.4 t-80 82.48 101.1 0.05 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.74 1.616 . . . . 74.340000000000003 111.98 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 87.7 m -113.13 96.13 37.61 Favored Pre-proline 0 N--CA 1.409 -2.486 0 N-CA-C 106.809 -1.552 . . . . 54.439999999999998 106.809 172.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -41.63 -43.7 6.29 Favored 'Trans proline' 0 CA--C 1.517 -0.334 0 C-N-CA 125.247 3.964 . . . . 71.530000000000001 114.341 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.61 68.85 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 112.161 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.431 ' HB3' HD21 ' A' ' 174' ' ' ASN . 95.4 mttt -78.98 -45.66 19.84 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 120.55 -0.46 . . . . 53.32 110.221 176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 211' ' ' VAL . 46.1 tp -65.1 -41.7 94.68 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.687 -0.688 . . . . 53.43 109.829 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -62.06 -39.44 92.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 74.140000000000001 111.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -42.5 90.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.052 -0.722 . . . . 44.140000000000001 109.052 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 214' ' ' LEU . 10.2 mp -64.63 -41.16 96.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.024 -0.534 . . . . 65.25 110.984 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 225' ' ' TRP . 94.3 t -65.25 -40.34 88.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.981 -0.377 . . . . 64.040000000000006 109.981 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.57 91.51 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.582 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -68.6 -39.0 81.07 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 116.644 -0.253 . . . . 74.219999999999999 111.431 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 210' ' ' LEU . 86.6 mt -63.56 -39.22 93.85 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.658 -0.497 . . . . 72.129999999999995 109.658 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.595 ' HB2' HG11 ' A' ' 223' ' ' VAL . 29.1 t -71.86 -27.87 63.17 Favored 'General case' 0 N--CA 1.435 -1.179 0 O-C-N 123.616 0.572 . . . . 72.329999999999998 109.823 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.64 -19.95 64.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.984 0.914 . . . . 54.439999999999998 111.072 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -63.8 124.12 83.87 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 120.702 -0.399 . . . . 70.400000000000006 110.842 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 105.9 0.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.846 2.364 . . . . 74.409999999999997 112.405 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 139.69 -9.79 3.14 Favored Glycine 0 C--N 1.297 -1.608 0 CA-C-N 115.476 -0.784 . . . . 64.010000000000005 112.395 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 214' ' ' LEU . 91.1 t -71.14 131.7 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 121.407 0.622 . . . . 61.340000000000003 111.296 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -88.16 -44.45 10.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.612 -0.884 . . . . 74.420000000000002 108.612 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -164.16 159.63 20.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.387 -0.824 . . . . 73.549999999999997 110.351 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.595 HG11 ' HB2' ' A' ' 215' ' ' SER . 14.3 p -147.33 147.62 17.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.781 -0.822 . . . . 61.340000000000003 108.781 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -158.27 140.51 14.2 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.391 -0.596 . . . . 71.299999999999997 109.391 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . 0.461 ' CD1' HG21 ' A' ' 211' ' ' VAL . 57.7 p-90 -114.87 149.65 36.81 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.264 -0.574 . . . . 75.230000000000004 110.446 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -142.21 143.93 33.14 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.083 -0.962 . . . . 74.530000000000001 109.15 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.54 37.82 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.894 -0.41 . . . . 74.409999999999997 109.894 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.28 117.44 3.34 Favored Glycine 0 N--CA 1.427 -1.942 0 C-N-CA 120.017 -1.087 . . . . 61.409999999999997 110.982 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -64.85 -40.09 94.6 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 124.889 1.276 . . . . 70.0 110.818 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -94.35 14.14 21.42 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.038 -0.983 . . . . 75.430000000000007 109.584 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 58.51 67.18 0.97 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.001 -0.999 . . . . 42.130000000000003 109.517 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -83.04 92.6 7.42 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.575 -1.193 . . . . 63.350000000000001 110.388 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -95.94 90.24 5.52 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.555 -1.646 . . . . 70.340000000000003 106.555 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.859 -0.609 . . . . 75.430000000000007 111.262 -175.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.052 -1.092 . . . . 73.019999999999996 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -141.32 144.43 34.59 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.892 -0.323 . . . . 74.299999999999997 110.436 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . 0.264 3.2 m-20 58.29 54.86 5.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 114.94 1.459 . . . . 73.140000000000001 114.94 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.14 69.75 9.94 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.491 -0.777 . . . . 64.430000000000007 109.174 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.82 -48.36 0.03 OUTLIER Glycine 0 C--N 1.287 -2.182 0 N-CA-C 109.016 -1.634 . . . . 61.020000000000003 109.016 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.41 156.05 16.48 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 106.36 -1.719 . . . . 73.319999999999993 106.36 175.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -84.76 113.03 47.0 Favored Pre-proline 0 C--N 1.285 -2.212 0 N-CA-C 109.881 -0.414 . . . . 74.349999999999994 109.881 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.29 125.4 7.76 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.495 2.13 . . . . 74.010000000000005 112.074 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -134.66 138.38 44.4 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.156 -0.929 . . . . 72.409999999999997 108.895 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -109.63 119.8 40.52 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 107.251 -1.389 . . . . 61.020000000000003 107.251 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.45 112.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 N-CA-C 108.044 -1.095 . . . . 65.540000000000006 108.044 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 194' ' ' THR . 1.3 ptm180 -108.7 117.17 33.5 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.514 0.673 . . . . 75.540000000000006 111.079 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.4 p -105.86 116.51 49.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 115.471 -0.786 . . . . 62.020000000000003 109.846 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.82 119.85 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.033 -1.469 . . . . 73.109999999999999 107.033 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.92 170.2 18.2 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 121.119 0.485 . . . . 74.010000000000005 110.978 -174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.1 138.91 95.0 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.502 -0.925 . . . . 74.420000000000002 108.502 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 190' ' ' ASN . 31.8 Cg_exo -54.87 -27.57 54.01 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.658 2.239 . . . . 55.450000000000003 116.157 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -69.88 -25.09 63.54 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.818 -0.753 . . . . 73.219999999999999 110.133 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -83.58 -38.4 21.69 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.594 -0.891 . . . . 72.019999999999996 108.594 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' HG2' HD21 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -43.66 -44.47 6.41 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 125.736 1.614 . . . . 74.120000000000005 111.584 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.7 m -60.44 -49.08 78.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 111.687 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -87.1 -20.12 27.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.459 -0.896 . . . . 55.299999999999997 112.467 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.5 t -73.63 -45.77 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.569 -0.53 . . . . 75.319999999999993 109.569 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -59.74 -41.39 90.85 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 112.361 0.504 . . . . 72.040000000000006 112.361 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.88 -28.15 64.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.138 0.494 . . . . 61.420000000000002 110.937 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -78.48 -37.71 42.69 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 109.405 -0.591 . . . . 74.150000000000006 109.405 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -57.91 -50.37 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 O-C-N 123.556 0.535 . . . . 54.210000000000001 110.404 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.74 -38.09 81.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.367 -0.533 . . . . 75.349999999999994 111.624 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.72 -40.05 56.31 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.973 -0.691 . . . . 74.239999999999995 111.262 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 0.4 OUTLIER -70.71 -36.98 73.5 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.498 -175.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.0 p -74.39 -38.04 63.23 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.075 -0.65 . . . . 74.329999999999998 110.129 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 15.4 t -57.74 -38.65 75.7 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.582 -0.735 . . . . 71.120000000000005 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.0 t -79.94 -19.17 48.62 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.536 0.569 . . . . 64.209999999999994 112.536 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -100.15 28.89 4.59 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.383 1.253 . . . . 75.140000000000001 114.383 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.83 18.48 5.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.251 1.02 . . . . 65.319999999999993 110.866 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.4 mt -107.26 137.76 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 N-CA-C 108.072 -1.085 . . . . 75.329999999999998 108.072 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.7 m -114.19 144.49 43.1 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.263 -1.755 . . . . 61.140000000000001 106.263 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.99 142.81 27.77 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.746 -0.782 . . . . 71.010000000000005 110.353 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.425 HH11 ' CE1' ' A' ' 196' ' ' HIS . 50.3 ttt180 -94.39 -39.73 10.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.315 -0.994 . . . . 75.150000000000006 108.315 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.21 38.15 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.436 -1.066 . . . . 71.530000000000001 110.436 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.27 112.52 25.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.524 -0.917 . . . . 74.209999999999994 108.524 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.73 113.16 26.09 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 115.774 -0.648 . . . . 72.310000000000002 110.033 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.3 t -98.4 129.48 45.04 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.613 -0.884 . . . . 72.239999999999995 108.613 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.63 146.74 17.02 Favored Glycine 0 C--O 1.216 -0.99 0 CA-C-O 119.203 -0.776 . . . . 75.510000000000005 111.934 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.2 146.68 94.17 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.59 2.193 . . . . 61.219999999999999 111.177 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.68 -3.19 33.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.207 -0.597 . . . . 74.120000000000005 112.428 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.68 -57.77 0.63 Allowed Glycine 0 N--CA 1.424 -2.126 0 C-N-CA 120.244 -0.979 . . . . 71.109999999999999 114.752 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -84.12 -77.39 0.26 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.163 0.506 . . . . 70.329999999999998 112.31 -174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -161.16 44.76 0.17 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 123.648 1.689 . . . . 71.200000000000003 106.821 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 1.5 p-10 -148.09 163.3 37.33 Favored 'General case' 0 CA--C 1.469 -2.16 0 CA-C-N 111.636 -2.529 . . . . 73.430000000000007 109.827 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.3 tt -140.98 151.36 20.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 107.847 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 26.6 m -118.86 130.66 55.87 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-O 121.157 0.503 . . . . 52.109999999999999 110.749 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 160' ' ' GLU . 85.3 mt -101.23 107.95 19.48 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.134 -1.061 . . . . 42.210000000000001 108.134 175.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 79.7 m -99.65 105.43 17.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.979 -1.119 . . . . 74.340000000000003 107.979 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.23 117.51 31.6 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.925 -0.769 . . . . 63.130000000000003 108.925 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' CE1' HH11 ' A' ' 179' ' ' ARG . 3.7 t60 -88.99 108.23 19.46 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 106.043 -1.836 . . . . 72.530000000000001 106.043 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.37 151.56 25.34 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.549 -0.751 . . . . 63.130000000000003 110.061 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.31 119.54 29.6 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 105.571 -2.011 . . . . 73.099999999999994 105.571 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.1 mtp -107.25 126.04 51.91 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.81 -0.756 . . . . 73.219999999999999 111.038 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.1 t -78.07 124.38 36.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 106.056 -1.831 . . . . 64.420000000000002 106.056 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 202' ' ' HIS . . . 84.3 -67.51 3.69 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 119.775 -1.202 . . . . 53.539999999999999 112.892 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 201' ' ' GLY . 23.9 t-80 84.36 95.4 0.03 OUTLIER 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.976 1.311 . . . . 72.140000000000001 111.471 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.9 m -113.0 94.64 30.88 Favored Pre-proline 0 N--CA 1.404 -2.739 0 CA-C-N 114.325 -1.307 . . . . 73.530000000000001 107.657 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -42.66 -41.25 8.21 Favored 'Trans proline' 0 N--CA 1.478 0.599 1 C-N-CA 125.519 4.146 . . . . 54.229999999999997 114.514 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.0 -31.16 69.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.108 0.48 . . . . 74.230000000000004 112.036 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 210' ' ' LEU . 52.2 mtpt -78.99 -40.56 31.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.503 -0.555 . . . . 74.25 109.503 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.74 -40.96 88.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.043 -0.526 . . . . 75.209999999999994 110.206 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -64.39 -29.52 70.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.582 -0.736 . . . . 75.430000000000007 110.215 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -72.57 -47.07 51.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.009 -0.541 . . . . 53.229999999999997 109.967 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 206' ' ' LYS . 10.9 mp -63.08 -41.54 99.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.79 -0.641 . . . . 65.409999999999997 112.069 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.22 -24.5 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 119.954 -0.698 . . . . 60.439999999999998 110.655 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.49 40.92 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 116.055 -0.52 . . . . 72.340000000000003 110.176 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 49.5 mt-10 -66.99 -38.59 86.29 Favored 'General case' 0 CA--C 1.503 -0.862 0 O-C-N 123.285 0.366 . . . . 64.25 111.498 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.4 mt -68.25 -32.95 73.49 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.666 -0.414 . . . . 54.200000000000003 111.321 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.53 ' HA ' HG11 ' A' ' 220' ' ' VAL . 54.5 p -86.14 -16.79 36.8 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 119.501 -0.88 . . . . 75.120000000000005 110.865 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.2 tp -73.62 -27.29 61.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.802 0.841 . . . . 72.120000000000005 110.203 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 65.1 mt-30 -63.23 131.23 94.7 Favored Pre-proline 0 C--O 1.245 0.835 0 CA-C-N 115.882 -0.599 . . . . 63.310000000000002 110.698 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.87 108.19 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.526 2.818 . . . . 72.409999999999997 113.853 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.19 -12.22 4.4 Favored Glycine 0 C--N 1.296 -1.641 0 CA-C-N 114.963 -1.017 . . . . 21.440000000000001 112.073 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 214' ' ' LEU . 99.4 t -80.81 132.27 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-O 121.17 0.51 . . . . 62.0 111.42 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -79.27 -53.45 6.93 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.746 -1.205 . . . . 75.329999999999998 107.746 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.56 161.58 16.11 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 114.714 -1.13 . . . . 72.019999999999996 110.44 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.23 133.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 108.452 -0.944 . . . . 71.409999999999997 108.452 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -130.3 133.36 46.41 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.223 -1.029 . . . . 63.329999999999998 108.223 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -124.42 148.03 47.88 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.26 -0.976 . . . . 75.420000000000002 111.09 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -137.15 140.05 41.57 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.241 -0.89 . . . . 73.519999999999996 109.34 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -79.96 141.33 36.1 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.142 0.496 . . . . 53.340000000000003 111.392 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.85 -173.44 50.08 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.28 -0.728 . . . . 42.32 111.28 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -93.73 64.99 3.57 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.866 -1.161 . . . . 60.130000000000003 107.866 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.94 24.69 13.72 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.231 -1.349 . . . . 74.319999999999993 110.914 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.25 55.45 6.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.397 -1.274 . . . . 74.209999999999994 111.067 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -109.74 129.52 55.61 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.534 -1.212 . . . . 70.430000000000007 108.117 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -100.42 107.56 19.33 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.181 0.515 . . . . 74.439999999999998 111.38 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--N 1.303 -1.437 0 N-CA-C 107.842 -1.17 . . . . 74.519999999999996 107.842 175.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--O 1.238 0.492 0 N-CA-C 107.778 -1.193 . . . . 34.210000000000001 107.778 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 71.56 115.36 0.05 Allowed 'General case' 0 C--O 1.244 0.788 0 C-N-CA 125.335 1.454 . . . . 71.319999999999993 110.488 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.82 107.88 4.21 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 114.892 -1.049 . . . . 74.019999999999996 112.964 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.78 19.72 4.63 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 123.137 1.446 . . . . 53.140000000000001 110.43 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.95 -46.7 5.56 Favored Glycine 0 C--N 1.273 -2.932 0 CA-C-N 112.038 -2.346 . . . . 71.329999999999998 107.71 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.21 142.05 47.87 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 102.422 -3.177 . . . . 74.049999999999997 102.422 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 8.7 tp-100 -88.69 121.13 70.19 Favored Pre-proline 0 C--N 1.291 -1.978 0 C-N-CA 118.564 -1.254 . . . . 71.239999999999995 110.481 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 13.9 Cg_exo -70.71 126.86 13.12 Favored 'Trans proline' 0 N--CA 1.435 -1.942 0 C-N-CA 122.645 2.23 . . . . 73.430000000000007 112.109 175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -125.93 138.21 53.76 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 114.207 -1.36 . . . . 73.510000000000005 107.488 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 35.8 mt-30 -109.67 125.33 52.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.775 -1.194 . . . . 73.349999999999994 107.775 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.08 115.05 48.12 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 N-CA-C 107.948 -1.13 . . . . 61.409999999999997 107.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 194' ' ' THR . 56.6 mtp180 -103.07 106.84 17.44 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.023 -0.732 . . . . 75.319999999999993 109.023 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 220' ' ' VAL . 1.8 p -109.5 123.9 65.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 121.221 0.534 . . . . 73.019999999999996 109.597 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.86 113.3 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 N-CA-C 106.275 -1.75 . . . . 74.319999999999993 106.275 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.6 p -140.76 169.71 17.13 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 108.735 -0.839 . . . . 65.030000000000001 108.735 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -72.55 152.84 91.78 Favored Pre-proline 0 C--N 1.278 -2.528 0 N-CA-C 108.956 -0.757 . . . . 74.5 108.956 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.12 -30.42 86.92 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.091 1.861 . . . . 51.229999999999997 114.042 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -71.16 -19.29 62.44 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 121.778 -0.576 . . . . 74.310000000000002 110.621 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -83.67 -36.29 23.9 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 116.163 -0.471 . . . . 34.219999999999999 109.739 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -46.12 -35.73 5.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.818 1.647 . . . . 71.519999999999996 110.638 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -63.51 -49.45 73.48 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.593 -0.73 . . . . 73.400000000000006 111.963 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 17.8 p90 -86.51 -24.56 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.388 -0.525 . . . . 74.540000000000006 111.653 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 214' ' ' LEU . 22.4 t -67.41 -48.64 76.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.581 -0.736 . . . . 64.540000000000006 110.893 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 59.7 ttp180 -66.31 -39.01 89.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 119.539 -0.864 . . . . 75.239999999999995 109.484 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.9 98.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.449 -0.796 . . . . 70.420000000000002 111.358 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -64.72 -45.12 87.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.47 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.84 -44.23 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 O-C-N 123.781 0.676 . . . . 71.340000000000003 110.394 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 84.4 t -65.68 -38.38 82.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.652 0.263 . . . . 65.129999999999995 111.506 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -72.7 -39.68 66.81 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.751 -0.78 . . . . 64.329999999999998 111.608 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 174' ' ' ASN . 31.2 ttm180 -76.72 -29.03 56.06 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.236 -0.986 . . . . 71.430000000000007 111.682 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 22.0 p -71.99 -41.97 67.02 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 120.49 -0.484 . . . . 73.340000000000003 110.638 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.0 t -62.82 -42.35 99.68 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 116.29 -0.414 . . . . 75.25 110.174 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.7 m -73.65 -31.95 63.76 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.463 0.542 . . . . 71.150000000000006 112.463 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.43 ' OD1' ' HD2' ' A' ' 206' ' ' LYS . 40.5 m-80 -100.28 20.8 14.05 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.364 1.246 . . . . 73.129999999999995 114.364 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 60.87 39.27 17.12 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.147 0.975 . . . . 70.150000000000006 112.632 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 43.1 mt -108.42 115.88 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 107.107 -1.442 . . . . 74.319999999999993 107.107 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.6 m -90.94 127.19 36.3 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.315 -0.624 . . . . 75.409999999999997 109.315 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.8 mp -87.95 125.26 34.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.754 -0.462 . . . . 54.329999999999998 109.754 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.8 -39.52 19.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.165 -0.679 . . . . 73.219999999999999 109.165 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.16 35.33 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.679 -0.968 . . . . 63.329999999999998 110.679 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 62.9 mt -136.16 109.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.751 -0.833 . . . . 72.150000000000006 108.751 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -97.25 118.69 34.27 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.542 -0.91 . . . . 74.549999999999997 108.542 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 m -110.08 123.63 50.05 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.459 -0.571 . . . . 73.439999999999998 109.459 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -142.51 147.14 18.52 Favored Glycine 0 C--N 1.313 -0.733 0 CA-C-O 119.09 -0.839 . . . . 43.340000000000003 111.88 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 134.93 60.0 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.63 2.887 . . . . 63.43 111.684 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.6 -8.68 24.16 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.997 0.427 . . . . 71.310000000000002 111.897 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 167.99 -75.84 0.12 Allowed Glycine 0 N--CA 1.406 -3.325 0 C-N-CA 119.961 -1.114 . . . . 52.240000000000002 112.303 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -139.8 -70.74 0.39 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.161 -0.616 . . . . 65.040000000000006 111.976 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -109.6 25.42 11.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 123.301 1.524 . . . . 64.439999999999998 108.072 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . 1.8 p30 -136.75 156.61 48.29 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.322 -1.763 . . . . 62.340000000000003 111.628 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.28 139.75 19.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 CA-C-N 113.499 -1.682 . . . . 75.420000000000002 107.875 -177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.1 m -104.07 127.35 51.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.936 -0.477 . . . . 65.5 110.936 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.85 116.86 33.73 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.438 -1.319 . . . . 34.009999999999998 107.438 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 152' ' ' ARG . 28.8 m -104.93 105.78 15.99 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.099 -1.074 . . . . 71.239999999999995 108.099 177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -101.37 116.83 33.67 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 116.078 -0.51 . . . . 71.129999999999995 110.39 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -89.56 105.79 18.03 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.171 -1.418 . . . . 70.349999999999994 107.171 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 66.8 mt -115.88 144.88 43.42 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.092 -0.504 . . . . 72.230000000000004 109.953 -173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.4 120.92 40.36 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.504 -0.924 . . . . 73.310000000000002 108.504 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 45.9 ttm -110.17 134.0 52.65 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.078 -0.649 . . . . 75.140000000000001 111.049 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 44.5 t -72.25 129.83 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 107.119 -1.437 . . . . 55.039999999999999 107.119 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.79 -61.76 4.48 Favored Glycine 0 C--N 1.301 -1.377 0 C-N-CA 120.633 -0.794 . . . . 72.329999999999998 114.63 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.59 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 20.8 t-80 85.08 99.2 0.04 OUTLIER 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 126.019 1.728 . . . . 73.299999999999997 110.049 -175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 13.2 m -110.49 96.05 25.58 Favored Pre-proline 0 N--CA 1.384 -3.737 0 CA-C-N 112.993 -1.912 . . . . 52.450000000000003 106.21 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.1 -39.62 8.33 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 124.681 3.587 . . . . 74.040000000000006 113.175 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.86 84.12 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.524 -0.762 . . . . 64.310000000000002 111.587 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.43 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 51.0 mtmt -66.78 -37.0 83.72 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 120.939 0.4 . . . . 74.120000000000005 110.778 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 41.4 tp -70.9 -42.92 69.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.671 -0.695 . . . . 74.239999999999995 110.113 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.5 -39.57 81.2 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 116.163 -0.472 . . . . 70.340000000000003 110.725 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 45.3 mtp-105 -68.75 -27.11 65.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 73.230000000000004 110.89 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -71.04 -50.08 37.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.126 -0.488 . . . . 71.129999999999995 109.726 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 99.6 t -63.75 -42.49 96.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.816 -0.629 . . . . 62.100000000000001 110.454 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.44 -42.31 92.52 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.349 -0.387 . . . . 64.409999999999997 111.75 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 44.1 tt0 -76.97 -30.07 55.81 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 120.274 -0.57 . . . . 72.209999999999994 110.143 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 163' ' ' VAL . 3.4 tm? -72.01 -42.79 65.99 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 109.092 -0.707 . . . . 73.519999999999996 109.092 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.6 m -71.37 -27.72 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.262 0.554 . . . . 52.100000000000001 110.143 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.03 -24.53 64.2 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.164 0.985 . . . . 44.520000000000003 111.194 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 74.1 mt-30 -69.97 122.27 85.51 Favored Pre-proline 0 C--N 1.313 -0.991 0 C-N-CA 120.268 -0.573 . . . . 74.439999999999998 110.498 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.98 110.99 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.847 2.364 . . . . 70.230000000000004 111.568 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.7 -23.74 1.04 Allowed Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 114.983 -1.008 . . . . 64.109999999999999 111.257 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 153' ' ' VAL . 88.3 t -81.56 134.71 26.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.166 0.587 . . . . 64.129999999999995 110.67 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.569 ' CE2' ' HB3' ' A' ' 190' ' ' ASN . 96.9 m-85 -95.09 -48.8 5.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.965 -0.561 . . . . 72.549999999999997 109.57 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -155.75 162.52 40.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.469 -0.787 . . . . 51.43 109.289 -177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.47 142.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 109.578 -0.527 . . . . 73.349999999999994 109.578 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -143.21 127.03 17.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.507 -0.923 . . . . 52.229999999999997 108.507 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -111.88 140.55 46.44 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.224 -0.99 . . . . 75.010000000000005 110.804 173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -128.06 121.63 30.16 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 114.68 -1.145 . . . . 74.409999999999997 109.66 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -72.65 142.4 48.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.199 -0.455 . . . . 55.439999999999998 110.287 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 100.48 161.47 28.11 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 109.975 -1.25 . . . . 64.049999999999997 109.975 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.98 77.49 6.1 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.266 1.031 . . . . 71.530000000000001 111.039 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.409 ' H ' ' NE2' ' A' ' 150' ' ' GLN . 42.1 t60 74.87 -13.27 0.85 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.495 -1.684 . . . . 62.32 112.803 176.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.6 43.58 7.49 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 106.083 -1.821 . . . . 65.219999999999999 106.083 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -76.17 106.32 7.72 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 112.04 -2.345 . . . . 54.340000000000003 109.168 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -78.69 95.42 5.28 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.541 -0.911 . . . . 45.310000000000002 108.541 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 106.613 -1.625 . . . . 74.530000000000001 106.613 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.242 0.707 0 CA-C-O 121.753 0.787 . . . . 74.109999999999999 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -119.37 141.27 49.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.484 -1.302 . . . . 72.439999999999998 107.484 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.459 ' OD1' HD21 ' A' ' 198' ' ' LEU . 45.9 m-20 -86.48 86.17 7.33 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 113.691 0.997 . . . . 72.310000000000002 113.691 -168.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -118.08 35.59 4.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.655 -1.157 . . . . 72.349999999999994 109.556 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.91 -53.78 0.13 Allowed Glycine 0 C--N 1.256 -3.862 0 N-CA-C 108.117 -1.993 . . . . 74.540000000000006 108.117 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.0 140.44 49.74 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 104.467 -2.42 . . . . 75.129999999999995 104.467 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.2 131.1 51.88 Favored Pre-proline 0 C--N 1.286 -2.161 0 O-C-N 123.403 0.439 . . . . 74.120000000000005 109.983 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -78.3 104.58 1.85 Allowed 'Trans proline' 0 N--CA 1.432 -2.097 0 C-N-CA 121.944 1.763 . . . . 72.409999999999997 111.245 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -97.93 137.76 36.29 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 107.159 -1.422 . . . . 74.040000000000006 107.159 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -111.04 120.15 41.42 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.667 -0.813 . . . . 70.239999999999995 109.026 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.4 t -107.72 110.7 32.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.645 -1.242 . . . . 62.310000000000002 107.645 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -105.3 103.74 13.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.525 0.678 . . . . 71.109999999999999 110.499 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.451 HG23 HG13 ' A' ' 220' ' ' VAL . 1.6 p -103.29 122.63 56.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.834 -0.621 . . . . 73.540000000000006 110.226 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.03 117.68 42.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 106.989 -1.486 . . . . 72.439999999999998 106.989 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.3 p -143.88 169.13 18.38 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 109.773 -0.454 . . . . 74.239999999999995 109.773 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -71.17 142.0 86.83 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 106.857 -1.534 . . . . 71.010000000000005 106.857 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 18.6 Cg_endo -58.16 -23.23 60.55 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.837 2.358 . . . . 73.010000000000005 113.327 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -71.91 -21.09 61.68 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.821 -0.627 . . . . 71.450000000000003 109.625 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -98.26 -32.01 11.77 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 115.548 -0.751 . . . . 72.010000000000005 110.778 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -52.17 -35.98 50.4 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 123.637 0.585 . . . . 75.430000000000007 112.45 -175.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 m -62.08 -50.54 71.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 O-C-N 123.491 0.495 . . . . 54.450000000000003 111.018 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -80.87 -23.37 39.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.307 -1.357 . . . . 64.239999999999995 112.833 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 167' ' ' ILE . 99.3 t -67.96 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.93 0 N-CA-C 108.305 -0.998 . . . . 44.109999999999999 108.305 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' GLU . 56.2 ttt180 -60.91 -43.12 98.98 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 124.658 1.183 . . . . 74.510000000000005 109.582 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 169' ' ' GLN . . . -65.4 -37.17 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.859 -0.609 . . . . 72.340000000000003 110.53 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -68.87 -40.01 79.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.585 -0.524 . . . . 73.430000000000007 109.585 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.1 mt -58.18 -49.33 82.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 O-C-N 123.73 0.644 . . . . 54.0 110.56 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.72 -31.74 54.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.42 -0.512 . . . . 43.450000000000003 112.289 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 165' ' ' ALA . 73.5 mt-30 -75.1 -45.15 43.09 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.156 176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.427 HH12 ' HG2' ' A' ' 213' ' ' GLU . 7.9 tpt180 -67.9 -35.58 78.72 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.918 -0.583 . . . . 74.109999999999999 110.784 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 178' ' ' LEU . 18.0 p -68.53 -40.18 80.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.559 0.219 . . . . 74.420000000000002 110.779 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.8 m -66.27 -36.75 83.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 53.329999999999998 109.763 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.2 t -71.69 -34.05 69.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.847 -0.615 . . . . 64.310000000000002 111.094 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -96.5 17.54 15.97 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.865 1.431 . . . . 72.430000000000007 114.865 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 70.14 19.89 6.55 Favored 'General case' 0 N--CA 1.513 2.691 0 C-N-CA 123.073 0.549 . . . . 72.420000000000002 111.947 176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 30.1 mt -94.72 135.53 28.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 109.669 -0.493 . . . . 44.140000000000001 109.669 -175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 61.7 m -98.08 134.0 41.76 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.845 -1.539 . . . . 75.109999999999999 106.845 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD11 ' OG1' ' A' ' 171' ' ' THR . 5.3 mp -88.62 132.84 34.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.418 -0.913 . . . . 63.200000000000003 109.266 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 198' ' ' LEU . 7.7 tpt85 -94.94 -33.62 12.7 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.503 -0.925 . . . . 71.5 108.503 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 167.51 165.53 25.07 Favored Glycine 0 CA--C 1.495 -1.204 0 CA-C-N 115.289 -0.869 . . . . 63.009999999999998 110.939 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.8 mt -127.71 113.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.806 -1.183 . . . . 73.239999999999995 107.806 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.507 ' HD3' ' NE2' ' A' ' 196' ' ' HIS . 50.2 mtp180 -112.85 114.59 27.18 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.894 -0.78 . . . . 72.310000000000002 108.894 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.487 HG22 ' HG ' ' A' ' 193' ' ' LEU . 29.5 p -101.7 148.35 25.37 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 120.997 0.427 . . . . 64.329999999999998 110.546 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.32 134.35 5.31 Favored Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 110.247 -1.141 . . . . 70.5 110.247 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.37 130.8 30.18 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 123.056 2.504 . . . . 74.129999999999995 110.07 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.13 12.41 21.91 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 112.643 0.609 . . . . 35.549999999999997 112.643 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.56 -90.19 0.11 Allowed Glycine 0 N--CA 1.411 -3.026 0 C-N-CA 120.035 -1.078 . . . . 74.099999999999994 112.623 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -138.58 -60.9 0.59 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.769 0.795 . . . . 70.219999999999999 110.442 -174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -119.11 37.69 4.05 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 123.214 1.483 . . . . 75.239999999999995 107.104 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 5.3 p-10 -150.18 153.94 37.15 Favored 'General case' 0 CA--C 1.471 -2.079 0 CA-C-N 113.227 -1.806 . . . . 64.319999999999993 112.169 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 tt -146.09 143.74 21.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.913 0 CA-C-N 112.769 -2.014 . . . . 63.140000000000001 108.192 -176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 13.5 t -104.91 135.35 46.43 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.066 -0.716 . . . . 63.229999999999997 109.066 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 183' ' ' THR . 4.2 mp -110.32 108.84 19.05 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 107.018 -1.475 . . . . 72.439999999999998 107.018 176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 64.0 m -95.55 105.95 17.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 108.141 -1.059 . . . . 55.109999999999999 108.141 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.23 116.58 28.94 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.777 -0.823 . . . . 64.439999999999998 108.777 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.507 ' NE2' ' HD3' ' A' ' 182' ' ' ARG . 11.7 m170 -87.4 110.82 20.54 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.658 -1.979 . . . . 63.0 105.658 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 81.9 mt -116.37 144.01 44.82 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 109.256 -0.646 . . . . 63.409999999999997 109.256 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 179' ' ' ARG . 1.5 mp -111.73 118.86 36.76 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 107.383 -1.34 . . . . 75.129999999999995 107.383 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.504 ' HG2' HG12 ' A' ' 176' ' ' ILE . 83.1 mtp -123.46 144.32 49.59 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.28 -0.568 . . . . 62.009999999999998 110.412 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.37 122.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 108.007 -1.108 . . . . 75.120000000000005 108.007 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 59.12 -123.12 32.48 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-O 121.569 0.538 . . . . 33.109999999999999 112.355 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -172.44 103.72 0.16 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.571 -0.814 . . . . 74.150000000000006 109.254 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 31.6 m -109.82 89.69 8.17 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 107.665 -1.235 . . . . 75.450000000000003 107.665 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -42.11 -46.38 7.18 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.153 3.902 . . . . 65.549999999999997 114.814 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.01 83.15 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.678 0.622 . . . . 73.400000000000006 112.678 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -74.57 -23.31 58.74 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.53 -0.468 . . . . 71.340000000000003 111.533 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 210' ' ' LEU . 60.4 tp -79.01 -46.37 18.31 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -65.24 -37.55 87.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.154 -0.475 . . . . 73.25 109.796 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -66.2 -36.52 83.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.782 -0.367 . . . . 71.120000000000005 111.412 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 207' ' ' LEU . 4.1 pp -71.86 -36.51 70.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.434 -0.906 . . . . 74.349999999999994 109.577 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' LEU . 96.4 t -62.67 -38.36 81.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.195 -0.669 . . . . 72.040000000000006 109.195 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -60.96 -48.51 81.48 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.554 -0.748 . . . . 51.109999999999999 110.668 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.427 ' HG2' HH12 ' A' ' 170' ' ' ARG . 0.5 OUTLIER -62.08 -38.18 87.85 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.176 0.436 . . . . 74.340000000000003 112.176 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 220' ' ' VAL . 97.0 mt -66.05 -46.64 77.07 Favored 'General case' 0 C--O 1.209 -1.032 0 O-C-N 123.815 0.697 . . . . 71.120000000000005 109.97 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.465 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 67.9 p -66.87 -29.68 69.65 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 120.626 -0.43 . . . . 75.439999999999998 111.671 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.24 -11.45 58.66 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 113.77 1.026 . . . . 73.049999999999997 113.77 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.91 119.77 75.24 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 119.098 -1.041 . . . . 74.310000000000002 109.316 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -63.25 111.4 1.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.499 2.133 . . . . 72.019999999999996 111.948 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.46 -22.74 2.03 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.744 -1.343 . . . . 65.209999999999994 109.744 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 214' ' ' LEU . 81.9 t -77.4 129.42 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-N 114.743 -0.728 . . . . 73.319999999999993 110.138 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 92.3 m-85 -85.3 -47.96 9.53 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.417 -0.957 . . . . 70.230000000000004 108.417 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -163.67 155.87 17.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.892 -0.594 . . . . 53.219999999999999 109.91 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.3 p -140.31 138.09 36.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 109.117 -0.697 . . . . 75.439999999999998 109.117 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -134.95 140.01 45.38 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.28 -1.007 . . . . 62.140000000000001 108.28 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -114.52 149.24 36.72 Favored 'General case' 0 CA--C 1.483 -1.629 0 C-N-CA 119.733 -0.787 . . . . 73.540000000000006 109.319 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -139.23 129.34 25.21 Favored 'General case' 0 C--N 1.268 -2.975 0 N-CA-C 108.335 -0.987 . . . . 72.150000000000006 108.335 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -81.66 127.35 32.81 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.322 -0.621 . . . . 72.239999999999995 109.322 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 103.3 135.56 8.7 Favored Glycine 0 N--CA 1.422 -2.242 0 N-CA-C 110.28 -1.128 . . . . 72.519999999999996 110.28 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -76.07 -25.57 55.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.353 -0.98 . . . . 71.010000000000005 108.353 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -67.73 96.64 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.687 -1.142 . . . . 54.130000000000003 109.382 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.56 79.97 1.3 Allowed 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.492 0.663 . . . . 73.420000000000002 109.353 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -139.49 94.06 2.74 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.075 -1.824 . . . . 71.019999999999996 106.075 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -141.55 103.36 4.37 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.508 -0.923 . . . . 64.329999999999998 108.508 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 107.286 -1.376 . . . . 51.240000000000002 107.286 179.118 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.728 0.299 . . . . 71.400000000000006 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -128.97 93.66 3.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.904 -1.147 . . . . 74.239999999999995 107.904 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -102.5 19.38 19.08 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 122.93 1.347 . . . . 74.230000000000004 109.029 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.19 62.2 1.1 Allowed 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 112.58 -2.1 . . . . 75.420000000000002 109.41 -175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.19 -46.78 0.03 OUTLIER Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 112.999 -1.91 . . . . 74.129999999999995 108.93 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.88 169.84 8.21 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 113.673 -1.264 . . . . 64.129999999999995 108.26 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.75 114.19 65.16 Favored Pre-proline 0 C--N 1.284 -2.267 0 N-CA-C 109.097 -0.705 . . . . 70.430000000000007 109.097 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 24.1 Cg_exo -64.06 134.66 43.81 Favored 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.415 2.076 . . . . 75.400000000000006 110.907 176.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 227' ' ' ALA . 57.3 m-85 -130.82 166.22 21.31 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.922 -1.035 . . . . 75.25 109.189 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 26.9 pt20 -150.56 128.66 11.89 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 120.968 0.413 . . . . 75.310000000000002 110.649 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.6 116.84 53.18 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 108.175 -1.046 . . . . 63.310000000000002 108.175 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -104.98 109.94 22.14 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.718 -0.845 . . . . 70.209999999999994 108.718 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.407 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.4 p -121.59 132.35 70.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.603 -0.726 . . . . 62.240000000000002 110.318 -176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.17 123.39 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 106.019 -1.845 . . . . 73.409999999999997 106.019 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 28.0 p -147.82 177.29 9.44 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 118.278 0.49 . . . . 74.519999999999996 110.098 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -62.59 140.89 96.9 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 115.45 -0.796 . . . . 74.150000000000006 110.302 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.8 -36.39 62.38 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 122.455 2.103 . . . . 32.039999999999999 113.038 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -72.65 -15.54 61.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.398 -0.521 . . . . 71.530000000000001 110.539 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.44 -39.99 15.79 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 108.998 -0.742 . . . . 71.109999999999999 108.998 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.406 ' HG3' HD13 ' A' ' 191' ' ' ILE . 12.7 tm-20 -44.28 -36.93 2.97 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.899 1.68 . . . . 73.430000000000007 111.118 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 m -60.54 -49.41 77.64 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.51 -0.768 . . . . 72.120000000000005 111.437 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -87.45 -24.4 24.16 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 119.276 -0.969 . . . . 75.450000000000003 111.509 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 167' ' ' ILE . 60.0 t -65.19 -43.45 95.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 116.383 -0.371 . . . . 63.409999999999997 110.975 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -66.23 -38.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 74.200000000000003 110.563 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.2 71.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.446 0.641 . . . . 71.049999999999997 109.961 178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -67.28 -42.07 84.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.51 -0.768 . . . . 74.129999999999995 109.957 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.4 mt -58.53 -47.61 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 110.28 -0.267 . . . . 71.530000000000001 110.28 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.95 -41.1 91.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.101 0.477 . . . . 70.420000000000002 111.249 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.01 -33.16 61.77 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.651 0.612 . . . . 74.129999999999995 112.651 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 170' ' ' ARG . 2.3 mmp_? -77.43 -33.36 54.86 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 120.019 -0.672 . . . . 42.520000000000003 111.19 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.3 p -70.19 -41.34 73.83 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.276 -0.57 . . . . 73.129999999999995 111.357 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.2 p -62.66 -35.57 80.07 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.937 0.398 . . . . 65.430000000000007 111.505 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 38.9 m -77.68 -26.36 50.22 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 111.832 176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.98 11.42 29.74 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.263 0.838 . . . . 73.129999999999995 113.263 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 72.22 23.94 3.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.792 1.237 . . . . 74.450000000000003 112.212 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.03 133.41 53.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.931 -0.577 . . . . 62.5 109.925 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 45.9 m -101.89 148.32 25.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.407 -0.96 . . . . 61.229999999999997 108.407 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.58 143.42 28.48 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.801 -0.562 . . . . 73.420000000000002 110.121 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 198' ' ' LEU . 64.6 ttt180 -101.85 -26.76 13.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.364 -1.347 . . . . 75.019999999999996 107.364 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 166.25 164.9 22.68 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.924 -1.271 . . . . 74.129999999999995 109.924 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 71.1 mt -134.04 118.17 27.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.922 -0.77 . . . . 75.409999999999997 108.922 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -109.41 113.22 25.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.055 -1.091 . . . . 75.049999999999997 108.055 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -112.41 124.59 52.82 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.146 -0.687 . . . . 51.219999999999999 109.146 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.67 138.85 7.62 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-O 119.082 -0.843 . . . . 53.119999999999997 111.801 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.97 137.81 9.25 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.103 3.202 . . . . 64.010000000000005 111.961 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -90.49 -19.69 23.54 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 112.422 0.526 . . . . 51.210000000000001 112.422 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.8 -67.37 0.28 Allowed Glycine 0 N--CA 1.416 -2.669 0 C-N-CA 119.58 -1.295 . . . . 54.140000000000001 114.115 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.25 -68.29 0.94 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.784 1.031 . . . . 43.299999999999997 113.784 -174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -143.73 38.79 1.36 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 123.364 1.554 . . . . 74.530000000000001 107.202 -166.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -154.54 164.81 38.13 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 112.229 -2.26 . . . . 54.030000000000001 110.765 -173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.406 HD13 ' HG3' ' A' ' 160' ' ' GLU . 20.0 tt -146.77 143.6 20.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.616 -1.175 . . . . 62.219999999999999 109.694 -176.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 25.5 m -108.91 127.83 54.39 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.186 0.517 . . . . 73.109999999999999 110.276 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.58 123.32 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.759 -1.2 . . . . 75.219999999999999 107.759 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -107.05 105.41 15.41 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.729 -1.582 . . . . 73.319999999999993 106.729 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -98.67 115.15 28.06 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.624 -0.88 . . . . 60.109999999999999 108.624 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -94.19 125.49 38.85 Favored 'General case' 0 N--CA 1.419 -2.017 0 N-CA-C 105.562 -2.014 . . . . 74.25 105.562 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 47.7 mt -116.01 164.91 13.74 Favored 'General case' 0 C--N 1.282 -2.33 0 C-N-CA 123.639 0.776 . . . . 74.439999999999998 110.162 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 179' ' ' ARG . 94.1 mt -137.14 115.43 11.76 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.934 -1.506 . . . . 61.310000000000002 106.934 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.9 ttt -116.58 140.89 48.89 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.943 -0.703 . . . . 71.129999999999995 111.25 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.45 121.85 21.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.166 -1.42 . . . . 71.530000000000001 107.166 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 62.99 -123.36 29.99 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 110.905 -0.878 . . . . 70.319999999999993 110.905 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -179.61 104.87 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 124.957 1.303 . . . . 72.299999999999997 107.52 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 m -111.86 92.41 17.6 Favored Pre-proline 0 N--CA 1.406 -2.661 0 N-CA-C 106.327 -1.731 . . . . 54.25 106.327 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -37.17 -52.86 1.36 Allowed 'Trans proline' 0 CA--C 1.513 -0.53 1 C-N-CA 125.601 4.201 . . . . 72.340000000000003 114.928 -176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.79 -34.56 74.68 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 112.756 0.65 . . . . 51.039999999999999 112.756 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -72.0 -40.59 68.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.869 0.366 . . . . 72.510000000000005 110.098 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.7 tp -73.91 -39.94 63.48 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 115.609 -0.723 . . . . 71.230000000000004 109.381 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.53 -40.32 89.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.609 -0.723 . . . . 74.439999999999998 110.636 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -69.64 -29.49 66.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.182 0.515 . . . . 73.430000000000007 109.926 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 -51.27 61.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.305 -0.861 . . . . 62.399999999999999 108.698 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 207' ' ' LEU . 61.0 t -65.32 -36.59 78.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.292 0 CA-C-N 116.013 -0.539 . . . . 62.329999999999998 110.636 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.44 75.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.188 0.44 . . . . 74.299999999999997 112.188 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.55 -31.19 32.81 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.047 -0.661 . . . . 72.5 109.471 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -75.65 -37.78 59.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.321 -0.854 . . . . 62.409999999999997 110.188 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 36.7 p -72.46 -36.06 68.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.176 0.512 . . . . 64.549999999999997 111.268 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.19 -2.64 58.55 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 111.933 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.8 tp-100 -62.52 114.53 12.27 Favored Pre-proline 0 C--O 1.244 0.791 0 N-CA-C 108.367 -0.975 . . . . 55.200000000000003 108.367 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 50.0 Cg_exo -49.39 111.4 0.49 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.796 2.997 . . . . 64.329999999999998 113.794 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 133.6 -12.42 4.87 Favored Glycine 0 C--N 1.308 -1.027 0 CA-C-N 115.428 -0.805 . . . . 75.540000000000006 112.546 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 96.2 t -77.05 134.09 29.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.491 0.662 . . . . 74.540000000000006 111.925 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -88.84 -56.65 3.2 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.579 -0.897 . . . . 73.540000000000006 108.579 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -148.35 153.77 39.06 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.184 -0.916 . . . . 65.140000000000001 108.811 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 153' ' ' VAL . 4.8 p -161.38 137.24 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 110.025 -0.361 . . . . 74.439999999999998 110.025 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -152.48 144.2 23.56 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.811 -1.181 . . . . 73.230000000000004 107.811 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -110.85 156.47 21.1 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 119.844 -0.743 . . . . 75.120000000000005 110.639 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.447 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 37.2 m-85 -142.5 169.68 17.13 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.992 -1.485 . . . . 73.120000000000005 106.992 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 230' ' ' HIS . . . -77.12 144.86 38.15 Favored 'General case' 0 C--O 1.263 1.79 0 N-CA-C 107.196 -1.409 . . . . 61.340000000000003 107.196 170.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -69.49 119.24 9.09 Favored Glycine 0 CA--C 1.484 -1.866 0 O-C-N 123.56 0.538 . . . . 73.219999999999999 113.084 -169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 69.1 14.83 8.76 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 122.648 1.213 . . . . 72.120000000000005 110.755 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 50.8 m80 -105.62 -59.01 1.83 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.686 -1.143 . . . . 61.310000000000002 108.607 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 226' ' ' TYR . . . 59.54 86.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.491 -1.231 . . . . 73.310000000000002 112.949 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 69.49 39.15 1.64 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.504 1.122 . . . . 71.319999999999993 111.334 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 230' ' ' HIS . . . -130.66 125.29 33.62 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.222 -1.354 . . . . 43.119999999999997 107.393 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.987 -1.116 . . . . 61.340000000000003 107.987 -178.547 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.764 0.792 . . . . 70.510000000000005 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -153.58 95.34 1.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.513 -1.221 . . . . 75.430000000000007 109.91 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 57.41 65.34 1.37 Allowed 'General case' 0 C--O 1.244 0.764 0 O-C-N 124.142 0.901 . . . . 71.230000000000004 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.09 57.09 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.208 -0.905 . . . . 71.340000000000003 111.937 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -39.66 0.05 OUTLIER Glycine 0 N--CA 1.416 -2.653 0 CA-C-N 114.965 -1.016 . . . . 54.119999999999997 110.636 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.41 144.89 35.39 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 106.604 -1.628 . . . . 72.340000000000003 106.604 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -91.19 122.5 66.26 Favored Pre-proline 0 C--N 1.293 -1.886 0 N-CA-C 109.156 -0.683 . . . . 73.140000000000001 109.156 -177.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.3 Cg_exo -64.6 119.51 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.303 2.002 . . . . 63.049999999999997 110.82 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -120.58 155.0 34.62 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.357 -0.838 . . . . 74.430000000000007 109.037 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' HG2' ' ND1' ' A' ' 196' ' ' HIS . 58.6 mt-30 -129.58 120.95 26.15 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.627 -1.249 . . . . 73.129999999999995 107.627 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 194' ' ' THR . 93.8 t -107.51 117.22 52.79 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 106.9 -1.518 . . . . 61.130000000000003 106.9 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -115.44 118.28 32.77 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.775 -0.454 . . . . 73.430000000000007 109.775 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.3 134.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.833 -0.621 . . . . 63.140000000000001 110.407 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.37 117.56 51.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.969 -1.493 . . . . 74.239999999999995 106.969 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.56 171.14 14.47 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.043 -0.725 . . . . 55.340000000000003 109.043 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -72.63 149.93 90.91 Favored Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 123.167 0.292 . . . . 72.319999999999993 110.335 176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -52.96 -37.98 78.95 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 123.498 2.799 . . . . 71.239999999999995 115.7 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.78 -20.92 66.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.001 0.429 . . . . 52.509999999999998 110.875 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.57 -36.8 18.68 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.703 -0.681 . . . . 63.229999999999997 109.549 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -44.05 -50.19 8.49 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.373 1.469 . . . . 62.5 110.875 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.8 m -62.04 -40.86 97.19 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.533 -1.212 . . . . 64.409999999999997 112.344 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . 0.27 46.1 p90 -87.68 -24.44 23.88 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 118.721 -1.192 . . . . 75.219999999999999 112.469 176.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 167' ' ' ILE . 59.0 t -66.41 -42.21 90.05 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.873 0 N-CA-C 109.414 -0.587 . . . . 71.340000000000003 109.414 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -60.21 -44.76 94.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.82 -0.627 . . . . 63.329999999999998 110.457 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 169' ' ' GLN . . . -66.19 -37.71 86.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.607 -0.724 . . . . 55.009999999999998 110.455 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -65.96 -45.09 83.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.759 -0.655 . . . . 65.540000000000006 109.571 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 163' ' ' VAL . 79.9 mt -57.48 -49.07 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 O-C-N 123.377 0.423 . . . . 63.310000000000002 110.388 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 178' ' ' LEU . 12.4 p -66.81 -31.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 120.852 0.358 . . . . 64.010000000000005 111.723 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 165' ' ' ALA . 14.2 mm100 -78.5 -42.76 28.73 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.046 -0.662 . . . . 72.519999999999996 110.916 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -75.25 -28.3 59.8 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.492 -0.483 . . . . 75.340000000000003 111.563 -174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.424 ' OG1' HD21 ' A' ' 178' ' ' LEU . 19.2 p -71.55 -40.48 69.99 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 120.134 -0.627 . . . . 74.209999999999994 110.238 176.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 26.5 t -64.34 -37.43 87.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.334 -0.617 . . . . 54.039999999999999 109.334 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.6 t -69.09 -39.02 79.28 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 115.479 -0.782 . . . . 72.409999999999997 110.421 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -87.92 17.65 4.74 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.667 0.746 . . . . 73.439999999999998 111.208 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 70.87 10.11 6.93 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.537 1.535 . . . . 75.019999999999996 112.921 174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.451 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 63.3 mt -84.64 139.36 17.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 122.84 0.456 . . . . 74.549999999999997 110.493 -174.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.8 m -99.39 148.47 24.17 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.252 -1.018 . . . . 74.430000000000007 108.252 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.424 HD21 ' OG1' ' A' ' 171' ' ' THR . 59.3 mt -111.08 143.73 41.35 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.469 0.544 . . . . 62.229999999999997 112.469 -172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -89.82 -56.21 3.33 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.31 -1.366 . . . . 61.020000000000003 107.31 167.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.19 177.09 41.46 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 113.812 -1.54 . . . . 55.5 110.036 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 66.3 mt -127.58 120.86 55.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.74 -0.837 . . . . 72.409999999999997 108.74 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 182' ' ' ARG . 2.7 tmt_? -98.67 128.22 44.87 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.421 -0.955 . . . . 75.310000000000002 108.421 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.0 t -121.57 123.41 41.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.273 -0.421 . . . . 44.109999999999999 110.343 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.21 143.38 11.51 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-O 119.069 -0.851 . . . . 61.409999999999997 111.534 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.35 136.3 74.76 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 123.638 2.892 . . . . 74.200000000000003 112.209 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -92.38 -19.53 21.99 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 112.221 0.452 . . . . 73.430000000000007 112.221 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 165.67 -84.1 0.1 Allowed Glycine 0 N--CA 1.408 -3.174 0 C-N-CA 119.712 -1.233 . . . . 73.400000000000006 113.695 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.94 -71.99 0.73 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.844 -0.742 . . . . 65.150000000000006 111.877 -173.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -124.68 34.2 5.06 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 123.544 1.64 . . . . 73.329999999999998 108.273 -172.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.5 p30 -143.37 161.99 36.9 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 112.821 -1.99 . . . . 64.0 111.269 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.5 tt -147.73 146.79 17.86 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 CA-C-N 113.658 -1.61 . . . . 73.109999999999999 107.831 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.8 m -107.85 130.68 54.98 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.941 0.4 . . . . 70.129999999999995 110.442 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.51 129.53 56.67 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.265 -1.383 . . . . 62.109999999999999 107.265 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 13.8 t -124.09 116.0 22.07 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.907 0.86 . . . . 75.420000000000002 109.629 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.69 119.63 34.53 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 114.993 -1.003 . . . . 72.25 108.617 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.404 ' ND1' ' HG2' ' A' ' 150' ' ' GLN . 2.5 t60 -96.52 117.43 30.91 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.556 -1.275 . . . . 73.430000000000007 107.556 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 17.4 mt -119.6 168.02 11.43 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.281 -0.872 . . . . 63.240000000000002 110.594 -169.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.09 116.2 16.74 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.379 -1.712 . . . . 65.530000000000001 106.379 171.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 25.7 ttt -123.45 144.86 49.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 110.303 -0.258 . . . . 71.25 110.303 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 11.4 m -68.7 127.03 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.383 0.611 . . . . 71.129999999999995 111.493 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.69 -115.22 4.66 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-N 114.029 -1.441 . . . . 43.530000000000001 111.811 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 204' ' ' PRO . 15.6 t-80 -171.48 103.83 0.2 Allowed 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.895 -1.52 . . . . 75.400000000000006 106.895 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.8 m -107.08 88.11 3.52 Favored Pre-proline 0 N--CA 1.409 -2.514 0 N-CA-C 107.533 -1.284 . . . . 75.099999999999994 107.533 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 202' ' ' HIS . 94.9 Cg_exo -42.3 -52.01 4.53 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 124.886 3.724 . . . . 43.340000000000003 114.285 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.37 86.55 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.552 0.575 . . . . 60.409999999999997 112.552 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -73.77 -37.56 64.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.699 -0.4 . . . . 74.409999999999997 111.122 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 6.8 tt -72.74 -43.67 62.63 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.303 -0.629 . . . . 65.239999999999995 109.303 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.49 ' HA ' HG22 ' A' ' 211' ' ' VAL . 49.8 mt-10 -71.52 -32.04 67.73 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.962 -0.563 . . . . 73.230000000000004 112.352 -176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 209' ' ' ARG . 2.8 tmt_? -73.88 -32.89 63.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.191 -1.04 . . . . 71.209999999999994 108.191 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.11 -45.28 77.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.986 -0.552 . . . . 73.5 110.665 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 208' ' ' GLU . 33.3 m -70.68 -24.17 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.566 -0.454 . . . . 61.130000000000003 111.679 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 216' ' ' LEU . . . -68.87 -44.52 73.13 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.97 -0.752 . . . . 72.109999999999999 108.97 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.69 -38.15 83.29 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.462 0.705 . . . . 72.430000000000007 110.41 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.92 -34.92 78.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.624 -0.716 . . . . 72.239999999999995 110.193 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.3 p -83.25 -18.53 38.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.605 -0.838 . . . . 73.230000000000004 111.621 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 212' ' ' ALA . 41.2 mt -70.5 -21.91 62.7 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.335 -0.393 . . . . 73.200000000000003 110.943 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -49.29 117.13 6.4 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.937 0.773 . . . . 71.319999999999993 109.859 172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.26 100.47 0.15 Allowed 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 123.406 2.737 . . . . 74.340000000000003 114.549 -173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 135.06 -7.03 4.41 Favored Glycine 0 C--N 1.291 -1.956 0 C-N-CA 120.091 -1.052 . . . . 61.219999999999999 112.687 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.87 129.4 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 110.062 -0.348 . . . . 74.0 110.062 174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 95.1 m-85 -89.85 -42.87 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.596 -0.891 . . . . 74.310000000000002 108.596 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.64 27.76 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.404 -0.816 . . . . 73.439999999999998 110.371 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.0 p -149.85 146.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.838 -0.801 . . . . 50.509999999999998 108.838 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -148.42 141.42 24.85 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.133 -1.062 . . . . 72.510000000000005 108.133 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -117.02 149.49 40.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.316 0.579 . . . . 74.439999999999998 110.857 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -131.43 142.61 50.05 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 115.331 -0.85 . . . . 73.549999999999997 108.965 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.02 130.38 48.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.139 -0.689 . . . . 71.450000000000003 109.139 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 130.07 158.62 9.46 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.333 -0.937 . . . . 54.140000000000001 111.763 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.84 -47.44 4.39 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.659 0.742 . . . . 72.209999999999994 110.841 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -85.74 -65.33 1.02 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.42 -0.955 . . . . 73.319999999999993 108.42 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 173.99 49.48 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.015 -1.476 . . . . 65.219999999999999 107.015 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -68.11 114.14 6.37 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.133 -1.394 . . . . 64.340000000000003 113.074 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -125.3 85.36 2.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 104.271 -2.492 . . . . 63.240000000000002 104.271 168.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.291 -1.97 0 CA-C-N 114.743 -1.117 . . . . 60.350000000000001 109.37 -171.025 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 122.083 0.944 . . . . 42.039999999999999 109.695 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.97 162.58 40.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.04 -0.982 . . . . 75.200000000000003 109.045 -171.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -103.4 41.06 1.31 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.813 0.816 . . . . 72.200000000000003 110.065 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -86.19 69.25 10.46 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.748 1.261 . . . . 73.219999999999999 111.199 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.74 -40.88 0.04 OUTLIER Glycine 0 C--N 1.29 -2.021 0 CA-C-N 112.599 -2.092 . . . . 13.52 107.877 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.95 -171.91 1.94 Allowed 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 104.191 -2.522 . . . . 64.150000000000006 104.191 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -115.09 118.71 39.94 Favored Pre-proline 0 C--N 1.263 -3.191 0 N-CA-C 109.217 -0.66 . . . . 53.240000000000002 109.217 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 54.3 Cg_endo -74.29 129.57 13.15 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 121.942 1.761 . . . . 52.140000000000001 111.696 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.13 137.97 54.49 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.384 -1.339 . . . . 72.299999999999997 107.384 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -111.59 115.1 28.6 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.737 -1.208 . . . . 74.200000000000003 107.737 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.7 t -108.06 112.91 42.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.014 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.943 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 152' ' ' ARG . 8.8 ptp180 -96.89 115.69 27.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.556 -0.905 . . . . 74.310000000000002 108.556 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.42 122.06 65.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 CA-C-O 121.287 0.565 . . . . 61.310000000000002 109.589 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -98.37 118.85 45.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 106.791 -1.559 . . . . 72.349999999999994 106.791 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -145.43 164.5 31.37 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.658 -0.497 . . . . 75.239999999999995 109.658 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -68.97 148.33 97.88 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.402 -0.817 . . . . 74.5 109.331 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 189' ' ' ASP . 44.2 Cg_exo -55.73 -29.94 73.59 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.94 2.427 . . . . 74.129999999999995 114.19 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -68.24 -26.05 65.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.0 0.429 . . . . 72.420000000000002 110.062 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -87.9 -36.24 17.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.664 -0.698 . . . . 60.130000000000003 110.101 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.494 ' HG3' HG21 ' A' ' 191' ' ' ILE . 14.9 tm-20 -46.26 -36.27 6.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.794 1.638 . . . . 74.310000000000002 111.65 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.3 p -62.56 -50.81 69.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.516 -0.766 . . . . 65.349999999999994 111.888 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.7 p90 -84.44 -23.47 29.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 120.591 -0.443 . . . . 64.109999999999999 111.512 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.1 t -66.63 -51.04 61.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.659 -0.497 . . . . 65.109999999999999 109.659 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 168' ' ' VAL . 27.9 ptt180 -68.35 -33.09 73.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.4 -0.92 . . . . 75.099999999999994 111.029 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.89 82.43 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.015 -0.539 . . . . 53.210000000000001 109.807 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 70.7 t60 -63.25 -37.55 87.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.844 -0.616 . . . . 73.409999999999997 109.933 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 163' ' ' VAL . 73.8 mt -60.24 -46.37 94.85 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 N-CA-C 110.107 -0.331 . . . . 72.230000000000004 110.107 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 164' ' ' ARG . 58.2 t -63.92 -42.21 95.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.259 0.552 . . . . 74.219999999999999 110.952 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.99 -44.42 76.66 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.641 -0.708 . . . . 72.530000000000001 110.321 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -71.33 -35.97 71.39 Favored 'General case' 0 C--O 1.185 -2.294 0 C-N-CA 119.909 -0.717 . . . . 73.450000000000003 111.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.7 p -65.38 -39.41 92.21 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.844 -0.742 . . . . 65.430000000000007 110.718 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.3 m -60.47 -45.0 95.31 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.21 -0.45 . . . . 65.409999999999997 110.094 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.2 p -79.74 -33.26 40.91 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.574 0.954 . . . . 72.230000000000004 113.574 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -93.99 16.01 15.5 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.025 0.75 . . . . 72.340000000000003 113.025 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 69.4 27.75 4.91 Favored 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 123.396 0.678 . . . . 73.310000000000002 112.608 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.52 ' O ' ' HB ' ' A' ' 171' ' ' THR . 57.4 mt -114.63 130.35 69.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.423 -0.584 . . . . 73.540000000000006 109.423 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 17.2 m -98.69 136.72 38.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.916 -1.142 . . . . 64.030000000000001 107.916 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 167' ' ' ILE . 80.9 mt -80.18 138.52 36.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.364 -0.976 . . . . 70.329999999999998 108.364 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -93.17 -40.48 10.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.721 -1.214 . . . . 73.150000000000006 107.721 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.35 162.4 24.47 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 109.088 -1.605 . . . . 71.409999999999997 109.088 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 69.7 mt -135.06 118.05 23.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.437 -0.579 . . . . 64.120000000000005 109.437 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -97.19 112.03 24.0 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.64 -1.244 . . . . 73.409999999999997 107.64 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.0 t -119.65 109.64 15.89 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.934 0.397 . . . . 60.32 110.178 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.99 158.22 27.62 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.543 -0.837 . . . . 64.239999999999995 112.374 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.423 ' HA ' HG12 ' A' ' 191' ' ' ILE . 10.0 Cg_endo -53.42 137.59 65.07 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 124.081 3.188 . . . . 62.130000000000003 111.781 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -114.33 3.34 15.02 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 113.505 0.928 . . . . 74.319999999999993 113.505 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.68 -84.99 0.15 Allowed Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 118.055 -2.022 . . . . 72.329999999999998 115.574 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.25 -72.48 0.71 Allowed 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.964 -0.694 . . . . 52.530000000000001 111.874 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 34.3 t70 -131.57 27.69 4.67 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 123.343 1.544 . . . . 70.129999999999995 108.071 -177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 8.3 p-10 -128.1 160.02 33.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.576 -1.647 . . . . 61.240000000000002 113.664 -177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.494 HG21 ' HG3' ' A' ' 160' ' ' GLU . 5.4 mt -137.14 141.18 40.95 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 112.051 -2.34 . . . . 63.219999999999999 105.366 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 88.9 m -116.9 119.34 35.06 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 120.305 -0.558 . . . . 72.209999999999994 109.771 177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.54 113.86 25.47 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.728 -1.212 . . . . 74.129999999999995 107.728 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 7.1 m -95.7 104.99 16.93 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.149 -1.797 . . . . 74.150000000000006 106.149 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.75 117.37 34.74 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.52 -0.764 . . . . 50.130000000000003 110.003 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -89.2 111.26 22.0 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.912 -1.514 . . . . 73.510000000000005 106.912 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 50.6 mt -106.51 152.81 23.19 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.955 -1.128 . . . . 75.040000000000006 107.955 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 62.2 mt -124.99 117.94 25.13 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.122 -1.436 . . . . 73.5 107.122 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -126.12 140.71 52.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.49 -0.559 . . . . 54.109999999999999 109.49 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.23 118.27 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 122.652 0.381 . . . . 74.329999999999998 110.534 -176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 63.16 -117.1 10.35 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.986 -0.846 . . . . 63.219999999999999 110.986 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -172.89 102.13 0.13 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.036 -0.727 . . . . 51.020000000000003 109.036 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.9 m -108.88 87.74 4.82 Favored Pre-proline 0 N--CA 1.418 -2.038 0 N-CA-C 107.529 -1.286 . . . . 73.239999999999995 107.529 172.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.6 -39.07 12.88 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 124.829 3.686 . . . . 71.319999999999993 114.562 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 209' ' ' ARG . . . -58.19 -52.5 65.32 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.432 0.458 . . . . 53.130000000000003 111.463 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -71.35 -30.4 66.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 111.484 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.76 -41.6 74.97 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.399 -0.593 . . . . 44.210000000000001 109.399 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -66.17 -34.82 78.9 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.888 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 205' ' ' ALA . 3.2 mmp_? -58.74 -48.48 81.05 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 120.757 0.313 . . . . 74.340000000000003 110.541 176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -43.44 91.52 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.379 -0.828 . . . . 74.319999999999993 110.166 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.24 -37.95 78.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.229 -0.441 . . . . 71.450000000000003 111.001 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.01 83.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 120.763 -0.375 . . . . 55.340000000000003 111.704 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 43.7 mt-10 -73.59 -37.63 65.41 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.797 -1.161 . . . . 72.219999999999999 111.413 -178.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.401 ' O ' HG21 ' A' ' 220' ' ' VAL . 1.7 tm? -72.76 -36.32 67.67 Favored 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 123.891 0.744 . . . . 61.229999999999997 109.674 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.4 t -75.59 -32.77 60.45 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.235 0.541 . . . . 52.149999999999999 110.202 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.6 tp -84.79 -8.28 58.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 112.236 0.458 . . . . 72.150000000000006 112.236 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 79.4 mt-30 -58.25 128.62 82.4 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 120.534 -0.466 . . . . 73.340000000000003 111.07 175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.4 107.27 0.56 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.708 2.272 . . . . 71.010000000000005 111.877 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.71 -18.27 3.63 Favored Glycine 0 C--N 1.298 -1.572 0 CA-C-N 115.33 -0.85 . . . . 74.340000000000003 111.045 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 214' ' ' LEU . 85.7 t -81.33 136.47 23.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.03 -0.585 . . . . 70.310000000000002 110.05 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 38.7 m-85 -84.25 -53.83 5.22 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.041 -1.096 . . . . 71.420000000000002 108.041 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 159.12 16.7 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.885 -1.052 . . . . 72.340000000000003 110.5 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.66 129.29 61.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.288 -1.004 . . . . 72.319999999999993 108.288 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -133.92 128.3 34.23 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.237 -1.023 . . . . 74.420000000000002 108.237 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -116.72 146.91 42.46 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.711 0.767 . . . . 75.150000000000006 112.945 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -112.72 150.28 31.76 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.926 -1.488 . . . . 74.540000000000006 107.117 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -109.71 134.85 51.51 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 109.053 -0.721 . . . . 51.039999999999999 109.053 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.93 -156.41 27.46 Favored Glycine 0 N--CA 1.412 -2.91 0 CA-C-N 115.557 -0.747 . . . . 75.5 111.956 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.35 10.05 31.7 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.51 0.671 . . . . 71.140000000000001 110.808 177.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -88.83 102.92 15.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.001 -1.0 . . . . 73.430000000000007 108.63 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.32 72.69 9.78 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.69 0.757 . . . . 53.219999999999999 109.162 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -99.41 112.33 24.54 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.798 -1.092 . . . . 72.239999999999995 110.207 -174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.68 15.2 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.382 -0.372 . . . . 74.439999999999998 111.174 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--N 1.315 -0.905 0 N-CA-C 107.467 -1.308 . . . . 74.409999999999997 107.467 175.474 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.468 0.468 0 N-CA-C 109.89 -0.411 . . . . 75.209999999999994 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -92.29 130.8 37.89 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 108.034 -1.098 . . . . 51.5 108.034 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -90.31 71.46 7.13 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.606 -0.838 . . . . 74.439999999999998 110.59 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -133.26 24.98 4.18 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 122.524 1.154 . . . . 64.400000000000006 111.066 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -97.43 -40.98 3.53 Favored Glycine 0 C--N 1.268 -3.222 0 N-CA-C 106.375 -2.69 . . . . 61.420000000000002 106.375 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -130.01 128.65 42.43 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 103.235 -2.876 . . . . 72.329999999999998 103.235 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.75 125.84 79.37 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.471 -0.566 . . . . 72.349999999999994 109.471 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 56.2 Cg_endo -76.47 100.45 1.39 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.252 1.968 . . . . 74.530000000000001 111.969 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.423 ' OH ' ' HD2' ' A' ' 202' ' ' HIS . 89.1 m-85 -92.03 148.9 21.83 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 115.672 -0.695 . . . . 74.409999999999997 109.24 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.82 115.09 23.15 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 108.545 -0.909 . . . . 75.209999999999994 108.545 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.69 114.04 45.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.287 -0.87 . . . . 55.240000000000002 108.954 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -98.8 103.26 15.19 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.803 -0.814 . . . . 44.030000000000001 108.803 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 220' ' ' VAL . 2.1 p -110.53 122.29 64.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.439 0.638 . . . . 63.130000000000003 110.76 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 154' ' ' ILE . 3.0 mp -99.73 117.94 45.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.411 -1.7 . . . . 55.009999999999998 106.411 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 20.6 p -144.42 173.99 11.31 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.624 -0.51 . . . . 71.519999999999996 109.624 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -63.12 145.26 96.94 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 123.35 0.406 . . . . 62.32 110.54 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.61 -32.12 82.0 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.943 2.429 . . . . 74.219999999999999 113.855 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.44 -5.1 58.47 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.938 0.399 . . . . 63.43 111.209 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -92.53 -35.42 13.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.43 -0.581 . . . . 71.109999999999999 109.43 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.37 -38.07 12.39 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.064 1.346 . . . . 62.549999999999997 111.731 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.9 p -61.19 -48.81 79.84 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.666 -0.697 . . . . 74.109999999999999 112.339 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 16.0 p90 -85.04 -26.38 27.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.923 -0.711 . . . . 74.019999999999996 111.763 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.6 t -66.22 -49.35 76.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.245 -0.434 . . . . 71.239999999999995 110.241 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 168' ' ' VAL . 35.4 ttp85 -62.85 -40.21 96.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.603 -0.272 . . . . 75.530000000000001 111.086 -178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -67.77 -39.77 84.1 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.339 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -67.37 -36.65 81.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.825 -0.625 . . . . 71.150000000000006 109.742 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.0 mt -59.04 -47.92 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 109.624 -0.51 . . . . 74.530000000000001 109.624 175.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' ARG . 62.0 t -61.15 -41.84 91.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 64.150000000000006 110.453 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -65.92 -42.43 90.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.534 -0.303 . . . . 74.25 111.631 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.25 -40.36 81.97 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.385 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.5 p -70.87 -40.61 72.18 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.644 -0.423 . . . . 72.209999999999994 111.094 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 44.6 m -67.57 -25.15 65.65 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 111.859 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.1 m -97.15 -36.31 10.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.787 -0.765 . . . . 43.200000000000003 112.776 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.21 29.86 3.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 115.017 1.488 . . . . 72.530000000000001 115.017 -169.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 76.05 23.1 1.32 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 114.932 1.456 . . . . 70.349999999999994 114.932 168.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 210' ' ' LEU . 43.0 mt -117.71 136.31 55.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 C-N-CA 120.064 -0.655 . . . . 64.25 109.957 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 198' ' ' LEU . 16.2 m -100.98 148.9 24.49 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.772 -1.196 . . . . 53.350000000000001 107.772 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.33 135.97 36.28 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.787 0.721 . . . . 72.109999999999999 109.695 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -94.87 -36.76 11.51 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.415 -1.328 . . . . 74.319999999999993 107.415 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 170.4 166.04 28.7 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.59 -1.186 . . . . 63.299999999999997 110.43 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.58 118.82 31.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 109.028 -0.73 . . . . 73.319999999999993 109.028 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -106.16 138.57 42.12 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.623 -1.251 . . . . 74.510000000000005 107.623 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.0 t -135.57 135.04 39.99 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 109.567 -0.531 . . . . 70.129999999999995 109.567 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.09 142.27 10.4 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.817 -0.706 . . . . 41.119999999999997 111.6 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.24 133.68 47.98 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.015 2.477 . . . . 74.120000000000005 111.055 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.51 10.6 39.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.233 -0.439 . . . . 71.150000000000006 111.373 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 121.67 -109.98 1.57 Allowed Glycine 0 N--CA 1.405 -3.398 0 C-N-CA 120.652 -0.785 . . . . 73.420000000000002 112.569 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 189' ' ' ASP . 4.9 p-10 -50.44 -82.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 124.772 1.229 . . . . 62.0 113.667 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.421 ' H ' ' CG ' ' A' ' 188' ' ' ASP . 21.1 t70 -148.9 38.66 0.83 Allowed 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 122.863 1.316 . . . . 61.539999999999999 109.218 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.39 158.12 31.84 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.106 -1.406 . . . . 74.209999999999994 107.381 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.1 tt -138.34 142.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.936 -1.505 . . . . 75.219999999999999 106.936 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 28.9 m -114.01 126.64 55.35 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.442 -0.503 . . . . 71.409999999999997 110.674 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.14 130.69 48.83 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.286 -1.005 . . . . 53.549999999999997 108.286 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 16.3 m -108.43 105.49 15.19 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 105.672 -1.973 . . . . 72.439999999999998 105.672 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -97.86 117.32 31.91 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.715 -0.846 . . . . 73.430000000000007 108.715 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' TYR . 64.3 m-70 -96.08 112.08 23.92 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.305 -1.739 . . . . 65.230000000000004 106.305 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.6 mt -117.11 151.82 36.03 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 116.038 -0.528 . . . . 61.299999999999997 109.925 -173.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 177' ' ' THR . 73.7 mt -118.14 114.49 23.15 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.185 -1.043 . . . . 61.009999999999998 108.185 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 51.4 ttp -114.74 141.73 47.45 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.779 -0.452 . . . . 74.439999999999998 109.779 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.3 125.3 27.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 O-C-N 123.539 0.524 . . . . 70.0 111.565 -172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 67.38 -114.1 6.03 Favored Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.89 -1.05 . . . . 71.329999999999998 112.0 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.423 ' HD2' ' OH ' ' A' ' 149' ' ' TYR . 14.6 t-80 -164.36 93.25 0.67 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.816 0.846 . . . . 60.210000000000001 109.289 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.6 m -128.43 81.94 69.58 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 107.516 -1.29 . . . . 41.439999999999998 107.516 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.68 -22.97 74.84 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.089 2.526 . . . . 74.319999999999993 113.696 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.17 86.29 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.458 . . . . 71.230000000000004 111.779 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 210' ' ' LEU . 65.5 mttm -66.02 -45.62 80.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.804 0.335 . . . . 72.0 110.297 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.5 tp -66.02 -42.69 89.33 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.375 -0.829 . . . . 71.299999999999997 109.828 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.3 -38.94 92.81 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.001 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -64.49 -41.41 96.47 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.208 -0.597 . . . . 62.149999999999999 110.963 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.511 HD22 HD12 ' A' ' 176' ' ' ILE . 10.9 mp -67.53 -40.4 85.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.242 -0.436 . . . . 74.400000000000006 111.549 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 207' ' ' LEU . 71.1 t -64.05 -41.86 93.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.175 0.297 . . . . 72.219999999999999 110.806 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.18 99.43 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.783 0.325 . . . . 60.240000000000002 111.274 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 217' ' ' GLN . 11.1 tp10 -69.19 -39.13 78.84 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 123.299 0.64 . . . . 71.239999999999995 110.01 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.72 -41.02 84.19 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.697 -0.853 . . . . 62.009999999999998 108.697 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.5 t -63.74 -36.35 83.58 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-O 121.599 0.714 . . . . 71.109999999999999 109.969 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.26 -22.87 61.16 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.086 -0.961 . . . . 72.310000000000002 111.939 -175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 213' ' ' GLU . 85.2 mm-40 -57.76 121.03 46.54 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 109.721 -0.474 . . . . 73.030000000000001 109.721 176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.42 106.74 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.057 2.504 . . . . 72.519999999999996 112.218 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 144.12 -20.1 2.12 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 115.197 -0.91 . . . . 72.329999999999998 111.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 153' ' ' VAL . 99.0 t -79.87 131.27 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 115.547 -0.326 . . . . 55.399999999999999 110.936 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -84.59 -52.61 5.99 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.169 -0.678 . . . . 73.109999999999999 109.169 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -159.27 157.35 30.45 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.933 -1.031 . . . . 75.209999999999994 109.696 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.5 129.23 13.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.247 0.546 . . . . 63.539999999999999 110.375 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.94 134.36 55.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.744 -1.206 . . . . 71.230000000000004 107.744 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -114.6 146.51 40.72 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 118.874 -1.13 . . . . 71.340000000000003 108.953 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -148.37 146.45 28.5 Favored 'General case' 0 C--N 1.256 -3.491 0 N-CA-C 107.022 -1.473 . . . . 73.310000000000002 107.022 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.26 169.59 18.01 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.64 -0.504 . . . . 73.439999999999998 109.64 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -61.72 113.35 5.64 Favored Glycine 0 CA--C 1.483 -1.916 0 N-CA-C 111.141 -0.784 . . . . 72.239999999999995 111.141 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -69.75 -66.71 0.55 Allowed 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.649 -1.241 . . . . 74.120000000000005 107.649 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -128.47 -49.27 1.28 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.34 -1.726 . . . . 73.099999999999994 106.34 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 52.11 40.16 28.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.93 -1.486 . . . . 73.299999999999997 109.567 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -98.32 129.13 45.01 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 113.173 -1.83 . . . . 53.140000000000001 109.638 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -83.42 86.43 7.08 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.47 0.653 . . . . 63.530000000000001 109.924 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 107.443 -1.317 . . . . 55.399999999999999 107.443 176.283 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.365 0 CA-C-O 122.119 0.961 . . . . 73.400000000000006 110.274 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.33 80.03 4.43 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.454 -0.794 . . . . 71.129999999999995 109.105 -172.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 61.17 31.54 19.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.851 1.26 . . . . 51.409999999999997 110.343 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.31 71.6 9.95 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.104 -1.862 . . . . 72.519999999999996 110.016 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.69 -37.64 0.05 OUTLIER Glycine 0 C--N 1.274 -2.865 0 CA-C-N 112.176 -2.284 . . . . 62.240000000000002 107.662 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.31 149.73 30.21 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 105.26 -2.126 . . . . 62.219999999999999 105.26 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.27 111.73 20.78 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.848 -0.427 . . . . 73.129999999999995 109.848 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.79 131.69 14.84 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 122.366 2.044 . . . . 73.299999999999997 111.589 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.528 ' CE1' ' HZ3' ' A' ' 225' ' ' TRP . 69.5 m-85 -141.24 165.54 27.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.579 -1.192 . . . . 75.099999999999994 110.411 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 231' ' ' ALA . 43.7 mt-30 -136.44 131.12 33.64 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.326 -1.361 . . . . 72.129999999999995 107.326 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.34 121.71 62.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.607 0 N-CA-C 107.993 -1.114 . . . . 72.219999999999999 107.993 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 18.1 ptt180 -117.04 131.63 56.89 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 120.356 -0.537 . . . . 75.5 109.856 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 p -123.22 129.9 74.64 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.678 -0.692 . . . . 60.219999999999999 109.694 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.23 115.73 44.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.576 -1.268 . . . . 71.329999999999998 107.576 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 23.5 p -142.79 174.51 10.59 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.722 -0.391 . . . . 55.009999999999998 111.166 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -58.25 142.72 80.7 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 124.273 0.983 . . . . 74.230000000000004 109.909 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.79 -36.12 94.72 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.526 2.151 . . . . 72.450000000000003 113.852 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -72.52 -16.2 61.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.936 0.398 . . . . 64.349999999999994 110.958 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.71 -35.36 20.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.174 -0.676 . . . . 73.219999999999999 109.174 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.66 -48.17 10.55 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 125.519 1.528 . . . . 71.329999999999998 111.182 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.4 m -60.95 -40.6 93.94 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.762 -1.108 . . . . 64.140000000000001 112.252 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -87.28 -29.96 21.24 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 118.265 -1.374 . . . . 65.209999999999994 111.245 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.593 HG13 HD12 ' A' ' 214' ' ' LEU . 34.0 t -63.23 -48.82 85.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 O-C-N 123.553 0.533 . . . . 74.209999999999994 111.098 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 168' ' ' VAL . 18.1 ttp85 -62.52 -39.74 94.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.823 0.344 . . . . 72.25 111.249 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -71.11 -37.37 72.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 61.409999999999997 110.51 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -67.39 -38.73 85.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.761 -0.654 . . . . 70.030000000000001 109.589 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 163' ' ' VAL . 75.7 mt -59.7 -45.2 94.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 N-CA-C 109.79 -0.448 . . . . 64.420000000000002 109.79 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 164' ' ' ARG . 65.1 t -61.92 -40.48 87.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.081 0.467 . . . . 72.540000000000006 110.994 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.43 -39.59 77.74 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.36 -0.536 . . . . 75.310000000000002 111.826 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.89 -46.73 74.01 Favored 'General case' 0 C--O 1.195 -1.793 0 C-N-CA 120.577 -0.449 . . . . 42.200000000000003 110.928 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.406 ' OG1' HD11 ' A' ' 178' ' ' LEU . 19.6 p -62.29 -41.66 98.69 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 111.942 0.349 . . . . 72.109999999999999 111.942 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.8 p -66.75 -27.35 67.53 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.039 0.447 . . . . 72.420000000000002 111.527 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.6 t -91.04 -32.84 15.75 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 116.303 -0.408 . . . . 64.25 111.837 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.4 16.25 7.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.45 0.907 . . . . 74.010000000000005 113.45 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 71.69 28.23 2.78 Favored 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 123.143 0.577 . . . . 74.439999999999998 111.558 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.89 128.9 73.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.384 0.612 . . . . 65.430000000000007 110.708 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 25.0 m -100.91 147.82 25.69 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.302 -1.37 . . . . 71.329999999999998 107.302 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.406 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.0 mp -102.16 142.81 32.83 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.971 -0.456 . . . . 74.409999999999997 110.839 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.14 -6.91 18.23 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 122.995 0.518 . . . . 54.549999999999997 110.891 177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 152.1 162.72 11.03 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 110.901 -0.88 . . . . 63.210000000000001 110.901 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.13 120.6 30.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.549 -0.908 . . . . 70.549999999999997 108.549 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.93 148.38 43.58 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.355 -1.35 . . . . 74.530000000000001 107.355 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.9 t -147.94 140.69 24.69 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 120.252 -0.579 . . . . 75.040000000000006 109.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.86 143.19 11.1 Favored Glycine 0 N--CA 1.425 -2.054 0 CA-C-O 119.325 -0.708 . . . . 42.340000000000003 111.593 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.92 127.09 16.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.447 2.765 . . . . 72.400000000000006 110.011 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.16 0.95 41.56 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 113.86 1.059 . . . . 63.350000000000001 113.86 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 168.72 -83.31 0.09 OUTLIER Glycine 0 N--CA 1.421 -2.334 0 C-N-CA 120.347 -0.93 . . . . 73.140000000000001 112.391 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.45 -69.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 120.765 0.316 . . . . 64.319999999999993 111.106 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -121.7 46.39 2.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 123.566 1.65 . . . . 71.049999999999997 107.561 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.0 p30 -147.05 159.23 43.83 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-N 112.82 -1.991 . . . . 64.340000000000003 110.681 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.3 tt -146.41 138.38 19.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 CA-C-N 113.656 -1.611 . . . . 64.140000000000001 108.06 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 15.3 t -102.44 131.73 48.92 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.8 -0.815 . . . . 74.340000000000003 108.8 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.4 mp -112.39 120.17 40.76 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.401 -1.333 . . . . 64.299999999999997 107.401 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 28.6 m -111.14 110.32 20.78 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 109.17 -0.678 . . . . 74.340000000000003 109.17 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -102.48 126.12 49.42 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.268 -0.642 . . . . 42.299999999999997 109.268 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -90.96 125.42 35.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 105.46 -2.052 . . . . 72.430000000000007 105.46 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.7 mt -127.04 155.31 43.44 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-O 121.433 0.635 . . . . 62.530000000000001 111.717 -172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 93.5 mt -131.69 119.73 21.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 105.762 -1.94 . . . . 74.310000000000002 105.762 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 202' ' ' HIS . 23.0 ttt -107.49 130.28 54.86 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.365 -1.334 . . . . 74.230000000000004 111.286 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 32.8 t -77.1 124.84 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 107.278 -1.378 . . . . 54.149999999999999 107.278 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.41 -56.73 5.07 Favored Glycine 0 C--N 1.308 -1.008 0 C-N-CA 119.687 -1.244 . . . . 73.120000000000005 114.001 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.568 ' HA ' ' SD ' ' A' ' 199' ' ' MET . 27.7 t-80 77.57 94.59 0.06 Allowed 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 124.815 1.246 . . . . 75.310000000000002 109.772 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.5 m -116.24 95.03 44.06 Favored Pre-proline 0 N--CA 1.392 -3.342 0 CA-C-N 113.376 -1.738 . . . . 74.349999999999994 107.129 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -41.3 -40.89 4.69 Favored 'Trans proline' 0 C--O 1.206 -1.124 0 C-N-CA 125.04 3.827 . . . . 71.439999999999998 114.105 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.38 88.04 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.234 0.457 . . . . 73.109999999999999 112.234 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.02 -41.23 67.77 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.196 0.522 . . . . 63.299999999999997 109.78 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 211' ' ' VAL . 59.4 tp -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.281 -0.872 . . . . 62.229999999999997 110.102 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -72.26 -31.52 65.85 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.754 -0.657 . . . . 72.140000000000001 109.702 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -65.61 -45.05 84.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.034 -0.728 . . . . 61.5 109.034 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 47.1 tp -56.34 -49.19 75.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.982 0.801 . . . . 74.340000000000003 110.648 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' LEU . 89.4 t -64.68 -39.26 85.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.875 -0.602 . . . . 72.040000000000006 110.329 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.95 84.22 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 116.379 -0.373 . . . . 61.299999999999997 110.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 217' ' ' GLN . 8.3 tp10 -61.97 -48.61 79.59 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 122.86 0.464 . . . . 65.219999999999999 110.475 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.593 HD12 HG13 ' A' ' 163' ' ' VAL . 3.5 mm? -78.64 -14.59 59.23 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.419 -0.912 . . . . 61.109999999999999 113.165 -176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.5 p -87.08 -37.27 17.57 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 119.602 -0.839 . . . . 73.099999999999994 111.319 172.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.37 -9.47 59.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 64.120000000000005 112.738 -173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 213' ' ' GLU . 73.5 mt-30 -70.83 143.54 89.49 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 120.175 -0.61 . . . . 75.519999999999996 111.874 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.45 112.17 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.288 2.658 . . . . 74.209999999999994 114.018 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.76 -0.16 10.98 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 115.336 -0.847 . . . . 61.219999999999999 112.868 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 214' ' ' LEU . 61.2 t -86.82 131.59 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 120.859 0.361 . . . . 62.119999999999997 110.105 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 17.8 m-85 -81.21 -50.2 9.86 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.809 -0.811 . . . . 72.040000000000006 108.809 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -168.96 162.56 11.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.432 -0.804 . . . . 53.049999999999997 110.645 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.34 155.04 41.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.017 -1.105 . . . . 73.430000000000007 108.017 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -153.53 132.69 12.64 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.584 -1.265 . . . . 75.519999999999996 107.584 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . 0.528 ' HZ3' ' CE1' ' A' ' 149' ' ' TYR . 48.3 p-90 -129.5 157.56 41.66 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 61.299999999999997 111.035 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -151.47 145.47 25.23 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.882 -0.599 . . . . 74.049999999999997 110.227 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.413 ' HA ' ' CD1' ' A' ' 149' ' ' TYR . . . -74.28 149.28 40.8 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.482 0.713 . . . . 45.409999999999997 112.738 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.94 144.26 15.81 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.351 -1.099 . . . . 74.120000000000005 110.351 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -24.26 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.707 0.753 . . . . 44.420000000000002 111.225 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -125.1 5.63 7.89 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.194 0.521 . . . . 71.340000000000003 110.435 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.425 ' HB2' HE22 ' A' ' 150' ' ' GLN . . . 69.39 54.94 0.4 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.228 1.011 . . . . 60.039999999999999 111.84 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.34 110.49 23.07 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 105.29 -2.115 . . . . 74.230000000000004 105.29 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -87.71 99.82 12.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 110.174 -0.306 . . . . 61.109999999999999 110.174 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 107.161 -1.422 . . . . 54.439999999999998 107.161 177.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 108.336 -0.987 . . . . 72.239999999999995 108.336 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.07 107.87 8.58 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 105.489 -2.041 . . . . 72.319999999999993 105.489 170.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.53 66.97 0.73 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.346 1.07 . . . . 74.5 112.103 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -140.91 32.99 1.77 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.766 1.746 . . . . 71.430000000000007 107.745 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.87 -45.92 1.24 Allowed Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 111.459 -2.609 . . . . 61.32 106.854 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -111.73 163.63 13.93 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.665 -2.717 . . . . 71.239999999999995 103.665 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -92.35 116.46 66.52 Favored Pre-proline 0 C--N 1.283 -2.305 0 CA-C-N 118.269 0.486 . . . . 74.129999999999995 109.804 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.55 124.65 7.78 Favored 'Trans proline' 0 N--CA 1.435 -1.953 0 C-N-CA 122.401 2.067 . . . . 71.329999999999998 111.488 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -125.23 137.43 54.11 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 107.911 -1.144 . . . . 74.329999999999998 107.911 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -110.3 121.55 45.54 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.193 -1.04 . . . . 73.310000000000002 108.193 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.51 105.21 18.36 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.716 0 N-CA-C 107.831 -1.174 . . . . 71.150000000000006 107.831 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.474 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 36.3 ttm180 -97.15 107.37 19.88 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.937 -1.029 . . . . 72.219999999999999 110.523 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 220' ' ' VAL . 2.4 p -114.25 123.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.539 0.685 . . . . 72.400000000000006 111.01 -177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.5 mt -98.15 116.01 39.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.723 -1.584 . . . . 53.399999999999999 106.723 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 18.8 p -139.51 169.06 18.44 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.539 -0.911 . . . . 41.520000000000003 108.539 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -69.02 152.98 96.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 109.59 -0.522 . . . . 71.510000000000005 109.59 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 52.8 Cg_exo -53.22 -39.55 80.33 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.013 2.476 . . . . 63.240000000000002 115.297 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -77.16 -8.92 58.35 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.162 -0.615 . . . . 72.129999999999995 111.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -84.89 -30.9 24.02 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 109.522 -0.547 . . . . 65.299999999999997 109.522 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HG2' HD21 ' A' ' 193' ' ' LEU . 9.1 tm-20 -44.9 -46.11 10.72 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 125.364 1.466 . . . . 71.340000000000003 111.267 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 m -65.8 -40.18 91.65 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.725 -0.671 . . . . 73.120000000000005 112.744 -174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 14.8 p90 -87.47 -21.92 25.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.381 -0.927 . . . . 62.109999999999999 112.731 177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -70.76 -48.43 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.84 -0.8 . . . . 72.200000000000003 108.84 176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.57 -41.65 90.68 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.363 1.065 . . . . 72.200000000000003 111.017 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.04 90.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.292 0.568 . . . . 75.219999999999999 110.658 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -66.92 -40.66 87.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.985 -0.552 . . . . 73.409999999999997 109.657 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 163' ' ' VAL . 80.8 mt -58.84 -50.08 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.896 -0.593 . . . . 72.329999999999998 110.126 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 -32.12 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 120.605 -0.438 . . . . 75.239999999999995 111.347 -175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -75.5 -31.6 60.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.593 0.59 . . . . 61.310000000000002 112.593 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.558 ' HE ' ' HA ' ' A' ' 170' ' ' ARG . 1.4 mmp_? -85.68 -30.29 23.3 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.781 -0.767 . . . . 72.510000000000005 111.58 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 176' ' ' ILE . 24.1 p -72.11 -38.52 69.29 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.512 -0.475 . . . . 52.439999999999998 110.578 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.8 t -64.75 -38.82 92.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.254 -0.43 . . . . 75.109999999999999 109.861 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 26.5 p -75.74 -44.03 43.81 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 120.649 0.261 . . . . 60.509999999999998 111.675 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 3.22 20.04 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.439 0.904 . . . . 72.120000000000005 113.439 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 66.31 36.28 5.43 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.841 0.829 . . . . 65.010000000000005 111.758 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 171' ' ' THR . 58.5 mt -103.77 120.77 54.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.688 -1.597 . . . . 64.420000000000002 106.688 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.9 m -89.19 142.27 27.8 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 109.711 -0.478 . . . . 71.310000000000002 109.711 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.58 129.17 35.2 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.542 -0.54 . . . . 75.010000000000005 109.542 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -31.53 21.01 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 105.525 -2.028 . . . . 74.439999999999998 105.525 176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.56 175.62 31.76 Favored Glycine 0 N--CA 1.434 -1.472 0 N-CA-C 109.94 -1.264 . . . . 62.340000000000003 109.94 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.53 117.83 28.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.822 -0.807 . . . . 73.329999999999998 108.822 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -98.97 112.05 24.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.671 -1.603 . . . . 74.099999999999994 106.671 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.9 t -116.9 123.36 46.83 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.635 -0.505 . . . . 54.509999999999998 109.635 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.19 138.01 7.71 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.951 -0.86 . . . . 70.209999999999994 110.951 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 84.6 Cg_exo -45.9 142.56 7.8 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.146 3.231 . . . . 34.530000000000001 113.23 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.46 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -111.98 14.38 20.83 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.469 0.652 . . . . 73.420000000000002 109.986 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.74 -99.7 0.19 Allowed Glycine 0 N--CA 1.398 -3.863 0 N-CA-C 109.897 -1.281 . . . . 53.409999999999997 109.897 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.04 -64.29 0.92 Allowed 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.988 0.423 . . . . 71.519999999999996 110.642 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.421 ' C ' ' HD3' ' A' ' 157' ' ' PRO . 32.2 t70 -101.0 24.68 8.99 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.799 1.285 . . . . 74.310000000000002 109.754 -175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.432 HD22 ' HB3' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -150.49 147.09 27.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 114.547 -1.206 . . . . 73.040000000000006 111.928 175.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 16.7 tt -139.31 144.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 113.955 -1.475 . . . . 73.439999999999998 107.924 -176.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.474 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 30.7 m -109.89 122.28 47.17 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-O 121.174 0.511 . . . . 64.109999999999999 111.12 -177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 160' ' ' GLU . 5.2 mp -102.21 111.17 23.35 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.594 -1.262 . . . . 73.450000000000003 107.594 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 152' ' ' ARG . 34.0 m -98.2 106.04 18.28 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 106.851 -1.537 . . . . 71.340000000000003 106.851 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.84 116.68 29.02 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.796 -0.816 . . . . 61.43 108.796 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -89.42 110.0 20.86 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.929 -1.878 . . . . 73.129999999999995 105.929 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 79.0 mt -114.79 149.21 37.34 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 109.85 -0.426 . . . . 73.530000000000001 109.85 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.13 115.03 22.3 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.524 -1.287 . . . . 71.109999999999999 107.524 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 23.4 ttt -111.91 134.43 53.48 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.798 -0.761 . . . . 64.510000000000005 111.432 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.64 125.31 28.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.479 -1.304 . . . . 62.32 107.479 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.11 -126.11 9.3 Favored Glycine 0 N--CA 1.418 -2.547 0 C-N-CA 120.318 -0.944 . . . . 43.539999999999999 110.932 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 179.33 102.45 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.755 -1.202 . . . . 61.399999999999999 107.755 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 83.93 5.42 Favored Pre-proline 0 C--N 1.29 -1.995 0 N-CA-C 109.037 -0.727 . . . . 73.120000000000005 109.037 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.39 -35.21 53.59 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 123.687 2.925 . . . . 54.409999999999997 113.15 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.75 92.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.146 -0.479 . . . . 52.539999999999999 111.707 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -76.14 -41.96 48.29 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.292 -0.413 . . . . 73.140000000000001 110.133 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.52 -40.57 95.87 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.875 -0.602 . . . . 70.230000000000004 111.274 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.89 -40.91 87.89 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.328 -0.397 . . . . 52.049999999999997 111.944 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -78.73 -25.37 44.58 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 119.73 -0.788 . . . . 72.340000000000003 111.172 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 67.3 tp -65.15 -52.26 56.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.921 -0.581 . . . . 73.310000000000002 109.88 174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 34.3 m -70.26 -25.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 120.017 -0.673 . . . . 73.319999999999993 111.253 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.83 -42.08 64.15 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.077 -0.511 . . . . 71.030000000000001 110.606 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.583 0.23 . . . . 75.439999999999998 111.14 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.67 -44.31 70.75 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.261 -0.644 . . . . 70.040000000000006 109.261 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.57 ' HA ' HG11 ' A' ' 220' ' ' VAL . 20.7 p -73.58 -24.34 60.06 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.217 0.532 . . . . 74.510000000000005 111.351 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.45 -19.21 58.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.98 -0.554 . . . . 65.25 111.302 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.63 120.47 15.63 Favored Pre-proline 0 C--O 1.243 0.75 0 N-CA-C 108.936 -0.765 . . . . 70.120000000000005 108.936 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.21 103.72 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.498 2.132 . . . . 73.420000000000002 111.449 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 143.59 -20.47 2.21 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.342 -0.845 . . . . 74.230000000000004 111.543 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 215' ' ' SER . 88.8 t -82.36 134.09 27.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.053 0.454 . . . . 62.409999999999997 111.303 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.72 -48.54 5.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.622 -0.717 . . . . 72.200000000000003 110.215 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -152.87 155.44 37.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.344 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.4 p -140.85 134.05 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.362 0.601 . . . . 73.219999999999999 109.839 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -128.53 122.92 32.22 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.865 -1.161 . . . . 75.319999999999993 107.865 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -114.29 145.17 42.1 Favored 'General case' 0 CA--C 1.47 -2.1 0 C-N-CA 118.452 -1.299 . . . . 73.209999999999994 109.069 174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -140.35 139.13 35.32 Favored 'General case' 0 C--N 1.263 -3.156 0 CA-C-N 115.092 -0.958 . . . . 73.530000000000001 109.733 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -82.23 130.55 35.12 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.151 -0.477 . . . . 55.409999999999997 109.715 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.72 139.23 10.7 Favored Glycine 0 C--N 1.29 -1.989 0 N-CA-C 111.381 -0.687 . . . . 31.350000000000001 111.381 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -87.33 -44.77 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.167 0.508 . . . . 72.409999999999997 111.27 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -93.18 24.46 3.79 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.969 0.89 . . . . 72.230000000000004 108.683 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.76 57.11 2.75 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.045 -1.434 . . . . 53.149999999999999 111.149 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 66.28 89.51 0.1 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.587 -1.188 . . . . 72.030000000000001 110.438 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -80.35 88.49 5.55 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.594 0.711 . . . . 71.5 110.061 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 107.883 -1.154 . . . . 65.219999999999999 107.883 -178.441 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 122.138 0.971 . . . . 61.329999999999998 111.229 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -126.57 99.91 6.0 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.074 -1.454 . . . . 73.239999999999995 107.074 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -87.17 109.91 19.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 113.299 0.852 . . . . 64.319999999999993 113.299 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -147.88 31.66 0.86 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.174 1.464 . . . . 70.400000000000006 109.929 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -99.05 -49.69 1.56 Allowed Glycine 0 C--N 1.267 -3.252 0 N-CA-C 106.731 -2.547 . . . . 51.340000000000003 106.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.7 140.96 30.52 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 104.101 -2.555 . . . . 74.430000000000007 104.101 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.69 118.62 73.27 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 111.939 0.348 . . . . 75.430000000000007 111.939 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 38.0 Cg_endo -72.1 127.31 12.66 Favored 'Trans proline' 0 N--CA 1.432 -2.104 0 C-N-CA 122.065 1.843 . . . . 71.040000000000006 111.291 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.85 143.39 46.98 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.381 -1.281 . . . . 74.349999999999994 108.421 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 228' ' ' GLY . 42.3 mt-30 -108.75 124.07 50.0 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 106.678 -1.601 . . . . 75.310000000000002 106.678 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 97.5 t -107.15 104.94 17.87 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.604 0 N-CA-C 106.532 -1.655 . . . . 74.040000000000006 106.532 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 192' ' ' THR . 21.6 ttm180 -96.64 104.49 16.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.76 -1.109 . . . . 72.340000000000003 109.797 -177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 223' ' ' VAL . 2.3 p -113.59 132.07 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.026 -0.988 . . . . 72.439999999999998 110.774 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 70.9 mt -104.34 119.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.5 -1.296 . . . . 54.219999999999999 107.5 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . 0.403 ' SG ' HD13 ' A' ' 193' ' ' LEU . 25.0 p -140.56 171.13 14.55 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.836 -0.802 . . . . 64.340000000000003 108.836 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -71.62 146.51 91.27 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 107.596 -1.261 . . . . 74.430000000000007 107.596 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.5 -33.57 98.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.404 2.07 . . . . 75.450000000000003 113.685 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.25 -7.55 59.59 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.261 -0.575 . . . . 71.150000000000006 110.695 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -89.83 -35.88 15.41 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.844 -0.798 . . . . 74.310000000000002 108.844 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.2 tm-20 -42.76 -46.63 5.23 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 125.915 1.686 . . . . 41.200000000000003 111.39 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.7 m -62.32 -41.95 98.98 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 123.995 0.809 . . . . 61.100000000000001 112.274 -174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 159' ' ' ALA . 24.3 p90 -86.95 -26.01 24.06 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 118.989 -1.084 . . . . 73.510000000000005 111.705 178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -67.46 -41.3 85.91 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.246 -0.65 . . . . 64.120000000000005 109.246 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 19.5 ttt180 -58.86 -45.32 90.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.48 1.112 . . . . 75.319999999999993 110.366 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.26 -31.31 68.64 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.82 -0.627 . . . . 62.229999999999997 110.923 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -73.27 -41.82 63.18 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 109.26 -0.644 . . . . 72.319999999999993 109.26 176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 163' ' ' VAL . 76.5 mt -55.92 -51.11 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 C-N-CA 122.9 0.48 . . . . 74.400000000000006 110.745 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.64 -36.65 78.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.166 -0.614 . . . . 72.109999999999999 111.788 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -82.88 -23.64 33.52 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.951 -0.7 . . . . 73.400000000000006 112.314 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -85.96 -35.05 20.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.424 -0.584 . . . . 63.329999999999998 109.424 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.7 p -72.12 -39.97 68.48 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 120.939 -0.304 . . . . 62.409999999999997 111.104 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 11.1 p -64.46 -34.83 79.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.033 0.444 . . . . 64.310000000000002 110.694 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.1 m -77.34 -18.87 57.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.922 -0.581 . . . . 73.549999999999997 111.065 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.468 HD22 HD22 ' A' ' 210' ' ' LEU . 55.4 t30 -99.69 12.48 36.49 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.561 -173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 72.07 27.84 2.6 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 124.183 0.993 . . . . 52.200000000000003 111.669 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.8 mt -116.82 137.41 50.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 20.2 m -111.55 148.35 33.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.532 -0.914 . . . . 72.430000000000007 108.532 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mp -95.05 140.25 30.27 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.814 -0.554 . . . . 62.299999999999997 109.958 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -105.46 -35.89 7.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.872 -0.788 . . . . 61.32 108.872 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -179.87 168.26 38.48 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 110.379 -1.088 . . . . 65.310000000000002 110.379 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.8 mt -134.47 126.81 49.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.794 -0.817 . . . . 74.329999999999998 108.794 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 182' ' ' ARG . 0.5 OUTLIER -112.81 113.47 25.57 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.514 -0.921 . . . . 71.409999999999997 108.514 179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.461 HG22 ' HG ' ' A' ' 193' ' ' LEU . 3.8 p -100.36 130.77 46.5 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 122.373 0.269 . . . . 64.030000000000001 111.321 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.8 143.86 12.21 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-O 118.937 -0.924 . . . . 72.219999999999999 110.861 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.51 152.26 48.75 Favored 'Trans proline' 0 C--O 1.248 0.987 0 C-N-CA 123.141 2.561 . . . . 53.200000000000003 112.453 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 192' ' ' THR . . . -122.99 5.14 9.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.053 0.76 . . . . 53.240000000000002 113.053 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.13 -98.03 0.18 Allowed Glycine 0 N--CA 1.419 -2.465 0 C-N-CA 118.705 -1.712 . . . . 70.420000000000002 113.772 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -100.91 -77.32 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.142 0.972 . . . . 72.430000000000007 109.897 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.47 51.61 1.98 Allowed 'General case' 0 N--CA 1.403 -2.818 0 N-CA-C 106.409 -1.7 . . . . 75.230000000000004 106.409 -174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 2.4 p-10 -146.88 150.94 36.22 Favored 'General case' 0 CA--C 1.466 -2.254 0 CA-C-N 112.522 -2.126 . . . . 74.030000000000001 111.438 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 tt -142.44 143.09 26.44 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.964 0 CA-C-N 113.201 -1.818 . . . . 70.319999999999993 108.582 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.503 ' CG2' ' HG3' ' A' ' 152' ' ' ARG . 19.4 m -102.73 125.18 49.37 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 109.627 -0.508 . . . . 73.450000000000003 109.627 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 183' ' ' THR . 6.6 mp -103.31 112.64 25.61 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.392 -1.707 . . . . 73.010000000000005 106.392 174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 26.2 m -98.38 105.69 17.87 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.061 -1.459 . . . . 72.150000000000006 107.061 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -95.03 116.41 28.66 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.889 -0.782 . . . . 70.319999999999993 108.889 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -89.94 103.39 16.05 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 105.66 -1.978 . . . . 74.209999999999994 105.66 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 84.2 mt -109.3 161.35 15.34 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 115.479 -0.782 . . . . 73.239999999999995 110.538 -173.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.71 122.2 32.31 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.997 -1.483 . . . . 72.150000000000006 106.997 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.7 mtp -108.32 134.19 51.49 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 120.14 -0.624 . . . . 72.450000000000003 110.493 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 34.6 t -71.39 121.4 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.033 -1.469 . . . . 73.430000000000007 107.033 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 74.75 -116.99 5.28 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.78 -1.328 . . . . 75.510000000000005 109.78 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 166.51 102.89 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 126.135 1.774 . . . . 73.310000000000002 108.564 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 78.8 m -114.46 91.28 23.88 Favored Pre-proline 0 N--CA 1.419 -1.976 0 N-CA-C 108.77 -0.826 . . . . 72.030000000000001 108.77 174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.53 -38.57 35.91 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.432 3.422 . . . . 65.519999999999996 114.076 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.79 80.21 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.165 0.431 . . . . 71.099999999999994 112.165 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -72.14 -27.52 62.66 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 120.295 -0.562 . . . . 75.540000000000006 110.805 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.48 -45.44 59.43 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.155 -0.313 . . . . 72.409999999999997 110.155 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -66.01 -37.61 86.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 62.340000000000003 111.075 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -74.87 -35.51 62.32 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.052 -0.522 . . . . 71.030000000000001 110.271 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 174' ' ' ASN . 62.4 tp -63.32 -47.48 82.04 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 116.258 -0.428 . . . . 65.310000000000002 110.669 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 223' ' ' VAL . 35.1 m -68.37 -33.97 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.968 -0.693 . . . . 54.100000000000001 110.732 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -61.57 -51.01 70.33 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.25 -0.648 . . . . 73.329999999999998 109.25 176.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.87 -33.25 75.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.120000000000005 110.492 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.452 HD22 ' NE2' ' A' ' 217' ' ' GLN . 1.0 OUTLIER -68.06 -41.45 81.97 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 109.273 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.645 ' HA ' HG11 ' A' ' 220' ' ' VAL . 57.2 p -74.81 -27.57 60.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.191 0.519 . . . . 75.239999999999995 111.727 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 212' ' ' ALA . 7.9 mp -76.77 -11.67 59.87 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.683 0.623 . . . . 64.510000000000005 112.683 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.482 HE22 HG13 ' A' ' 163' ' ' VAL . 45.5 mt-30 -57.63 136.0 82.51 Favored Pre-proline 0 C--O 1.246 0.906 0 N-CA-C 109.62 -0.511 . . . . 72.540000000000006 109.62 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.29 105.95 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.268 1.979 . . . . 64.430000000000007 111.436 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 130.89 -9.86 5.72 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.45 -0.795 . . . . 53.329999999999998 112.038 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 215' ' ' SER . 58.8 t -98.43 137.26 26.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.413 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 84.3 m-85 -87.12 -49.77 7.08 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.131 -0.486 . . . . 60.399999999999999 109.974 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.6 172.18 10.95 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 116.511 -0.313 . . . . 72.400000000000006 111.109 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 215' ' ' SER . 11.1 p -153.05 142.47 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 123.735 0.647 . . . . 72.120000000000005 110.225 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -140.27 135.41 32.25 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.83 -1.174 . . . . 75.129999999999995 107.83 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -109.98 143.8 39.42 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.373 -0.931 . . . . 74.040000000000006 111.188 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -133.91 138.87 45.8 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.01 -0.996 . . . . 71.430000000000007 108.6 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.27 41.35 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.939 0.4 . . . . 71.219999999999999 111.955 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' GLN . . . 83.49 -158.8 36.1 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.044 -1.222 . . . . 55.210000000000001 110.044 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.55 19.09 3.6 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 117.699 0.75 . . . . 51.219999999999999 111.798 174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -96.42 103.61 15.52 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.428 -0.953 . . . . 70.549999999999997 108.428 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.29 5.57 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.828 -0.624 . . . . 64.530000000000001 109.94 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -104.5 113.15 26.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.548 -0.538 . . . . 61.009999999999998 109.548 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -90.94 84.61 5.8 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.404 0.621 . . . . 74.109999999999999 109.574 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 115.238 -0.892 . . . . 74.540000000000006 108.656 -179.127 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.505 -0.767 0 CA-C-O 121.51 0.672 . . . . 71.439999999999998 109.735 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -119.04 152.74 35.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.73 91.55 4.7 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.814 -0.439 . . . . 64.340000000000003 109.814 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -115.33 23.77 12.17 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 123.242 1.496 . . . . 75.329999999999998 110.71 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.02 -25.82 8.21 Favored Glycine 0 C--N 1.272 -2.997 0 CA-C-N 112.048 -2.342 . . . . 64.510000000000005 108.896 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.36 153.44 23.27 Favored 'General case' 0 N--CA 1.396 -3.137 0 N-CA-C 104.639 -2.356 . . . . 74.010000000000005 104.639 176.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 28.7 mm-40 -90.05 120.63 69.25 Favored Pre-proline 0 C--N 1.285 -2.216 0 C-N-CA 119.439 -0.904 . . . . 75.209999999999994 109.424 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.54 119.63 6.05 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 C-N-CA 122.134 1.889 . . . . 44.149999999999999 110.326 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -119.86 143.68 47.78 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 115.256 -0.884 . . . . 73.519999999999996 109.812 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 12.0 pt20 -122.31 118.09 27.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.115 -1.068 . . . . 62.399999999999999 108.115 171.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 194' ' ' THR . 95.4 t -107.94 115.58 49.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 N-CA-C 108.487 -0.931 . . . . 75.109999999999999 108.487 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -108.76 108.48 19.32 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.328 0.585 . . . . 64.450000000000003 110.058 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.6 p -113.72 137.65 46.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.65 115.3 49.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 106.937 -1.505 . . . . 72.319999999999993 106.937 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 19.7 p -140.23 167.77 21.36 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.236 -0.283 . . . . 72.140000000000001 110.236 -177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -54.8 150.43 18.74 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.544 -0.91 . . . . 52.140000000000001 108.544 175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.41 -24.41 31.32 Favored 'Trans proline' 0 N--CA 1.48 0.707 0 C-N-CA 121.446 1.431 . . . . 70.310000000000002 108.752 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -69.33 -25.01 64.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.166 -1.833 . . . . 74.129999999999995 109.166 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -90.21 -35.38 15.38 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.558 -0.747 . . . . 62.229999999999997 109.332 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 164' ' ' ARG . 6.7 tm-20 -48.45 -35.89 13.81 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 125.075 1.35 . . . . 73.099999999999994 111.343 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.0 m -59.82 -52.02 67.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 116.199 -0.455 . . . . 52.43 111.481 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 21.5 p90 -86.71 -21.95 26.32 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.894 -0.722 . . . . 61.539999999999999 112.011 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 167' ' ' ILE . 73.8 t -73.5 -40.54 55.74 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.1 0 CA-C-N 116.314 -0.403 . . . . 62.43 110.407 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 160' ' ' GLU . 43.1 ttt180 -62.38 -43.06 99.72 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.0 -31.23 68.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.45 -0.796 . . . . 71.140000000000001 110.459 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -72.23 -42.26 65.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 109.463 -0.569 . . . . 62.329999999999998 109.463 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 163' ' ' VAL . 77.5 mt -58.86 -47.64 88.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 123.272 0.357 . . . . 60.450000000000003 110.377 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.6 m -68.6 -28.31 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.326 0.491 . . . . 73.540000000000006 112.326 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.08 -40.0 24.8 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.949 0.404 . . . . 74.25 110.681 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -44.56 89.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.763 -0.653 . . . . 65.310000000000002 109.854 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 19.6 p -68.05 -39.77 82.96 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.359 -0.382 . . . . 54.329999999999998 110.935 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 46.7 t -61.96 -35.83 79.61 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.413 -0.812 . . . . 72.109999999999999 110.081 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.4 m -78.36 -37.68 43.76 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.426 0.528 . . . . 70.150000000000006 112.426 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -100.71 40.47 1.26 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.752 1.019 . . . . 60.539999999999999 113.752 -169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 68.58 28.26 5.88 Favored 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 123.739 0.816 . . . . 60.229999999999997 112.915 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 70.6 mt -115.04 136.72 50.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-O 121.575 0.702 . . . . 72.510000000000005 111.759 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 38.2 m -107.45 136.59 46.97 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.577 -1.638 . . . . 74.310000000000002 106.577 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 197' ' ' LEU . 4.5 mp -96.23 139.08 32.9 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.379 -0.528 . . . . 72.010000000000005 111.574 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -87.1 -53.89 4.62 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.669 -1.234 . . . . 74.010000000000005 107.669 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.45 170.99 40.48 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.482 -1.235 . . . . 35.140000000000001 110.531 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.6 116.57 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 109.188 -0.671 . . . . 72.540000000000006 109.188 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -95.39 112.36 24.08 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.933 -1.506 . . . . 73.150000000000006 106.933 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 192' ' ' THR . 1.2 t -124.35 133.09 53.54 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 116.2 -0.455 . . . . 70.099999999999994 110.512 -173.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.19 147.49 18.5 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 115.709 -0.678 . . . . 63.520000000000003 111.791 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.88 139.89 64.24 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.556 2.171 . . . . 71.420000000000002 110.569 176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.442 ' HB3' ' ND2' ' A' ' 190' ' ' ASN . . . -102.47 3.16 37.33 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.784 -0.366 . . . . 64.010000000000005 111.533 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.65 -88.91 0.43 Allowed Glycine 0 N--CA 1.423 -2.209 0 C-N-CA 120.493 -0.86 . . . . 40.350000000000001 114.706 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.91 -81.77 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.59 1.156 . . . . 72.209999999999994 113.567 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -158.25 62.07 0.45 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.791 -1.929 . . . . 53.229999999999997 105.791 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -158.48 153.24 24.84 Favored 'General case' 0 CA--C 1.464 -2.333 0 CA-C-N 112.801 -2.0 . . . . 62.310000000000002 112.65 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.418 HG21 ' HG3' ' A' ' 160' ' ' GLU . 4.5 mt -133.31 138.93 50.3 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.278 0 CA-C-N 113.144 -1.844 . . . . 63.219999999999999 106.629 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 183' ' ' THR . 11.0 t -103.61 128.7 50.86 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 109.268 -0.641 . . . . 60.219999999999999 109.268 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -108.84 114.38 28.11 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.466 -1.309 . . . . 55.32 107.466 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 23.1 m -107.62 104.89 14.53 Favored 'General case' 0 N--CA 1.409 -2.506 0 N-CA-C 106.295 -1.743 . . . . 73.200000000000003 106.295 175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.86 132.92 40.62 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 109.461 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -100.94 113.73 26.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.841 -1.54 . . . . 62.329999999999998 106.841 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 1.8 mm? -117.8 162.47 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.203 -0.908 . . . . 63.210000000000001 110.039 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 87.1 mt -130.38 121.19 25.5 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 105.974 -1.861 . . . . 72.219999999999999 105.974 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 50.4 ttm -107.03 135.84 47.91 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.908 -0.717 . . . . 71.310000000000002 109.073 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.92 120.78 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 108.867 -0.79 . . . . 73.430000000000007 108.867 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 90.22 -113.23 4.19 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.972 -1.251 . . . . 61.539999999999999 109.972 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 174.76 93.85 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.917 1.287 . . . . 74.319999999999993 107.824 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.6 m -126.24 83.36 63.96 Favored Pre-proline 0 N--CA 1.422 -1.84 0 N-CA-C 109.286 -0.635 . . . . 72.140000000000001 109.286 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -54.48 -38.25 89.87 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.795 2.997 . . . . 72.450000000000003 113.965 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.66 -32.38 67.84 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.403 -0.362 . . . . 65.450000000000003 111.738 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -64.42 -42.67 95.92 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.733 -0.84 . . . . 72.230000000000004 108.733 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.7 tp -68.77 -40.45 79.73 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.389 -0.823 . . . . 74.010000000000005 109.426 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.439 ' HA ' HG12 ' A' ' 211' ' ' VAL . 4.6 tm-20 -62.09 -38.8 90.24 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 124.191 0.996 . . . . 65.430000000000007 110.675 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -72.53 -39.57 67.44 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.349 -0.22 . . . . 71.200000000000003 110.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.5 pp -75.4 -33.05 60.96 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 119.861 -0.735 . . . . 51.32 111.587 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 208' ' ' GLU . 9.5 p -72.55 -27.91 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.094 -0.706 . . . . 74.25 109.094 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -61.96 -49.13 77.33 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.314 -0.995 . . . . 61.0 108.314 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.67 -41.43 86.13 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.874 0.734 . . . . 74.209999999999994 110.89 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.07 -42.27 99.02 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 123.155 0.284 . . . . 63.229999999999997 111.194 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.5 ' HB3' HG11 ' A' ' 223' ' ' VAL . 47.7 p -77.07 -21.65 54.05 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 112.387 0.514 . . . . 70.209999999999994 112.387 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 82.8 mt -84.62 -11.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 122.944 0.497 . . . . 71.450000000000003 110.814 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 218' ' ' PRO . 6.4 tp-100 -64.75 116.31 28.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 107.764 -1.199 . . . . 73.200000000000003 107.764 175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 217' ' ' GLN . 18.6 Cg_endo -57.14 110.56 0.62 Allowed 'Trans proline' 0 C--O 1.247 0.969 0 C-N-CA 122.884 2.389 . . . . 40.32 113.164 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.76 -16.0 2.63 Favored Glycine 0 C--N 1.311 -0.857 0 CA-C-N 114.817 -1.083 . . . . 72.25 112.189 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.23 136.14 25.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 123.183 0.593 . . . . 75.430000000000007 111.43 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 40.4 m-85 -91.58 -56.43 3.12 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.361 -0.978 . . . . 73.430000000000007 108.361 174.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -145.27 164.55 31.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.747 -1.115 . . . . 53.100000000000001 110.262 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 215' ' ' SER . 11.2 p -156.37 148.17 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 O-C-N 123.273 0.358 . . . . 41.329999999999998 110.705 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -159.91 137.51 9.8 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.095 -1.076 . . . . 74.129999999999995 108.095 174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -120.08 160.64 22.44 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.018 -0.673 . . . . 71.420000000000002 109.677 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -143.74 134.84 25.61 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.331 -0.618 . . . . 63.409999999999997 109.331 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -89.12 128.47 35.77 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.25 -1.389 . . . . 54.340000000000003 107.25 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA2' ' OE1' ' A' ' 232' ' ' GLN . . . 111.09 141.37 8.63 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 109.816 -1.313 . . . . 74.120000000000005 109.816 -173.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . 0.268 0.0 OUTLIER -96.15 -46.55 6.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.263 1.209 . . . . 74.519999999999996 114.263 -178.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -77.44 -69.16 0.55 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -178.87 71.71 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 125.278 1.431 . . . . 72.219999999999999 107.168 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.416 ' OE1' ' HA2' ' A' ' 228' ' ' GLY . 50.4 mt-30 -95.13 83.06 3.84 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.987 0.899 . . . . 74.219999999999999 111.546 -174.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -159.86 150.64 19.13 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.045 -1.835 . . . . 70.129999999999995 106.045 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.888 -1.153 . . . . 72.209999999999994 107.888 -179.407 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.504 -0.804 0 CA-C-O 121.793 0.806 . . . . 61.509999999999998 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -125.37 165.87 17.61 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.835 -1.172 . . . . 64.040000000000006 107.835 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' CG ' ' HE ' ' A' ' 179' ' ' ARG . 5.6 p-10 -82.66 70.3 9.61 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.877 1.322 . . . . 53.310000000000002 110.548 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 52.7 1.04 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.206 -1.776 . . . . 61.509999999999998 106.206 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -133.12 -48.73 0.1 OUTLIER Glycine 0 C--N 1.279 -2.605 0 N-CA-C 105.259 -3.136 . . . . 40.329999999999998 105.259 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HG ' HG22 ' A' ' 200' ' ' VAL . 6.4 mp -97.28 137.66 35.95 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 103.289 -2.856 . . . . 62.420000000000002 103.289 169.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -83.05 121.01 77.04 Favored Pre-proline 0 C--N 1.296 -1.721 0 C-N-CA 120.398 -0.521 . . . . 74.030000000000001 110.586 -173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.98 108.06 2.57 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.92 2.413 . . . . 71.400000000000006 113.755 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -95.03 142.21 27.78 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.646 -1.242 . . . . 74.299999999999997 107.646 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.68 115.29 29.59 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.505 -1.665 . . . . 73.349999999999994 106.505 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.35 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.252 -1.018 . . . . 51.020000000000003 108.252 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -101.92 111.85 24.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.722 0.772 . . . . 71.329999999999998 111.546 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 223' ' ' VAL . 1.5 p -111.72 127.78 68.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 114.501 -1.227 . . . . 74.209999999999994 109.836 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.629 HD11 HD22 ' A' ' 190' ' ' ASN . 3.7 tt -101.87 125.13 56.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 108.399 -0.963 . . . . 75.140000000000001 108.399 177.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 31.2 p -147.23 179.39 7.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.668 -0.493 . . . . 70.340000000000003 109.668 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -64.64 146.95 98.17 Favored Pre-proline 0 C--N 1.308 -1.223 0 O-C-N 124.129 0.893 . . . . 73.319999999999993 108.975 172.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.77 -47.09 28.58 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.102 2.535 . . . . 71.519999999999996 114.626 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.24 -13.52 62.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.138 0.494 . . . . 73.120000000000005 110.946 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . . . -84.28 -33.69 23.93 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.098 -0.501 . . . . 61.350000000000001 109.955 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -45.04 -51.19 10.3 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 125.366 1.466 . . . . 62.219999999999999 111.31 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 m -64.78 -35.83 82.34 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 112.55 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 159' ' ' ALA 0.272 28.6 p90 -87.2 -26.74 23.39 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 118.945 -1.102 . . . . 65.310000000000002 112.785 177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 167' ' ' ILE . 75.9 t -69.44 -40.66 80.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 108.584 -0.895 . . . . 71.109999999999999 108.584 178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' O ' HG23 ' A' ' 168' ' ' VAL . 46.6 ttt180 -58.65 -46.53 86.94 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.661 -1.154 . . . . 72.409999999999997 110.695 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.12 98.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.967 -0.561 . . . . 31.25 110.343 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -64.2 -40.92 97.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.691 -0.686 . . . . 64.420000000000002 110.061 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 163' ' ' VAL . 84.9 mt -60.02 -47.67 90.9 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 116.012 -0.54 . . . . 44.399999999999999 110.079 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 164' ' ' ARG . 59.8 t -62.05 -42.03 93.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.882 0.372 . . . . 72.310000000000002 111.122 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -69.47 -41.85 75.62 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.385 -0.371 . . . . 43.140000000000001 111.486 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -83.53 -17.9 40.27 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.998 -1.081 . . . . 74.409999999999997 111.677 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.419 ' OG1' HD11 ' A' ' 178' ' ' LEU . 17.7 p -80.39 -36.06 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 119.435 -0.906 . . . . 65.530000000000001 109.409 173.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -59.25 -45.67 90.55 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.631 -0.713 . . . . 71.409999999999997 109.941 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.1 p -69.08 -32.22 71.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.304 0.483 . . . . 72.129999999999995 112.304 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -97.16 19.03 13.65 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.641 0.978 . . . . 70.439999999999998 113.641 -172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 71.39 12.63 6.63 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 113.568 0.951 . . . . 71.340000000000003 113.568 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 62.6 mt -96.56 127.96 48.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.314 -0.995 . . . . 72.549999999999997 108.314 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.0 m -98.51 147.74 24.46 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.779 -1.193 . . . . 72.310000000000002 107.779 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD11 ' OG1' ' A' ' 171' ' ' THR . 4.6 mp -98.22 135.06 40.39 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 120.067 -0.653 . . . . 75.530000000000001 110.777 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 196' ' ' HIS . 25.0 ttt-85 -80.99 -43.58 19.41 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 105.923 -1.881 . . . . 75.409999999999997 105.923 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.71 168.84 28.51 Favored Glycine 0 N--CA 1.426 -2.024 0 CA-C-N 113.556 -1.656 . . . . 72.310000000000002 109.36 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.7 mt -122.24 114.23 41.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.684 -0.858 . . . . 71.530000000000001 108.684 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -95.32 112.45 24.16 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.273 -1.01 . . . . 74.420000000000002 108.273 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -108.0 129.32 55.13 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 116.309 -0.405 . . . . 72.510000000000005 110.338 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -146.52 152.1 24.27 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-O 119.404 -0.664 . . . . 53.420000000000002 111.466 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.15 151.4 84.99 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.721 2.28 . . . . 54.020000000000003 110.765 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -119.55 -7.16 10.17 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.801 -0.759 . . . . 71.219999999999999 112.972 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.28 -78.1 0.1 Allowed Glycine 0 N--CA 1.418 -2.533 0 C-N-CA 119.74 -1.219 . . . . 43.109999999999999 113.524 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -135.27 -68.05 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.112 0.482 . . . . 73.409999999999997 111.028 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -120.14 36.19 4.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 123.662 1.696 . . . . 74.329999999999998 107.468 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.629 HD22 HD11 ' A' ' 154' ' ' ILE . 2.5 p-10 -139.26 153.53 47.83 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.087 -1.87 . . . . 70.430000000000007 113.03 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.1 mt -143.95 142.81 24.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 CA-C-N 113.27 -1.787 . . . . 73.530000000000001 107.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 91.4 m -114.19 124.11 51.24 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 110.47 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.8 mp -100.46 118.59 36.98 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.216 -1.401 . . . . 71.109999999999999 107.216 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . . . . . . . . . 22.9 m -102.37 106.08 16.79 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.374 -1.343 . . . . 62.229999999999997 107.374 173.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -94.39 110.76 22.51 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.389 -1.338 . . . . 72.099999999999994 107.389 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 179' ' ' ARG . 84.9 m-70 -88.33 110.24 20.62 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.119 -1.808 . . . . 73.349999999999994 106.119 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 176' ' ' ILE . 82.3 mt -110.53 141.09 44.17 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 115.811 -0.631 . . . . 72.120000000000005 110.159 -173.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 146' ' ' LEU . 66.0 mt -112.15 114.46 27.3 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.76 -1.2 . . . . 64.209999999999994 107.76 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 42.4 ttp -123.02 137.4 54.96 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.017 0.437 . . . . 61.140000000000001 110.623 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.453 HG22 ' HG ' ' A' ' 146' ' ' LEU . 46.8 t -73.96 130.91 35.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.392 -0.822 . . . . 73.120000000000005 109.123 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.3 3.25 Favored Glycine 0 C--N 1.299 -1.474 0 C-N-CA 121.153 -0.546 . . . . 73.530000000000001 112.139 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 176.7 96.25 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.898 1.279 . . . . 63.399999999999999 108.478 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.0 m -115.31 81.74 8.64 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.676 -0.861 . . . . 71.140000000000001 108.676 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.5 -22.92 50.99 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.747 2.298 . . . . 74.530000000000001 113.867 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -61.28 -54.03 49.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.926 0.393 . . . . 61.119999999999997 111.946 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -71.34 -25.17 62.29 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.465 -0.494 . . . . 74.010000000000005 111.256 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.0 tp -73.41 -42.45 62.06 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.059 -0.519 . . . . 65.109999999999999 109.712 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -63.3 -40.31 96.99 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.332 -0.395 . . . . 72.329999999999998 111.61 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.34 -41.7 76.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 120.494 -0.482 . . . . 70.219999999999999 110.107 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.4 tp -58.54 -48.13 81.88 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.644 -0.707 . . . . 65.409999999999997 110.905 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.17 -29.99 38.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 119.946 -0.702 . . . . 62.439999999999998 111.346 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.16 -43.93 73.28 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.269 -0.423 . . . . 35.299999999999997 110.547 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.71 -21.25 41.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.397 -0.921 . . . . 75.230000000000004 111.339 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.62 -42.7 70.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.454 -0.943 . . . . 70.310000000000002 108.454 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.549 ' HA ' HG11 ' A' ' 220' ' ' VAL . 18.9 p -76.99 -23.44 52.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 119.6 -0.84 . . . . 41.5 110.977 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 40.7 tp -72.19 -16.51 61.96 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 110.534 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -62.67 113.82 10.2 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 108.032 -1.099 . . . . 75.140000000000001 108.032 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.59 110.08 0.61 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 122.682 2.254 . . . . 72.420000000000002 112.459 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.32 -22.15 2.58 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.385 -1.28 . . . . 61.409999999999997 110.133 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 215' ' ' SER . 97.0 t -85.54 134.94 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 114.754 -0.723 . . . . 72.310000000000002 110.077 176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.11 -50.97 9.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.873 -1.158 . . . . 72.510000000000005 107.873 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.24 168.38 9.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.074 -0.966 . . . . 70.109999999999999 110.057 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 153' ' ' VAL . 8.3 p -144.96 152.69 14.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.755 -0.832 . . . . 75.409999999999997 108.755 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -153.31 133.23 13.23 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.828 -0.804 . . . . 74.209999999999994 108.828 173.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -107.09 152.94 23.35 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-O 121.454 0.645 . . . . 72.230000000000004 110.465 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -137.89 147.24 44.24 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.277 -1.379 . . . . 75.219999999999999 107.277 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.49 179.37 5.95 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.908 0.385 . . . . 74.310000000000002 111.554 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -37.88 112.24 0.18 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 114.909 -1.041 . . . . 64.439999999999998 114.531 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.69 -50.77 61.79 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.434 -0.883 . . . . 70.420000000000002 110.009 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -101.33 -5.13 25.83 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.303 -0.862 . . . . 72.25 109.966 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.36 83.94 1.97 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.074 -0.512 . . . . 74.239999999999995 109.845 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -61.35 109.13 1.06 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.9 -1.046 . . . . 73.239999999999995 109.766 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.61 146.96 46.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.87 -0.605 . . . . 62.32 110.132 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.28 -2.455 0 N-CA-C 108.637 -0.875 . . . . 72.310000000000002 108.637 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.51 -0.561 0 N-CA-C 107.268 -1.382 . . . . 63.439999999999998 107.268 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -128.98 40.33 3.65 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.525 1.155 . . . . 63.210000000000001 108.476 -175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -100.41 58.61 0.97 Allowed 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.419 -1.719 . . . . 74.519999999999996 107.367 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -83.82 33.83 0.49 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.482 -1.236 . . . . 54.009999999999998 113.008 -171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.93 -7.84 37.76 Favored Glycine 0 C--N 1.26 -3.693 0 N-CA-C 108.914 -1.674 . . . . 53.140000000000001 108.914 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.0 mp -137.12 153.8 50.43 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 105.257 -2.127 . . . . 71.349999999999994 105.257 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.73 133.09 22.77 Favored Pre-proline 0 C--N 1.293 -1.866 0 N-CA-C 109.258 -0.645 . . . . 73.409999999999997 109.258 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 31.1 Cg_endo -69.54 117.96 5.39 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 121.703 1.602 . . . . 73.140000000000001 110.696 175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -120.0 137.76 53.89 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.212 -1.403 . . . . 72.329999999999998 107.212 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 18.4 pt20 -118.97 123.32 44.29 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 120.003 -0.679 . . . . 73.310000000000002 110.667 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 47.2 t -107.51 114.17 45.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 106.936 -1.505 . . . . 43.119999999999997 106.936 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 59.0 ttp180 -109.52 115.71 30.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.955 -0.566 . . . . 74.209999999999994 110.143 -174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 p -118.06 126.83 75.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.693 -0.685 . . . . 75.030000000000001 110.836 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 190' ' ' ASN . 4.2 tt -98.35 122.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.438 -0.949 . . . . 73.239999999999995 108.438 177.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 22.3 p -138.49 174.29 10.69 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.104 -0.332 . . . . 73.420000000000002 110.104 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HG3' ' HD2' ' A' ' 157' ' ' PRO . 0.1 OUTLIER -62.07 157.36 52.69 Favored Pre-proline 0 CA--C 1.556 1.21 0 N-CA-C 108.332 -0.988 . . . . 74.239999999999995 108.332 174.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.501 ' HD3' ' C ' ' A' ' 189' ' ' ASP . 36.9 Cg_endo -67.37 -29.08 38.63 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.15 1.233 . . . . 50.549999999999997 112.354 -174.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.95 -7.74 59.63 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.778 -0.646 . . . . 74.340000000000003 110.387 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 162' ' ' TYR . . . -86.34 -33.09 20.67 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.989 -176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -46.01 -44.79 15.43 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 111.597 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.4 m -65.58 -38.75 90.42 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.477 -0.783 . . . . 62.340000000000003 112.569 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 159' ' ' ALA . 18.3 p90 -87.26 -26.76 23.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.368 -0.933 . . . . 75.340000000000003 111.903 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 167' ' ' ILE . 76.0 t -68.79 -39.21 79.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 N-CA-C 109.628 -0.508 . . . . 71.209999999999994 109.628 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.31 -43.08 92.7 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.065 0.546 . . . . 73.030000000000001 110.15 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.33 88.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 72.049999999999997 109.677 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 213' ' ' GLU . 25.3 t60 -65.91 -38.4 88.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.459 -0.791 . . . . 75.0 110.268 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 163' ' ' VAL . 82.4 mt -62.55 -47.43 93.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.547 -0.297 . . . . 73.340000000000003 110.217 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.96 -36.2 76.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.718 -0.793 . . . . 63.420000000000002 111.318 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -69.67 -47.08 64.52 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.552 -0.295 . . . . 74.120000000000005 111.128 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 170' ' ' ARG . 26.0 mmt180 -70.67 -31.22 68.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 120.255 -0.578 . . . . 73.109999999999999 112.227 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.5 p -71.14 -44.0 66.45 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 119.894 -0.723 . . . . 73.120000000000005 110.64 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.6 m -64.48 -35.73 81.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.088 0.471 . . . . 73.439999999999998 110.905 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 10.1 t -79.17 -25.42 42.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 116.012 -0.54 . . . . 61.5 110.652 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 94.8 m-20 -99.2 14.74 28.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.263 0.838 . . . . 64.329999999999998 113.263 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 66.46 24.26 10.4 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 124.312 1.045 . . . . 74.450000000000003 111.891 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.479 HG12 ' HG2' ' A' ' 199' ' ' MET . 32.1 mt -102.96 129.12 55.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.664 -1.235 . . . . 70.120000000000005 107.664 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 49.2 m -96.07 145.26 25.62 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.673 -0.862 . . . . 73.310000000000002 108.673 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.3 mt -85.8 142.7 28.75 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.958 -0.756 . . . . 74.400000000000006 108.958 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -54.49 2.78 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 104.476 -2.416 . . . . 74.400000000000006 104.476 172.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.0 159.22 24.75 Favored Glycine 0 CA--C 1.49 -1.499 0 CA-C-N 114.892 -1.049 . . . . 65.439999999999998 110.643 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 65.1 mt -125.19 116.69 47.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 109.4 -0.593 . . . . 73.519999999999996 109.4 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.409 ' HB2' ' CG2' ' A' ' 194' ' ' THR . 87.0 mtt180 -101.22 117.09 34.29 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.357 -0.979 . . . . 74.209999999999994 108.357 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -112.22 132.15 55.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.062 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.62 137.89 7.28 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.192 -1.004 . . . . 55.539999999999999 112.617 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.93 151.0 78.47 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 123.209 2.606 . . . . 74.420000000000002 110.795 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -111.58 2.6 17.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.219 0.452 . . . . 72.219999999999999 112.219 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 117.28 -81.21 0.31 Allowed Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 121.079 -0.581 . . . . 53.130000000000003 113.761 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.14 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.994 1.718 . . . . 70.200000000000003 112.45 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.501 ' C ' ' HD3' ' A' ' 157' ' ' PRO 0.268 6.0 p-10 -169.37 66.0 0.06 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 124.22 1.962 . . . . 63.420000000000002 107.741 174.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.582 HD22 HD11 ' A' ' 154' ' ' ILE . 0.7 OUTLIER -153.31 148.74 27.12 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 111.514 -2.585 . . . . 63.219999999999999 111.988 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.9 mt -138.82 130.52 36.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.227 0 CA-C-N 113.475 -1.693 . . . . 61.130000000000003 106.798 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 6.3 m -108.97 128.17 54.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.09 -0.707 . . . . 65.430000000000007 109.09 -178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 152' ' ' ARG . 5.2 mp -107.7 119.48 39.54 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.509 -0.923 . . . . 75.319999999999993 108.509 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 182' ' ' ARG . 14.7 t -102.03 107.49 18.63 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 107.437 -1.32 . . . . 63.43 107.437 173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 150' ' ' GLN . . . -95.07 107.88 19.95 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.077 -0.965 . . . . 64.209999999999994 109.851 -176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -84.71 119.88 25.77 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.892 -1.892 . . . . 74.400000000000006 105.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 35.7 mt -120.5 160.55 22.93 Favored 'General case' 0 C--N 1.266 -3.052 0 C-N-CA 123.645 0.778 . . . . 63.509999999999998 109.064 -174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.18 116.03 24.16 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 105.35 -2.093 . . . . 73.230000000000004 105.35 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.479 ' HG2' HG12 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -116.44 143.56 45.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.704 -0.85 . . . . 54.229999999999997 108.704 -175.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 23.2 t -69.7 114.52 7.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 C-N-CA 123.259 0.624 . . . . 74.299999999999997 110.369 -174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 53.97 -115.7 5.34 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.522 -0.763 . . . . 33.310000000000002 111.353 -173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -153.88 94.93 1.81 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 121.789 0.804 . . . . 72.540000000000006 109.588 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 39.1 m -118.49 84.92 25.0 Favored Pre-proline 0 N--CA 1.41 -2.463 0 N-CA-C 107.564 -1.273 . . . . 74.420000000000002 107.564 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -59.65 -28.76 88.15 Favored 'Trans proline' 0 C--O 1.202 -1.284 0 C-N-CA 123.677 2.918 . . . . 63.399999999999999 114.247 -172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -56.94 -49.29 76.11 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 123.097 0.248 . . . . 54.299999999999997 111.419 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 174' ' ' ASN . 56.7 mtmt -74.31 -22.07 59.43 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.14 0.495 . . . . 75.439999999999998 111.756 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 210' ' ' LEU . 58.5 tp -82.74 -42.51 17.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.045 -0.525 . . . . 52.439999999999998 109.927 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.9 -25.64 56.27 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 116.258 -0.428 . . . . 63.409999999999997 111.233 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.87 -31.79 66.82 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 109.874 -0.417 . . . . 70.310000000000002 109.874 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 207' ' ' LEU . 26.3 tp -61.49 -50.15 73.9 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 108.185 -1.043 . . . . 75.040000000000006 108.185 171.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 207' ' ' LEU . 79.7 t -57.99 -39.16 70.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.031 -0.986 . . . . 70.329999999999998 110.763 177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.14 82.75 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.663 0.385 . . . . 74.400000000000006 111.68 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 166' ' ' HIS . 66.6 mm-40 -72.28 -39.98 67.94 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 122.246 -0.284 . . . . 74.200000000000003 110.885 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.432 ' O ' HG21 ' A' ' 220' ' ' VAL . 94.8 mt -67.67 -42.6 81.9 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.693 0.621 . . . . 71.230000000000004 111.235 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.506 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 12.8 p -69.83 -34.15 73.26 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.223 0.535 . . . . 73.510000000000005 111.767 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 mp -90.88 -0.37 57.71 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 112.748 0.647 . . . . 73.329999999999998 112.748 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.78 119.49 69.58 Favored Pre-proline 0 N--CA 1.439 -1.025 0 N-CA-C 109.215 -0.661 . . . . 71.349999999999994 109.215 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.82 111.87 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.285 2.657 . . . . 73.329999999999998 112.304 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.81 -8.78 6.83 Favored Glycine 0 C--N 1.308 -1.015 0 CA-C-N 115.533 -0.758 . . . . 61.439999999999998 112.61 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 214' ' ' LEU . 74.8 t -92.17 139.36 18.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.612 0.765 . . . . 65.409999999999997 112.682 -178.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -84.62 -53.24 5.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.452 -0.944 . . . . 63.210000000000001 108.452 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -165.4 168.59 16.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.153 -0.931 . . . . 62.530000000000001 110.431 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 215' ' ' SER . 7.5 p -151.49 146.47 15.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.582 -0.525 . . . . 74.239999999999995 109.582 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -143.3 152.43 41.65 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.289 -1.004 . . . . 73.430000000000007 108.289 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -127.33 147.22 50.25 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.212 0.53 . . . . 75.030000000000001 110.676 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -135.09 138.78 44.15 Favored 'General case' 0 C--N 1.272 -2.764 0 CA-C-N 114.641 -1.163 . . . . 74.349999999999994 109.738 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -87.36 129.63 34.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.27 -1.011 . . . . 63.020000000000003 108.27 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 114.17 161.18 13.81 Favored Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.896 -1.282 . . . . 72.409999999999997 109.896 -173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.1 -10.79 17.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.254 0.464 . . . . 74.409999999999997 112.254 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -78.1 111.38 13.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.002 -0.74 . . . . 73.439999999999998 109.002 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.03 38.49 0.76 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.715 0.769 . . . . 64.420000000000002 111.354 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -156.72 115.12 3.3 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 125.667 1.587 . . . . 73.140000000000001 108.928 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -167.09 -48.29 0.02 OUTLIER 'General case' 0 CA--C 1.476 -1.891 0 CA-C-O 123.488 1.613 . . . . 74.319999999999993 109.505 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 1 C--N 1.23 -4.621 0 CA-C-N 111.366 -2.652 . . . . 72.439999999999998 107.196 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.506 -0.724 0 N-CA-C 108.274 -1.01 . . . . 74.319999999999993 108.274 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -106.75 130.38 54.48 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.008 -1.108 . . . . 70.209999999999994 108.008 176.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.66 31.53 4.37 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 122.509 1.147 . . . . 72.010000000000005 110.68 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.64 39.79 1.04 Allowed 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 113.785 -1.552 . . . . 73.140000000000001 111.16 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -123.23 -5.28 8.04 Favored Glycine 0 C--N 1.279 -2.586 0 CA-C-N 112.921 -1.945 . . . . 62.450000000000003 108.929 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.59 150.77 45.58 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.427 -2.064 . . . . 63.210000000000001 105.427 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 201' ' ' GLY . 27.1 mm-40 -88.49 117.68 68.61 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.131 -0.628 . . . . 70.5 111.621 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 11.3 Cg_exo -70.78 119.48 6.36 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 123.11 2.54 . . . . 63.439999999999998 111.086 176.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -117.06 146.64 42.97 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 114.75 -1.114 . . . . 72.430000000000007 109.159 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -125.92 115.25 19.64 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.569 -1.641 . . . . 74.299999999999997 106.569 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.95 122.09 63.07 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 109.353 -0.61 . . . . 63.219999999999999 109.353 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -107.69 112.62 25.4 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.214 -0.661 . . . . 75.140000000000001 109.214 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.38 122.72 70.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.973 -1.012 . . . . 74.230000000000004 109.636 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 192' ' ' THR . 10.2 tt -100.52 115.85 42.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 109.031 -0.729 . . . . 60.119999999999997 109.031 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 25.3 p -136.45 167.07 22.05 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.52 -0.548 . . . . 54.520000000000003 109.52 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -63.96 144.81 98.09 Favored Pre-proline 0 C--N 1.294 -1.84 0 N-CA-C 109.452 -0.573 . . . . 62.140000000000001 109.452 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -23.84 72.25 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.818 2.345 . . . . 75.239999999999995 112.671 -173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -81.38 -5.37 57.8 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.609 -0.723 . . . . 75.439999999999998 110.89 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.35 -34.51 9.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.032 -0.729 . . . . 72.439999999999998 109.032 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -46.56 -36.45 6.83 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.716 1.207 . . . . 73.219999999999999 111.284 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p -58.95 -53.46 58.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.84 -0.618 . . . . 41.149999999999999 112.301 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -87.63 -23.49 24.24 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 119.648 -0.821 . . . . 63.520000000000003 112.083 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 167' ' ' ILE . 54.3 t -69.88 -39.67 77.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 110.397 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 168' ' ' VAL . 36.1 ttp-105 -62.06 -44.69 96.13 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.814 -0.439 . . . . 63.030000000000001 109.814 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.22 93.43 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.719 -0.673 . . . . 63.049999999999997 110.359 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -64.1 -44.61 91.79 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.796 -0.638 . . . . 73.409999999999997 109.538 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 163' ' ' VAL . 78.7 mt -56.53 -48.02 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 O-C-N 123.313 0.383 . . . . 75.239999999999995 110.335 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 164' ' ' ARG . 48.3 t -63.57 -41.09 91.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 O-C-N 123.31 0.381 . . . . 73.540000000000006 111.295 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.05 -38.39 57.18 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.138 0.494 . . . . 74.400000000000006 110.412 -177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -73.74 -34.07 64.6 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 116.061 -0.518 . . . . 73.129999999999995 110.679 -175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 29.1 p -75.38 -41.2 56.88 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 119.048 -1.061 . . . . 62.310000000000002 110.798 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 22.0 p -66.21 -31.86 72.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.811 -0.356 . . . . 52.140000000000001 111.539 -176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.5 t -75.83 -29.79 58.76 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.134 -0.484 . . . . 65.120000000000005 110.743 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -100.57 36.93 1.79 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.894 1.072 . . . . 64.299999999999997 113.894 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 71.96 15.44 5.65 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 123.875 0.87 . . . . 72.209999999999994 112.221 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 197' ' ' LEU . 52.6 mt -107.7 134.98 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 121.524 0.678 . . . . 71.200000000000003 109.835 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.6 m -107.33 147.37 30.38 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.178 -1.786 . . . . 75.030000000000001 106.178 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.27 142.75 26.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.816 -0.754 . . . . 75.219999999999999 111.07 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.4 ' HD3' HD11 ' A' ' 198' ' ' LEU . 16.6 tpt180 -100.6 -36.16 9.25 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.595 -0.891 . . . . 71.329999999999998 108.595 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 165.56 166.55 24.75 Favored Glycine 0 CA--C 1.496 -1.105 0 N-CA-C 110.644 -0.983 . . . . 75.409999999999997 110.644 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.8 mt -131.73 111.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 117.066 0.433 . . . . 70.239999999999995 110.105 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.466 ' HB3' ' HB ' ' A' ' 194' ' ' THR . 48.0 ttt180 -95.12 113.18 24.84 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.227 -1.027 . . . . 75.400000000000006 108.227 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 m -105.62 122.47 46.1 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.533 -0.543 . . . . 71.129999999999995 109.533 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.55 121.12 2.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.063 -1.065 . . . . 44.119999999999997 113.579 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 191' ' ' ILE . 37.3 Cg_endo -72.72 137.72 27.83 Favored 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 122.564 2.176 . . . . 74.340000000000003 111.111 175.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.557 ' HB3' ' ND2' ' A' ' 190' ' ' ASN . . . -94.02 -6.08 46.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.086 -0.645 . . . . 61.420000000000002 112.332 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 122.23 -65.64 0.49 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.625 -0.798 . . . . 50.340000000000003 114.971 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.88 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.035 1.124 . . . . 74.209999999999994 114.035 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -161.26 55.69 0.28 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.201 -1.777 . . . . 73.120000000000005 106.201 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -160.72 145.3 14.08 Favored 'General case' 0 CA--C 1.471 -2.088 0 CA-C-N 113.981 -1.463 . . . . 72.0 113.885 -175.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 185' ' ' PRO . 5.5 mt -134.7 130.69 53.22 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 112.906 -1.952 . . . . 74.530000000000001 107.624 -177.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 154' ' ' ILE . 25.9 m -99.49 116.99 32.9 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.021 -0.733 . . . . 61.43 109.021 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.44 118.21 31.76 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.806 -1.183 . . . . 73.230000000000004 107.806 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 182' ' ' ARG . 61.5 m -99.72 105.09 16.86 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 106.63 -1.618 . . . . 71.519999999999996 106.63 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -98.54 116.59 31.1 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 109.381 -0.6 . . . . 72.310000000000002 109.381 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -89.71 118.31 29.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.291 -2.114 . . . . 73.319999999999993 105.291 177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 73.9 mt -125.04 159.49 31.21 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.719 -0.475 . . . . 72.510000000000005 109.719 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.4 HD11 ' HD3' ' A' ' 179' ' ' ARG . 66.0 mt -134.3 118.33 17.4 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.094 -1.447 . . . . 73.019999999999996 107.094 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 207' ' ' LEU . 10.9 ptp -107.62 152.27 24.51 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.034 -1.466 . . . . 74.420000000000002 109.771 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.2 123.53 22.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . . . 77.17 -120.52 5.63 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 120.509 -0.853 . . . . 73.209999999999994 111.169 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -173.94 91.76 0.08 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 124.137 0.975 . . . . 73.439999999999998 108.877 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 m -139.65 86.02 14.28 Favored Pre-proline 0 C--N 1.289 -2.04 0 N-CA-C 108.997 -0.742 . . . . 43.200000000000003 108.997 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -64.42 -11.02 26.31 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.685 2.256 . . . . 54.039999999999999 114.262 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.52 89.3 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 120.677 0.275 . . . . 53.439999999999998 111.426 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.2 -33.84 73.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.064 0.459 . . . . 72.540000000000006 110.547 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' A' ' 199' ' ' MET . 53.8 tp -65.3 -47.84 75.18 Favored 'General case' 0 C--O 1.21 -0.999 0 CA-C-N 115.582 -0.735 . . . . 52.439999999999998 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -54.82 -46.71 74.59 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.553 1.141 . . . . 44.420000000000002 110.169 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -65.78 -38.98 90.5 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.009 -0.996 . . . . 70.030000000000001 111.054 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -79.5 -28.79 41.43 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 118.972 -1.091 . . . . 54.32 111.779 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 74.5 t -68.44 -35.48 70.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 109.97 -0.382 . . . . 73.430000000000007 109.97 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.09 -43.71 81.84 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 120.879 0.371 . . . . 74.150000000000006 110.034 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.71 -36.78 78.88 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.906 -0.588 . . . . 73.0 110.899 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.13 -39.32 86.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.838 -0.431 . . . . 63.130000000000003 109.838 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 15.8 p -78.5 -20.16 51.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.383 0.611 . . . . 75.239999999999995 111.625 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.6 tt -74.83 -22.44 58.7 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.469 -0.787 . . . . 73.200000000000003 110.48 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.03 135.14 73.98 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 110.403 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.84 109.62 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.16 2.573 . . . . 64.109999999999999 114.089 -173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.48 -10.68 5.53 Favored Glycine 0 C--N 1.297 -1.636 0 CA-C-N 114.816 -1.084 . . . . 35.520000000000003 112.974 175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.72 131.1 35.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.832 0.348 . . . . 71.450000000000003 111.048 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 190' ' ' ASN . 54.3 m-85 -84.77 -53.85 5.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.385 -0.969 . . . . 74.519999999999996 108.385 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.99 167.21 30.54 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.97 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.8 143.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.201 -0.666 . . . . 72.420000000000002 109.201 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -149.66 139.94 22.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.047 -1.094 . . . . 75.019999999999996 108.047 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' TRP . . . . . . . . . . . . . 55.1 p-90 -128.73 157.83 40.31 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.957 -0.697 . . . . 74.200000000000003 112.42 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -132.34 154.25 49.93 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.424 -1.262 . . . . 74.120000000000005 110.219 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -111.82 136.27 51.34 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.656 -0.702 . . . . 71.439999999999998 109.273 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 123.82 156.42 9.49 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 116.101 -0.5 . . . . 71.319999999999993 112.061 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -63.94 -44.58 92.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.898 0.856 . . . . 64.230000000000004 108.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -115.9 12.93 15.91 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.557 -1.201 . . . . 75.340000000000003 108.643 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 57.89 62.57 2.03 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.752 -1.113 . . . . 74.230000000000004 110.85 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.93 115.0 21.6 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.81 -1.086 . . . . 73.409999999999997 109.961 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.95 139.96 15.37 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.246 -1.761 . . . . 65.129999999999995 106.246 177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--N 1.288 -2.067 0 N-CA-C 108.816 -0.809 . . . . 73.310000000000002 108.816 -176.728 . . . . . . . . 0 0 . 1 stop_ save_